Utah State University

DigitalCommons@USU
All Graduate Theses and Dissertations

Graduate Studies

5-2015

In Vitro, Non-Invasive Imaging and Detection of Single Living
Mammalian Cells Interacting with Bio-Nano-Interfaces
Qifei Li
Utah State University

Follow this and additional works at: https://digitalcommons.usu.edu/etd
Part of the Biological Engineering Commons

Recommended Citation
Li, Qifei, "In Vitro, Non-Invasive Imaging and Detection of Single Living Mammalian Cells Interacting with
Bio-Nano-Interfaces" (2015). All Graduate Theses and Dissertations. 4520.
https://digitalcommons.usu.edu/etd/4520

This Dissertation is brought to you for free and open
access by the Graduate Studies at
DigitalCommons@USU. It has been accepted for
inclusion in All Graduate Theses and Dissertations by an
authorized administrator of DigitalCommons@USU. For
more information, please contact
digitalcommons@usu.edu.

IN VITRO, NON-INVASIVE IMAGING AND DETECTION OF SINGLE LIVING
MAMMALIAN CELLS INTERACTING WITH BIO-NANO-INTERFACES
by
Qifei Li
A dissertation submitted in partial fulfillment
of the requirements for the degree
of
DOCTOR OF PHILOSOPHY
in
Biological Engineering

Approved:

______________________
Anhong Zhou
Major Professor

____________________
S. Clay Isom
Committee Member

______________________
Xiaojun Qi
Committee Member

____________________
Charles D. Miller
Committee Member

______________________
Randy Lewis
Committee Member

____________________
Mark R. McLellan
Vice President for Research and
Dean of the School of Graduate Studies

UTAH STATE UNIVERSITY
Logan, Utah

2015

ii

Copyright © Qifei Li 2015
All Rights Reserved

iii

ABSTRACT

In vitro, Non-invasive Imaging and Detection of Single Living Mammalian Cells
Interacting with Bio-nano-interfaces
by
Qifei Li, Doctor of Philosophy
Utah State University, 2015

Major Professor: Dr. Anhong Zhou
Department: Biological Engineering
Understanding of bio-nano-interfaces of living mammalian cells will benefit the

identification of cellular alterations (e.g. nucleic acids, amino acids, biomechanics, etc.) due to
external stimuli, the design of biomaterials (e.g. nanoparticles, nanotubes) and the investigation
of the interaction between cells and bio-nano-interfaces (e.g. cell differentiation on 3D
nanostructured materials). Analytical techniques can be applied to evaluate the chemical,
physical, and mechanical properties of mammalian cells when exposed to such bio-nano-

interfaces. In this study, non-invasive advanced spectroscopy techniques including atomic force
microscopy (AFM) and Raman microscopy (RM), in conjunction with traditional biological
methods are utilized to elucidate specific characteristic information for biological samples and
how these property changes reflect the interaction with external stimuli.

The focus of this dissertation is on the biophysical, biochemical and cytotoxic
detection of mammalian cells interacting with bio-nano-interfaces, and this dissertation can
be classified into three topics: biomechanics/cellular biopolymers measurement, biointerfaces and nano-interfaces studies.
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For the topic of biomechanics/cellular biopolymers measurement, cellular biophysical
and biomechanical properties could be used as differentiation markers to classify cellular
differentiation. For the bio-interfaces part, it was observed that BRMS1 expression changed
cellular biochemical and biomechanical properties, and the expressions of reactive oxidative
species (ROS), apoptosis and cell viability of five types of cells displayed similar patterns
over doxorubicin (DOX) incubation time. Secondly, A549 cells were treated with diesel
exhaust particles (DEP) and resveratrol (RES) to study the effect of RES on the DEP-induced
cells, and it was found that RES can alleviate DEP intervention on cellular structure and
increase DEP-induced biomechanical and inflammatory changes. For the nano-interfaces
topic, first we synthesized a hybrid nanoparticle with the multimodal properties of
fluorescence imaging, Surface-enhanced Raman spectroscopy (SERS) detection and
photothermal therapy (PTT) for single living cell analysis of epidermal growth factor
receptor (EGFR) and specifically killed cancer cells with high EGFR expression.
Additionally, to increase surface area, light-heat conversion efficiency and biocompatibility,
we developed a silica coated nanoparticle conjugated with anti-human epidermal growth
factor receptor 2 (HER2) antibody. Finally, three-dimensional TiO2 nanotubes with Au
nanoparticles coating were synthesized and used to study trophoblast-derived stem-like cells
growth on such 3D nanostructures.
(251 pages)
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PUBLIC ABSTRACT

In vitro, Non-invasive Imaging and Detection of Single Living Mammalian Cells
Interacting with Bio-nano-interfaces
by
Qifei Li
Study of bio-nano-interfaces of living mammalian cells will help the identification of

cellular alterations (e.g. nucleic acids, amino acids, biomechanics, etc.) due to external stimuli,
the design of biomaterials (e.g. nanoparticles, nanotubes) and the investigation on the interaction
between cells and bio-nano-interfaces (e.g. cell differentiation on 3D nanostructured materials).
The chemical, physical, and mechanical changes of mammalian cells interacting with
biomaterials can be investigated by analytical techniques. In this dissertation, cellular responses
and property changes are evaluated by non-invasive spectroscopic technique, Raman microscopy
(RM), and atomic force microscopy (AFM) combined with traditional biological methods.

This dissertation includes the biophysical, biochemical and cytotoxic measurement of
cells interacting with bio-nano-interfaces, and this work can be divided into three topics:
biomechanics/cellular biopolymers measurement, bio-interfaces and nano-interfaces studies.
Cellular biomechanical, biochemical and genetic changes were detected in the topic
of biomechanics/cellular biopolymers measurement, and cellular differentiation can be
identified by cellular biophysical and biochemical properties. For the bio-interfaces, cellular
biochemical and biomechanical properties were affected by BRMS1 expression (a metastasis
suppressor) through the study of five metastatic and non-metastatic cancer cells. However,
both metastatic and non-metastatic cells exhibited similar patterns of reactive oxygen species
(ROS), apoptosis expression and cell viability changes over doxorubicin (DOX) incubation
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time. Then A549 cells were incubated with diesel exhaust particles (DEP) and an antioxidant
resveratrol (RES) to study the effect from DEP and RES, and it was found that RES can
decrease DEP-induced destructive effect on cellular structure and enhance DEP-induced
biomechanical and inflammatory changes. For the nano-interfaces, hybrid nanoparticles were
first developed with the function of fluorescence imaging, Surface-enhanced Raman
spectroscopy (SERS) detection and photothermal therapy (PTT). These nanoparticles were
applied for single living cells analysis of epidermal growth factor receptor (EGFR)
distribution and cancer therapy with high EGFR expression. Additionally, silica coated
nanoparticles conjugated with anti-human epidermal growth factor receptor 2 (HER2) were
synthesized to increase surface area, light-heat conversion efficiency and biocompatibility.
Cancer cells with high-HER2 expression were killed upon an 808 nm laser irradiation.
Moreover, trophoblast-derived stem-like cells were cultured on three-dimensional TiO2
nanotubes with Au to study cell viability, morphology and biochemical changes.
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CHAPTER 1
INTRODUCTION
1.1 OVERVIEW
In biological systems the cell is the basic unit of life, and an understanding of cellular
behavior is crucial for the area of bioengineering. Environmental stimuli (e.g. chemical and
physical factors) affect cellular functions, and elucidation of cellular responses to
environmental stimuli will help understand and discriminate cellular changes. Cellular
biomechanics and biocomposition are two important parameters to reflect cellular responses
to external stimuli or changes. Biomechanics plays an important role in cellular
morphogenesis, focal adhesion, motility, and metastasis [1-4]. Cellular biomechanical
properties including cell stiffness and cell adhesion directly reflect cell composition, affect or
can be affected by internal structure (cytoskeleton, organelles, etc.) and external interactions
(cell-cell and/or cell-ECM). Alterations in the mechanical properties of cells, therefore, can
be used to detect changes in their cellular composition that occur during differentiation, aging,
and other changes in physiological status [5, 6]. Not only do alterations in the mechanical
properties of cells reflect their status but also the mechanical properties of their surroundings,
extracellular matrix, and neighboring cells can directly induce changes in cell status [7].
Therefore, there has been an increasing interest in determining mechanical properties of cells.
A number of techniques have been used to measure the biomechanics of cells, such as
the atomic force microscope (AFM) indentation, capillary aspiration, twisted bead and
unconfined creep compression method [8]. Among these methods, AFM has proven itself to
be a valuable tool for high resolution imaging of surface topography and for quantitative
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measurement of the mechanical properties of cells without invasive labels. AFM is a
scanning analytical technique that is based on the movement of a sharp tip scanning over the
surface of a biological sample while measuring the near-field physical interactions between
the sample and tip by a laser detector [9, 10]. AFM is able to image the topographic features
of cytoskeleton, cellular microenvironments, and quantitatively measure cellular mechanical
properties at nanometer scales in situ [11]. Therefore, AFM was applied to evaluate the
biophysical properties of mammalian cells under the near-physiological conditions.
The biochemical information of cells is also important in biological systems.
Biochemical processes generate the complexity of living organisms by controlling the
biochemical signals and chemical energy through metabolism. To understand the whole
organism, it is necessary to study how biochemical molecules that occur within living cells
change. Techniques like Raman microspectroscopy (RM), infrared (IR) absorption
spectroscopy and fluorescence microscopy can be applied to detect the biochemical
information of organisms. Compared with other methods, RM is the prevalent approach to
probe the relationship between structure and function of biocomponent (e.g. nucleic acids,
proteins, pharmacologically relevant molecules, etc.) in the response to external changes [12]
because it is noninvasive, nondestructive and free from water interference as well as
maintaining chemical selectivity [13]. Based on inelastic scattering of the interaction between
laser light and molecular vibrations or other excitations, RM is a spectroscopic technique that
can identify chemical compositions though characteristic fingerprints in biological systems
[14]. RM permits biochemistry assessment of single living cells in situ in a simple and rapid
way, requiring minimal sample preparation and small sample volume, and it has been applied
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in diagnostic, toxicological and biomedical areas [15]. Clearly, RM is suitable to monitor the
biochemical changes in living mammalian cells.
Previously, our group has characterized the biomechanical and biochemical
alterations of mammalian cells and their corresponding responses to external stimuli by AFM,
RM and other approaches (e.g. qPCR, immunostaining, flow cytometry). Wu et al.
demonstrated the potential to apply AFM and RM techniques for in situ biophysical and
biochemical measurements of breast cancer cells with or without Breast Cancer Metastasis
Suppressor 1 (BRMS1) expression [16]. Tang et al. evaluated the effects from short time
exposure of diesel exhaust particles on normal epithelial cells and cancerous epithelial cells
by AFM, RM and multiplex ELISA [17]. By utilizing AFM and RM, Xiao et al. investigated
the potential relationship between biomechanics and cellular biopolymers of human lung
epithelial cells upon anti-cancer drug treatments [18]. At the single cell level, Xiao et al. also
studied the localization, spatial distribution and endocytosis of epidermal growth factor
receptor (EGFR) by surface-enhanced Raman spectroscopy (SERS) [19]. Additionally, the
differentiation of trophoblast-derived stem-like cells was successfully identified by
measuring cellular biophysical and biochemical alterations with the help of AFM and RM
[20]. These above works conducted in our research laboratory have demonstrated the
applications of AFM and RM as noninvasive technologies to study the responses of
mammalian cells to external stimuli.
The focus of this dissertation is to non-invasively image and detect single living
mammalian cells interacting with bio-nano-interfaces in vitro, and this topic is classified into
three categories from biomechanics/cellular biopolymers detection to bio-interfaces and
nano-interfaces studies. First, the biophysical and biochemical properties between
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undifferentiated cells and differentiated cells are distinguished by AFM and RM, respectively,
and these biophysical and biochemical differences could be applied as “biomarkers” for
identification purpose. Secondly, mammalian cells were reacted with bio-interfaces (e.g.
anticancer drug, diesel exhaust particles, and antioxidant) to study cellular responses and
changes.

Thirdly,

multifunctional

hybrid

nanoparticles

(CaMoO4:Eu@GNR

and

CaMoO4:Eu@SiO2-GNR-PB) and titanium nanotube were synthesized and characterized.
Mammalian cells were exposed to nano-interfaces to evaluate how these nano-interfaces
affect cellular responses. More details of this dissertation will be introduced in the following
sections.
1.2 SIGNIFICANCE
The impact of this work presented in this dissertation could have profound
implications. Detection of mammalian cells under different stimuli by traditional biological
methods (qPCR, immunostaining, flow cytometry, etc.) requires the cell sample destruction
(e.g., cell fixation in immunostaining), while AFM and RM applied in this study could
measure in situ the cellular biophysical properties and biocomposition at single cell level
under cellular physiological condition.
Recently biomechanical and biochemical properties of single cells were found to be
akin to gene and protein detection. We are able to identify differences in cellular
subpopulations, disease state, and cellular responses to drugs based on the biomechanical and
biochemical properties of single cells [21-27]. Cellular behavior depends on the organization
of subcellular structures and cellular composition, and detection of these changes by AFM
and RM could facilitate the understanding of cellular structure-function relationship,
reflecting cellular changes without modification.
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The applications of AFM and RM could benefit the areas of disease study,
exploration of new biomaterials, cellular differentiation and regenerative medicine.
Combined with traditional biological methods, the new non-invasive techniques can provide
additional information and new aspects to understand the changes of biological systems.
1.3 LITERATURE REVIEW
1.3.1 Techniques
1.3.1.1 Atomic force microscopy (AFM)
AFM is a high-resolution scanning probe first developed in 1986 by Binnig, et al.
[28]. It can detect sample topography by the local attractive and repulsive forces interaction
between the tip (mounted on silicon cantilever) and the sample in physiological conditions
[11, 29, 30]. AFM can also measure the force-distance curves of a sample to characterize its
biomechanical parameters by fitting theoretic model (e.g., the Hertz equation [31]). AFM is
able to detect the surface topography of non-conductive samples at the nanoscale, and AFM
can be operated in air, vacuum and liquid. Hence, AFM appeared suitable for biological
samples.
Different from other light microscopy techniques, AFM requires a sharp, tiny probe
that approaches the specimen surface to measure the physical parameters while the sensor is
scanned line by line over the sample surface. To keep the probe signal constant, the feedback
from the sensor maintains the strength of the interaction (current, force or amplitude)
constant [32]. There are three AFM modes during operation: contact, non-contact and
tapping mode (intermittent contact mode). In contact mode, the tip contacts with the sample
surface softly, and Silicon Nitride tips are normally applied for contact mode. The tip either
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scans at a constant force (force fixed) or a constant small height (height fixed) above the
surface, and the motion of the scanner in z-direction is detected. “Atomic resolution” images
can be obtained in contact mode. For contact mode imaging, the cantilever should be soft
enough to be deflected by small forces and has a high enough resonant frequency to prevent
vibrational instabilities. Under the non-contact mode the tips are silicon probes. The
cantilever should have high spring constant (20-100 N/m) to prevent the tip from sticking to
the specimen surface at small amplitudes. The tip-sample interaction can be ignored and the
probe operates within the attractive force region. This mode allows scanning without
affecting the shape of the specimen. In tapping or intermittent contact mode the probe
operates in the repulsive force region, and the cantilever is oscillated close to its resonance
frequency. The specimen surface is touched for a short time to minimize potential sample
damage.
AFM has some advantages compared to other imaging approaches such as
transmission electron microscopy and scanning electron microscopy. AFM possesses a high
signal-to-noise ratio that does not need signal averaging for contrast enhancement [33]. In
addition, AFM does not require quick-freezing, fixing and staining of the samples. The major
difference of AFM is that it has no lens and beam irradiation, so it does not suffer from a
limitation of space resolution. AFM measures the height of sample surface as a function of
position generating a quantitative 3-dimensional image of the specimen surface, and AFM
can accurately measure the lateral and vertical displacement by a computer-controlled piezo
scanner that allows precise detection of distances and heights [34]. The resolution for a light
microscope and an electron microscopy is limited by the wavelength of visible light and
electrons respectively, but the resolution for AFM is restricted by the probe sharpness. Even
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though AFM and electron microscopy normally have similar range of resolution, AFM
usually provides a smaller resolution than obtained by electron microscopy [34]. One
obvious advantage is that AFM can image samples in fluid condition, so biological samples
can be measured in near physiological conditions. Additionally, AFM can image real-time
processes of a biological sample.
AFM-based detection of mechanical properties of samples is a novel application in
the biological field that potentially allows for a better understanding of biomechanics at
different levels from the bio-interfaces of cellular structural organization to the nanointerfaces of complex interaction. Since the introduction of AFM, it has been used to
distinguish the differences in cellular subpopulations, cellular proliferation and
differentiation [35-37]. AFM is able to image and measure cellular biophysical properties at
single living cell level is important in the research of life sciences. Of particular significance
is the potential use in clinical applications, for example, for early cancer diagnosis before
diseases progress [38]. AFM is applied here to characterize cellular biomechanics and
topography. The applications of AFM have expanded as it has been used across multiple
research areas [39].
1.3.1.2 Raman spectroscopy (RM)
RM is a spectroscopic technique first developed in 1928 by C.V. Raman [40]. Based
on vibrational modes of molecules, RM can obtain biochemical information from single cells
without other invasive steps, providing spectral information about the molecular
compositions, structures, and quantities of cellular biopolymers with a minimal background
signal from water [41]. The detected Raman spectral frequencies in wavenumber are
proportional to vibrational energies of molecular polarizability [42].
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The photons can either be absorbed or scattered when incident light strikes molecules.
Infrared spectroscopy (IR) and ultraviolet-visible spectroscopy (UV-Vis spectroscopy) are
two typical absorption spectroscopic approaches that are based on photon absorption
phenomenon and they can measure the radiation loss as a function of frequency. RM is a
spectroscopic technique that is based on photon scattering phenomenon with energy transfer.
If there is no energy change of these photons, this scattering phenomenon is called elastic
scattering (Rayleigh scattering). If there is a net energy transfer, it is called inelastic
scattering (Raman scattering), as shown in Figure 1.1. Raman scattering is a low-probability
case, only occurring among one per 106-108 scattered photons [43]. There are two types of
Raman scattering: Stokes and anti-Stokes. If the molecule is excited from the ground state ν0
to a higher state ν1, it is called Stokes scattering; if the molecule drops from a higher
vibrational state down to a lower one, it is called anti-Stokes scattering. At room temperature
anti-Stokes scattering is usually less intense because of fewer molecules in excited states.
Thus, Stokes scattering is detected to acquire Raman spectra. However, if a strong
fluorescence interference is present, anti-Stokes scattering is preferred.
The energy of a vibrational transition between two energy states is called the Raman
shift (in cm-1). RM probes the molecular vibrational transitions that rely on chemical bonds,
so RM can detect “finger printing” information about chemical structure and conformation of
molecules. It should be noted that only those vibrational modes that change molecule
polarizability display Raman signal. The disadvantage of RM is that the Raman signal is
usually very weak, and can be interfered with autofluorescence. However, RM has unique
advantages over other techniques. First, RM can be combined with confocal microscopy [45]
to provide high spatial resolution (~1 μm). Another advantage of RM over other methods is

9

the non-invasive analysis of specimen without sample preparation (for example, no need of
labels, contrast agents or dyes). Moreover, Raman scattering is free from water interference,
which is important for cellular biopolymer spectroscopy over IR where water has strong
interference because of its high absorbance at IR wavelengths [46].

Figure 1.1 Diagram of IR absorption, Rayleigh scattering and Raman scattering (stokes
scattering or anti-stokes scattering) processes [44].

RM has been applied in a range of industrial areas, including semiconductors [47],
geosciences [48], archeology [49] and pharmaceuticals [50]. With the development of
instrumentation, currently RM has been widely utilized in bioanalytical fields for chemistry
[51], biology [52], and medicine studies [53]. Additionally, RM has gained increased
popularity in the area of mammalian cell research. RM is suitable for biological samples by
its successful applications in cell sorting, identification of cellular biopolymers, and assessing
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differentiation status [54, 55]. RM has successfully discriminated undifferentiated stem cells
from differentiated cells [56-58]. When distinct molecular components are selected, RM
becomes a powerful tool to identify the differences between normal and dysplasia tissue [59]
and principal component analysis can discriminate, through characteristic Raman bands,
normal from abnormal oral squamous cell carcinoma [60]. Similar applications of RM have
been performed for other types of cancer cell lines (e.g. liver [61], breast [62], prostate [63],
ovarian [64], and so on).
Clearly, RM is a good instrumental technique to study the cellular biopolymer
changes of mammalian cells. We utilized RM to track the biochemical changes (DNA/RNA,
lipids, proteins, and carbohydrates) of mammalian cells interacting in situ with bio-nanointerfaces.
1.3.1.3 Surface-enhanced Raman spectroscopy (SERS)
SERS is a RM technique that can greatly increase Raman signal from Raman-active
molecules that have been adsorbed onto certain specific metal surfaces (e.g. gold
nanoparticles, silver nanoparticles, etc.). Increases in the intensity of Raman signal can be as
much as 1010 to 1011 [65, 66]. RM is less effective for surface studies than SERS because the
incident photons from laser light simply distribute through the bulk and the signal of the bulk
overwhelms other Raman signal. However, the surface signal of SERS overwhelms the bulk
signal because of surface enhancement mechanisms, largely suppressing bulk signal. An
electromagnetic and a chemical enhancement are two primary mechanisms of enhancement
for SERS. The electromagnetic enhancement relies on the metal feature that contributes more
compared to chemical enhancement [67], while the chemical enhancement involves changes
of the adsorbate electronic states [68]. Previous research has reported using SERS probes to
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target cancer cells in vitro or in vivo, identifying the binding between probes and target
cancer cells [19, 69-71]. In this study, SERS is applied to locate the distribution of epidermal
growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) at
single living cells.
1.3.1.4 Quantitative polymerase chain reaction (qPCR)
Quantitative polymerase chain reaction (qPCR), is a laboratory technique to quantify
targeted DNA molecules in molecular biology [72]. Due to the detection sensitivity, high
throughput capabilities, accurate quantification and high degree of potential automation,
qPCR is selected to monitor gene expression [73]. qPCR has been applied to detect the
changes of biomechanics-related genes during the differentiation of mesenchymal stem cells
and human tendon stem/progenitor cells [74, 75]. However, few applications have been
conducted to sort out the potential correlation between the changes of cell biomechanics and
the changes of biomechanics-related genes during stem cell differentiation. In this
dissertation research, qPCR was used to assess the expression of biomechanics-related genes
during the process of trophoblast cell differentiation.
1.3.1.5 Photothermal therapy (PTT)
PTT, also known as photothermal ablation, is a minimally invasive approach to
cancer therapy. PTT requires photothermal conversion agents to generate rapid localized heat
to ablate cancerous cells specifically by absorbing light and converting the absorbed light
into heat [76]. Gold nanostructures are commonly applied as contrast agents because of their
features to tune optical properties via the localized surface plasmon effect. Gold
nanostructures with strong near-infrared (NIR) absorption are considered to be a relatively
noninvasive and effective treatment of cancer compared to the current cancer treatments
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(chemotherapy, radiotherapy, surgery, and so on), which usually result in severe adverse
effects and cancer recurrence [77-80]. Previous studies have reported the application of gold
nanostructures (e.g. Au nanoparticles [81], Au nanoshells [82], Au nanostar [83], etc.) for
PTT. In this work, a novel hybrid nanostructure was developed for simultaneous molecular
imaging and photothermal cancer therapy.
1.3.2 Treatment agents
1.3.2.1 Doxorubicin (DOX)
Doxorubicin (DOX, Figure 1.2), an antitumor antibiotic, has been widely used for
treating a variety of cancers in clinical trials. Several mechanisms of DOX have been
proposed, such as the inducement of DNA damage via the topoisomerase inhibition,
intercalation into DNA, interference with the structure of DNA and helicase activity [84-86].
In this dissertation we use DOX to treat cancer cells with or without BRMS1 to study cellular
responses.

Figure 1.2 Chemical structure of doxorubicin [87].
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1.3.2.2 Resveratrol (RES)
Resveratrol (trans-3, 4, 5-trihydroxystilbene, RES, Figure 1.3), a phenolic natural
component from the skin of grapes, blueberries, raspberries and mulberries, has potential
benefits to human health [88]. This natural compound has been found to possess many
pharmacological

effects,

including

modulatory

lipoprotein

metabolism,

platelet

antiaggregatory, anti-inflammatory, anti-fungal properties, cancer chemopreventive and
anticancer properties [89-92]. Previous studies have shown that RES can effectively inhibit
oxidative damage than other conventional antioxidants [93, 94] and has been shown to
scavenge free radicals such as lipid hydroperoxyl, hydroxyl (- OH), and superoxide anion
(O2-) radicals [95]. Interestingly, Birrell et al. [96] showed that RES inhibits
lipopolysaccharide-induced airway neutrophilia and inflammation through an NF-κBindependent and unidentified mechanism. The study conducted by King et al. [97] suggested
that RES significantly decreased intracellular ROS accumulation induced by basal and H2O2,
reducing H2O2 induced extracellular signal regulated kinase activation in retinal pigment
epithelial cells. In this study, the RES effect on DEP induced mammalian cells was detected
and compared with control groups.

Figure 1.3 Chemical structure of resveratrol [98].
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1.3.2.3 Diesel exhaust particles (DEP)
Diesel exhaust particles (DEP), mainly originated from the spark-ignition inside
diesel engines, are characterized by a carbonic nucleus, in which about 18,000 highmolecular-weight organic compounds are adsorbed [99]. It is reported that there is a
relationship between DEP and lung cancer incidence, cardiopulmonary deaths, and
respiratory and cardiovascular diseases for adults living in metropolitan areas [100-103].
DEP induce a variety of cardiovascular and respiratory diseases, which lead to significant
morbidity and mortality in susceptible populations [104, 105]. DEP exposure is associated
with asthma [106] and might exacerbate allergic lung inflammation and induce functional
lung changes [107]. On the cellular level, DEP exposure induces cytotoxic and proinflammatory responses [108], and significantly alters cytokine production [109]. In this
study, DEP exposure at different time was utilized to stimulate cellular responses, and
cellular biophysical and biochemical changes were measured.
1.3.2.4 Titanium nanotubes (TiO2 NT)
Titanium surfaces have been widely applied in clinical titanium implantations for the
purpose of bone, joint, or tooth replacements [110]. Compared with the titanium surface, a
thin TiO2 nanotube layer forms on Ti substrate has desirable bioactive (bone-growth)
properties [111]. TiO2 nanotube layer can improve the formation of fibrous tissue, alleviating
the implant and inflammation. By anodization there was vertically aligned yet laterally
arrayed nanoscale TiO2 nanotopography grown on the titanium surfaces. The TiO2 nanotubes
largely enhanced the adhesion and propagation of the osteoblast with the filopodia of
growing cells actually spreading into the nanotubes, inducing an interlocked cellular structure.
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In comparison with titanium surfaces, the growth rate of osteoblast cells was significantly
facilitated by as much as ~ 300–400% with the presence of the TiO2 nanotopography [112].
It was found that as nanoscale spacing models TiO2 nanotube surfaces can be utilized for
size-dependent cellular response [113]. The nanotube structure also offered nano-scale cues
to enhance cellular probing, cell sensing, and cell migration. For bovine aortic endothelial
cells (BAECs) grown on TiO2 nanotubes, it is of benefit to probe the surface and interlock
cellular extensions. Extracellular matrix (ECM) deposition and more natural “vascular bed”
were stimulated by TiO2 nanostructures, which also induced unidirectional cytoskeletons and
more organized lamellipodia, indicating the functionality of the TiO2 nanotopography
facilitating endothelialization and endothelial cell migration, especially in the raised
formation of ECM and increased level of nitric oxide/endothelin ratio [114]. Due to the
unique nanotopographical structures and biocompatibility of the TiO2 nanotube surface on Ti
foils, it can facilitate the mobility of endothelial cells [114]. In this study, trophoblast-derived
stem-like cells were culture on TiO2 nanotubes and cellular responses were detected.

1.4 DISSERTATION FORMAT
This dissertation is formatted in a multiple paper structure, and it can be divided into
three main topics as shown in Figure 1.4: biomechanics/cellular biopolymers of native cells
(Chapter 2); bio-interfaces (Chapter 3 - 4) and nano-interfaces (Chapter 5 - 7). All
subsequent chapters have been formatted as publications. Chapter 2 was published prior to
the completion of this dissertation. Chapters 3-5 were submitted and are under review.
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Figure 1.4 Schematic overview of three main topics covered in this dissertation.

In Chapter 2, AFM, RM and qPCR were applied to study the differentiation of
porcine trophoblast-derive stem-like cells (TE) on Petri dishes in response to serum and
serum-free media (Figure 1.5). Cellular biophysical properties were detected by AFM. RM
was used to collect cellular biopolymers information. Cellular gene expression was measured
by qPCR.

Figure 1.5 Trophoblast cells differentiation on Petri dish monitored by RM, AFM and qPCR.
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Figure 1.6 Cancer cells with or without BRMS1 expression treated with different time of
DOX.

Figure 1.7 Cancer cells treated with DEP only or RES first and then DEP exposure at
different time.

In Chapter 3, we evaluated the bio-interfaces interaction between human cancer cells
and DOX that cancer cells with or without BRMS1 expression (MDA-MB-231, MDA-MB435, MDA-MB-231/BRMS1, MDA-MB-435/BRMS1 and A549 cells) under different time
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points of DOX exposure (Figure 1.6). Cellular Young’s modulus and adhesion force were
measured by AFM. The biochemical information of cells was measured by RM. Cellular
viability, apoptosis expression and reactive oxygen species (ROS) level were analyzed with
and without DOX treatments.

Figure 1.8 Surface modification and conjugation of Au nanorods on the surface of
CaMoO4:Eu nanoparticles and their applications.

The focus of Chapter 4 was to study human lung cancer cells (A549) in response to
diesel exhaust particles (DEP) and resveratrol (RES) (Figure 1.7). AFM and fluorescence
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microscopy were used to collect cellular topography and fluorescence images. RM was
applied to obtain the subcellular biochemical compositions. Plasma membrane potential and
cell cycles were analyzed.
In Chapter 5 the nano-interfaces were studied, and we synthesized a hybrid
nanoparticle (HNP) with multifunctional properties: fluorescence, SERS and PTT. We
characterized this HNP and studied the effect of HNP on cellular biomechanical properties.
HNPs and cancer biomarker (EGFR) distribution on cells were monitored by SERS mapping
(Figure 1.8). The PTT effect from HNPs was investigated on cancer and non-cancer cells.

Figure 1.9 Schematic of silica coated nanoparticles and its application to PTT.

In Chapter 6, breast cancer cells (MDA-MB-435) were studied regarding their
response to silica coated nanoparticles (Figure 1.9), and the applications of silica coated
nanoparticles for fluorescence, SERS detection and photothermal effect were evaluated as
well. The biocompatibility of this silica coated nanoparticle was evaluated by Muse cell
analyzer.
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Figure 1.10 Schematic illustration of TiO2 nanotube coated with Au nanoparticles and
cellular responses.

In Chapter 7, my research focused on the morphological and biochemical changes of
trophoblast cells grown on 3D TiO2 nanotubes (NTs) with and without gold nanoparticles
(Au) (Figure 1.10). Cellular morphology was recorded by scanning electron microscopy. The
subcellular biochemical changes were measured by RM.
In Chapter 8, I presented a brief summary of my dissertation and discussed the
potential research for future directions.
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1.5 DISSERTATION OUTLINE
Technical
Chapter

Title of Chapter

Objectives

Chapter 2

Identification of
trophoblast-derived stemlike cell differentiation in
serum or serum-free
medium

Trophoblast stem-like cells have been
induced by serum or serum-free medium
to study cellular differentiation in
physiological conditions.

Chapter 3

Breast cancer cells with or
without BRMS1 in
response to doxorubicin

Evaluate BRMS1 expression to cellular
biomechanical and biochemical changes
upon DOX treatment.

Chapter 4

Human lung cancer cells in
response to diesel exhaust
particles and resveratrol

Study cellular biomechanical and
biochemical changes to diesel exhaust
particles and resveratrol exposure.

Chapter 5

Human lung cancer cells
and hepatocyte cells in
response to hybrid
nanoparticles and
photothermal effect of
nanoparticles

Chapter 6

Breast cancer cells and
hepatocyte cells in response
to silica coated
nanoparticles

Chapter 7

Morphology and cell
viability evaluation of
trophoblast cells on TiO2
nanotubes coated with Au

Hybrid nanoparticle with the properties
of fluorescence imaging, surfaceenhanced Raman spectroscopy detection
and photothermal therapy were
synthesized and its effects on cells were
evaluated.
Silica coated nanoparticles were
synthesized to increase light-heat
conversion efficiency as well as
biocompatibility, applying for
fluorescence imaging, surface-enhanced
Raman spectroscopy detection and
photothermal therapy.
Measure the viability, cellular
topography and biochemical changes of
trophoblast cells on TiO2 nanotubes
coated with Au.
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CHAPTER 2
LABEL-FREE AND NON-INVASIVE MONITORING OF PORCINE TROPHOBLAST
DERIVED CELLS: DIFFERENTIATION IN SERUM AND SERUM-FREE MEDIA
2.1 ABSTRACT
Traditional approaches to characterize stem cell differentiation are time-consuming,
lengthy and invasive. Here, Raman microspectroscopy (RM) and atomic force microscopy
(AFM)—both considered as non-invasive techniques—are applied to detect the biochemical
and biophysical properties of trophoblast derived stem-like cells incubated up to 10 days
under conditions designed to induce differentiation. Significant biochemical and biophysical
differences between control and differentiated cells were observed. Quantitative real time
PCR was applied to analyze gene expression. The relationship between cell differentiation
and associated cellular biochemical and biomechanical changes were discussed.
2.2 INTRODUCTION
In vitro characterization of cellular differentiation using traditional methods,
including immunocytochemistry, fluorescence activated cell sorting and RNA in situ
hybridization analysis, has limitations: all require large numbers of cells, lengthy steps and
cellular lysis or fixation [1-3]. Recently, there has been a drive to characterize and monitor
cellular differentiation processes in situ and in real-time by faster and non-invasive methods.
Raman microspectroscopy (RM) and atomic force microscopy (AFM) are two highly
sensitive analytical techniques able to characterize cellular biochemical [4] and
biomechanical [5] properties in cell samples under near physiological conditions [6].
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RM is a spectroscopic technique based on inelastic scattering that exhibits energy
shift of laser photons corresponding to frequencies of vibration within molecules from
samples. Raman shifts can serve as a "fingerprint"

to provide information about the

molecular compositions, structures, and quantities of cellular biopolymers with a minimal
background signal from water [7, 8], allowing the study of living cells under physiological
states, without labels or using other invasive steps [9]. Previous studies reported that Raman
intensities of nucleic acids on undifferentiated stem cells were dominant in comparison with
differentiated cells, while differentiated cells had larger spectral intensities of proteins and
lipids than undifferentiated cells [6, 7, 10-18].
AFM is a high-resolution scanning probe microscopy that involves the movement of a
sharp tip over the surface of a biological sample while detecting the near-field physical
interactions between the sample and tip [19, 20]. AFM can image cytoskeleton, cellular
microenvironments, and quantitatively detect cellular mechanical properties at nanometer
scales in physiological condition [5, 21, 22]. It was found that stem cell stiffness will increase
with differentiation [23-25] and cellular mechanical properties are indicative of stem cell
differentiation potential [26, 27].
In the earliest stages of eutherian mammalian embryo development, all the cells
(blastomeres) are functionally equivalent, and equally capable of giving rise to all cell types
necessary for proper and complete embryonic/fetal growth and survival. However, at a
species-specific timepoint (approximately day 3 in mice, day 5 in humans and pigs, and day
7 in cattle, e.g.), molecular and morphological transitions destine some of the cells for
development into the primitive placenta (i.e. the trophectoderm), while the remaining cells
give rise to the embryo/fetus proper (i.e. the so-called embryonic stem cells) and retain a
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relatively undifferentiated status [28-30]. Trophoblast cells are the first cells within the early
developing embryo to undergo a recognizable differentiation event, and the proper formation
and function of cells is essential to embryo and fetal survival. In fact, many instances of
early embryo mortality – at least in in vitro-manipulated embryos – can be traced back to
dysfunctional trophoblast cells [31-33]. Yet the process of trophoblast differentiation is
poorly understood. A thorough appreciation of the biochemical and biophysical aspects of
trophoblast differentiation may enhance trophoblast function for increased embryonic
survival.
In this experiment, trophoblast stem-like cells derived from day 10 porcine embryos
have been induced by serum and serum-free medium to study cellular differentiation in
physiological conditions. This is the first work to combine RM and AFM to monitor and
identify

discrete

biochemical

and

biomechanical

changes

during

serum-induced

differentiation.
2.3 HYPOTHESIS
The biochemical and biomechanical properties collected by RM and AFM could be
used as differentiation indicators to distinguish between differentiated and undifferentiated
trophoblast-derived stem-like cells.
2.4 MATERIALS AND METHODS
2.4.1 Preparation of trophoblast cells
The cells were collected from porcine embryos on gestational day 10 as described
elsewhere [34] and were passaged without senescence or morphological changes until
utilized for experiments. Cell colonies were transfected with an expression construct coding
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for green fluorescent protein (GFP) using Jet Pei reagent (Polyplus transfection Inc., New
York, NY, USA) according to instructions [34]. GFP cells help observe TE cells
morphological changes on magnesium fluoride (MgF2, United Crystals Co., Port Washington,
NY, USA) over time without chemical label. Cells were cultured in serum-free medium to
maintain undifferentiated, stem-like characteristics [35], whereas cells cultured in fetal
bovine serum medium (15% [v:v]) underwent dramatic and predictable changes to cell
morphology and behaviour. Table 2.1 lists formulations for serum-free and serum-containing
medium.

Table 2.1 Formulations for serum-containing and serum-free culture media.
Component

Serum-containing

Non serum-containing

DMEM

85% (v:v)

50% (v:v)

F12 Nutrient Mixture

---

50% (v:v)

Fetal Bovine Serum

15% (v:v)

---

B27 Serum-free Supplement

---

1X working concentration

Epidermal Growth Factor

---

20 ng/mL

Fibroblast Growth Factor, Basic

2 ng/mL

40 ng/mL

Gentamicin

20 μg/mL

20 μg/mL

2.4.2 Fluorescence imaging of trophoblast cells
Bright field and fluorescence images were collected by Olympus IX71 inverted
fluorescence microscope (Olympus America Inc., Center Valley, PA, USA) equipped with an
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Olympus DP30BW CCD camera using DP-BSW Controller and Manager Software. Images
were acquired via a 10× lens (Olympus), and cell samples grown on MgF2 substrates were
observed in medium. Fluorescence images were processed by ImageJ software and nucleus
diameter measurements were performed on 50~100 cells.
2.4.3 Raman spectroscopy
The Raman spectra were measured by Renishaw inVia Raman spectrometer (WiRE
3.0 software, Renishaw, Wotton-under-Edge, Gloucestershire, UK) equipped with a 300 mW
785 nm near-IR laser that was focused through a 63 × (NA = 0.90) water immersion
objective (Leica DMLM, Leica Microsystems, Buffalo Grove, IL, USA). Cells were cultured
on MgF2 and imaged in Earle's balanced salt solution (EBSS, Thermo Fisher Scientific,
Waltham, MA, USA).
The Raman laser spot size is about 24 μm × 0.5 μm, focusing primarily on the cellular
nuclear region. Raman spectra were collected at Raman static mode at 1 accumulation with
10s exposure time. For each treatment of the day, two MgF2 windows with cells were
measured. On each treatment group, 40 ~ 60 Raman spectra from multiple individual cells
(10 ~ 15 cells, each cell collected 4 spectra but position was changed about 3 μm) were
detected within 2 hours at room temperature. Renishaw Wire 3.3 software (Renishaw)
performed for Raman spectra baseline corrected, spectral smoothed and normalized at
maximum peaks. The processed spectra were imported to OriginPro 8 software (OriginLab
Corp., Northampton, MA, USA) for Raman intensity analysis. The significance testing was
employed by one-way ANOVA, and the data were reported as mean ± SD. Principal
component analysis (PCA) was processed in Matlab R2012b using baseline corrected data.
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2.4.4 Atomic force microscopy
Contact mode AFM controlled by Picoview software (Picoplus, Agilent Technologies,
Santa Clara, CA, USA) was applied to trophoblast cells on MgF2 in culture medium. Sharp
silicon nitride AFM probes (tip radius, 20nm) were employed (Bruker Corp., Billerica, MA,
USA). Spring constant of tips was calibrated as 0.10~0.11 N/m and deflection sensitivities
were 45~50 nm/V.
Scanning Probe Image Processor (SPIP) software (Image Metrology, Hørsholm,
Denmark) calculated Young’s modulus by converting the force-distance curves to forceseparation curves and fitting the Sneddon variation of Hertz model as below formula shows
[36-38]:
Ecell = 4 · F (∆Z) · (1 – η2cell)/3 · (∆Z1.5) · tan θ, where Ecell: Young’s modulus; F:
loading force; ηcell: Poisson ratio; ∆Z: indentation; θ: tip half cone opening angle.
The Poisson’s ratio was 0.5 and the tip half cone opening angle was 36◦. For each
group, at least 20 force curves of each cell (the total cells are over 15) were collected, and
detection was accomplished within 2 hours to approximate normal physiologic conditions.
The AFM images were processed with WSXM software (Nanotec Electrónica S.L., Tres
Cantos, Madrid, Spain) for deflection and 3-D view.
2.4.5 Quantitative real time PCR analysis
On days 3 and 10, total RNA was isolated from cells by the Total RNA kit I (Omega
Bio-tek; Norcross, GA, USA) following protocol. mRNA was reverse transcribed using
GoScript Reverse Transcription System kit from Promega (Madison, WI, USA).
Quantitative PCR (qPCR) was performed on the Eppendorf Mastercylcer Realplex2 machine
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using Promega GoTaq qPCR master mix with primers (Table 2.2) for HAND1, KLF4,
CYP17A1, KRT8 and EIF4A1 genes.

Table 2.2 Forward and reverse primer of HAND1, KLF4, KRT8 and EIF4A1 (Forty (40) twostep cycles (95° C/15 s denaturation – 60° C/30 s anneal/extend) were used for amplification,
followed by a melt curve analysis to confirm the identity of the fragments amplified. The
∆∆CT method was used to analyze the qPCR data. EIF4A1 was used as a housekeeping gene
to normalize CT values. The serum-free samples were used as control samples.
Gene

Forward primer

Reverse primer

HAND1

5’-GCGAGAGCAAGCGGAAAA-3’

5’-CCTGTGCGCCCTTTAATCC-3’

KLF4

5’-GGGAAGGGAGAAGACACTG-3’

5’-TCTTTGCTTCATGTGGGAGA-3’

CYP17A1 5’-GGACACAGATGTCGTCGTCAA-3’

5’-AAGCGCTCAGGCATGAACA-3’

KRT8

5’-AAGCGTACCGACATGGAGAA-3’

5’-TCCAGCTCGACCTTGTTCA-3’

EIF4A1

5’- AGGATCATGTCTGCGAGTCAGG-3’

5’- ATAGATGCCACGGAGGAGGGAC3’

2.5 RESULTS AND DISCUSSION
2.5.1 Fluorescence imaging for trophoblast cells
Figure 2.1 compares nucleus diameter of the groups at different days (Figure 2.1(A))
and shows representative cell images on each group (Figure 2.1(B)). According to Figure
2.1(A), the nucleus diameter of serum-free cell maintains similar value with time, from 27.5
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± 4.6 μm at day 3 to 26.1 ± 5.3 μm at day 10. On the contrary, the nucleus diameter of cells
in serum gradually increases with time, from 41.6 ± 9.5 μm at day 3 to 55.8 ± 9.1 μm at day
7, maximizing at day 10 (67.0 ± 9.7 μm).
Overall, the above observations indicate trophoblast cells maintain smaller nucleus
diameter in serum-free medium up to 10 days.

Figure 2.1 Nucleus diameter of trophoblast cells (A) and representative GFP images of cells
(B) in serum-free and serum medium at day 3, 5, 7 and 10 (Error bars of (A) are standard
deviation of the mean; N ≥ 50, *P < 0.05).

2.5.2 Raman intensity comparison
After exposure to 785 nm laser in Raman detection (within 2 hrs), LIVE/DEAD
Viability/Cytotoxicity was conducted by staining cells with Calcein AM (green, live
cells)/ethidium homodimer-1 (red, dead cells) (Invitrogen). Few dead cells were observed,
indicating little photodamage effect from Near Infrared light, which is consistent with
previous studies [39-41].
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Table 2.3 Tentative Raman band assignments of trophoblast cells.
Raman shift (cm-1)
Band assignment
624
Phenylalanine
643
C-C twist Phenylalanine
662
C-S stretching mode of cystine (collagen type I)
666
G, T-tyrosine-G backbone in RNA
672
C-S stretching mode of cytosine
717
CN− (CH3 )3 (lipids)
719
C-C-N+ symmetric stretching in phosphatidylcholine
720
DNA
760
Tryptophan
786
DNA & phosphdiester bands DNA
813
Phosphodiester bands RNA
832
PO−
2 stretch nucleic acids
854
Tyrosine
881
Tryptophan
939
Skeletal modes (polysaccharides)
961
Phosphate of HA; Calcium-phosphate stretch band
1006
Phenylalanine
1031
Phenylalanine
1057
lipids
−
1066
PO2 stretching; chain stretching; C-O, C-C stretching
1070-90
Symmetric PO−
2 stretching of DNA
1095
Lipid; Phosphodioxy group (PO−
2 in nucleic acids)
1129
C-C skeletal stretch transconformation
1158
Lipids and nucleic acids (C, G and A )
1179
Cytosine, guanine
1213
Tyrosine, phenylalanine
1254
Lipid; A,T breathing mode; Amide III (protein)
1304
CH2 deformation (lipid), adenine, cytosine
1306
C-N stretching aromatic amines
1317-9
Guanine (B,Z-marker)
1341
G (DNA/RNA); CH deformation
1400-30
γ(C=O) O- (amino acids aspartic & glutamic acid)
1451
CH2 deformation (nucleic acid, proteins, lipids)
1579
Pyrimidine ring (nucleic acids)
1608
Phenylalanine, Tryptophan
1660
Amide I
1740
Collagen III
Band assignment is based on [42-50].
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Table 2.3 lists the tentative Raman band assignments of trophoblast cells. There are
some remarkable differences among groups, for example, 717 cm-1 (CN-1(CH3)

3

(lipid/choline)), 760 cm-1 (Tryptophan), 786 cm-1 (DNA & phosphdiester bands DNA), 813
cm-1 (Phosphodiester bands RNA), 1006 cm-1 (Phenylalanine) and 1057 cm-1 (lipid). The
mean Raman peaks intensities were extracted to quantitatively analyze the differences, as
shown in Figure 2.2. For serum groups, the DNA intensity gradually decreases from 0.12 at
day 3 to 0.09 at day 10 (Figure 2.2(A)). However, the DNA intensity of cells in serum-free
medium fluctuates over time. Similar to DNA changes, the RNA intensity of serum groups
(Figure 2.2(B)) slowly drops, while that of cells in serum-free medium fluctuates over times.
The tryptophan (760 cm-1) intensity of serum groups (Figure 2.2(C)) increases over time.
However, for cells in serum-free medium the tryptophan intensity fluctuates. Similarly, for
serum groups the phenylalanine (1006 cm-1) intensity (Figure 2.2(D)) grows continuously,
while that of cells in serum-free medium fluctuates with time. The lipid/choline intensities
(717 cm-1 and 1057 cm-1) fluctuates with time regardless cells in serum or serum-free
medium (Figure 2.2(E-F)).
Our spectral results are similar to previous studies [10, 39, 51, 52] that an increase of
protein peak intensity and decrease of nucleic acids peak intensity are related to the
differentiation of stem cells. However, the lipid peak intensities exhibits an increasing trend.
Regardless of the days in culture, the lipid peaks of serum groups (differentiated cells) are
higher than those of serum-free groups (undifferentiated cells). The lipid peaks do not show a
steady increase in trophoblast cell system, which is not consistent with those observation in
multipotent and pluripotent stem cells [13]. The reason may be accounted for cell type
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difference, and the lipid expression of trophoblast cells may be different from stem cells
during their development.

Figure 2.2 Raman peak intensity analysis of trophoblast cells on DNA (A), RNA (B),
tryptophan (C), phenylalanine (D), lipid/choline (E) and lipid (F) at day 3 (black), 5 (red), 7
(blue) and 10 (cyan) in serum and serum-free medium (Error bars are standard deviation of
the mean; N ≥ 10, *P < 0.05).

2.5.3 Spectroscopic markers comparison and principal component analysis (PCA) of
Raman spectra
Previous studies indicate increasing 757 cm-1 to 784 cm-1 intensity ratio is correlated
with the reduction of Oct4 and Nanog expression, which decrease rapidly with the
differentiation of human embryonic stem cells (hESCs) [39, 53] and human induced
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pluripotent stem cells (hiPSCs) [54]. Here, the peak intensity ratio of 760 cm-1 (tryptophan)
to 786 cm-1 (DNA) was applied to assess trophoblast cells differentiation.

Figure 2.3 Raman peak ratio (760 cm-1/786 cm-1) in serum and serum-free medium (A)
(Inset fluorescence images of trophoblast cells at day 10, scale bar: 50 μm); distribution
diagram of two protein/nucleic acid peak intensity ratios (760/786 cm-1 and 854/786 cm-1)
(B), and PCA plot (C) (Error bars of (A) are standard deviation of the mean; N ≥ 10, *P <
0.05).

Peak intensity ratio (760 cm-1/786 cm-1) of trophoblast cells are presented in Figure
2.3(A) (inset fluorescence images of cells at day 10). The ratios in serum medium were larger
than those in serum-free medium at each day. For serum groups the ratio increase in the first
five days, then drops slightly, reaching the maximum at day 10. The ratio of serum-free
groups grows in the first seven days, then decrease largely at day 10. This ratio of serum
groups increased with time, probably suggesting the cellular differentiation. In contrast, the
ratio fluctuated for serum-free groups, which may indicate cells still remain undifferentiated
or differentiated slowly in serum-free medium.
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Figure 2.4 AFM deflection (A-H) and corresponding 3-D view (A’-H’) images of cells in
serum-free and serum medium at day 3, 5, 7 and 10. Insets in deflection images are the line
profiling of nucleus height.

Turner et al. have successfully assessed hESCs differentiation by distribution diagram
of two protein/nucleic acid intensity ratios (757 cm-1/784 cm-1 (tryptophan/nucleic acid) and
853 cm-1/784 cm-1 (tyrosine/ nucleic acid)) [39]. We applied the same method, as shown in
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Figure 2.3(B). The X-axis displays the peak intensity ratio of 760 cm-1/786 cm-1, and Y-axis
is the peak intensity ratio of 854 cm-1/786 cm-1. The serum group at day 10 (upper right) has
the largest distribution in comparison with other groups, even though over 50% of these
points overlay with other points.
PCA is also applied to analyze Raman spectra difference for serum and serum-free
groups (each group has ≈ 200 spectra). PCA simplifies the spectra by exhibiting the data with
principal component (PC) variables ordered from the largest variance to the least variance
[55]. The X-axis and Y-axis correspond to the 1st and the 2nd PC variables, respectively.
These two PCs account for 87.58% of variance and mainly represent the Raman spectra of
the cells. Similarly to Figure 2.3(B), the data points in serum group at day 10 (white
diamond) are not closely clustered, even over 50% of these points overlay with other groups
as shown in Figure 2.3(C). Clusters of other groups sit tightly with each other.
Our distribution diagram and PCA analysis (Figure 2.3(B, C) both imply that “Day 10
serum” group exhibits the largest distribution of cellular biocomponents (e.g.,
proteins/nucleic acids) among other groups.
2.5.4 Topography and biomechanics comparison
The nucleus diameter can be obtained by AFM, as shown in Figure 2.4. The inset is
the line profiling of nucleus height crossed cells. The nucleus diameter of cells in serum-free
medium (Figure 2.4 (A-D, A’-D’)) remains the similar value over time, while its
cytoskeleton structures (e.g., filamentous actin bundles) increase from over time. However,
the nucleus diameter of serum group (Figure 2.4 (E-H, E’-H’)) increases with time, and its
surrounding cytoskeleton structures become less visible over time. At day 3, mesh-like
structures are clearly visible on surface of cells in serum (Figure 2.4 (E, E’) black arrows
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pointed) in comparison with those of serum-free group (Figure 2.4(A, A’) one black arrow
pointed). Meantime, the nucleus diameter (~42 μm) of cells in serum medium is larger than
that (~27 μm) of cells in serum-free medium. At day 5, the nucleus diameter (~32 μm) of
cells in serum-free medium is still less than that (48 μm) of cells in serum medium. Similar
trends are observed over 7 days (cells in serum medium have larger nucleus diameter than
those in serum-free medium). For the height differences, the overall height (around 1.65 μm)
of cells in serum-free medium is higher than that (around 1.00 μm) of cells in serum medium
over time. The AFM image analysis confirms the result of nucleus diameter shown in Figure
2.1.
To analyze the biomechanics properties, we compare the Young’s modulus (via AFM
force-distance curve measurements) of different groups (Figure 2.5). Serum groups show a
gradual increase in Young’s modulus over time, from 3.16 ± 0.90 kPa at day 3 to 11.20 ±
4.41 kPa at day 10. However, Young’s modulus of serum-free groups remains unchanged
(~7.30 kPa) from day 3 to 7, then significantly increases to 13.70 ± 4.11 kPa at day 10.
The Young’s modulus gradually increases in serum groups over time, which is
similar to the mouse embryonic stem cells study conducted by Pillarisetti et al. [24].
However, that of serum-free groups maintains stable at first 7 days, followed by significant
increase at day 10. Further studies are needed to investigate the reason leading to Young’s
modulus increase of undifferentiated cells at day 10.
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Figure 2.5 Young’s modulus of cells in serum-free and serum medium at day 3, 5, 7 and 10.
Error bars are standard deviation of the mean; N ≥ 10, *P < 0.05.

2.5.5 Analysis of gene expression by qPCR
Four genes were selected for qPCR: CYP17A1, HAND1, KLF4 and KRT8. The gene
CYP17A1 is involved in the steroid biosynthetic pathway, testing for differentiation [56].
HAND1 is essential for placental development and to promote trophoblast giant cells
differentiation [57]. The KLF4 gene is a transcription factor that regulates proliferation,
differentiation, development and apoptosis [58]. KRT8 is prominent in simple single-layer
epithelial cells, such as differentiated trophoblast [59].
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Figure 2.6 Gene expression analysis of cells cultured 3 and 10 days in serum medium
compared to serum-free medium by qPCR. All values are presented as a ratio of fold-change
values:

Serum/Non-serum fold-change. A) CYP17A1 levels. The ratio at day 10 was

approach zero, which does not register on the scale used to present the data, but should not be
interpreted as an absent or null value (as in panel B); B) HAND1 levels; C) KLF4 levels; D)
Relative KRT8 levels. Error bars are standard error of the mean. (N = 3, *P < 0.05; N.S. =
non-serum; N/A = fold change ratio not available because of a null value for non-serum
group).

In Figure 2.6, the X-axis displays time point and the Y-axis shows the expression
ratio (fold-change; serum/non-serum). Figure 2.6(A) exhibits that on day 3 CYP17A1 are
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approximately 200-fold higher for serum group than serum-free group, but this discrepancy
has disappeared by day 10. Day 3 HAND1 from serum-treated cells are undetectable, thus
there is insufficient data (N/A = not available) in Panel B. Panel C shows there is a
numerical drop in relative KLF4 gene expression in serum- vs. un-treated cells, but this drop
is not statistically significant and relative KRT8 gene expression levels do not change
significantly across time in Panel D.
Cells express very low levels of CYP17A1 when cultured in serum-free conditions,
but CYP17A1 is turned on when these cells are in serum medium. After three days the cells
in serum medium showed a 200 fold upregulation of CYP17A1 compared to the serum-free
groups. There is a significant decrease of CYP17A1 from day 3 to day 10. HAND1
transcripts were undetectable in serum groups on day 3, so expression ratio was not feasible.
For day 10, the serum group had 12-fold higher HAND1 expression compared to the cells
cultured in non-serum medium, which is consistent with the role played by HAND1 in
cellular differentiation. qPCR results demonstrated a non-significant drop when analyzing
KLF4 and KRT-8 genes. Thus, these genes might not have an impact on these cells. The
medium and time differences might impact the expression of certain genes, and these
biomacromolecules variations can also be observed in Figure 2.2.
Our initial qPCR results give us clues that we may seek and screen more genes
related to cell biomechanics (e.g., cell adhesion, extracellular matrix) and cell differentiation
to sort out such potential correlation.
2.6 CONCLUSION
Porcine trophoblast derived cells are interesting model for stem like cell research for
their regenerative properties, indefinite passage, and foreign DNA receptivity. Trophoblast
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cells exhibit different morphologies and functions with/without serum medium, providing a
unique tool for studying trophoblast cell differentiation. This is the first work to combine RM
and AFM to compare trophoblast cell differentiation, showing that RM and AFM are able to
distinguish between undifferentiated and differentiated trophoblast cells. Meantime, this
work evaluated the biochemical and biophysical changes of both undifferentiated and
differentiating cells at the same day instead of only studying cellular differentiation over
time. Characterization of trophoblast cells biochemical and biophysical properties extends
the knowledge to further investigations as this area develops.
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CHAPTER 3
IN VITRO EVALUATION OF THE ROLE OF BREAST CANCER METASTASIS
SUPPRESSOR 1 (BRMS1) IN BREAST CNACER CELLS TO CHEMOTHERAPY USING
A MULTIMODAL APPOACH
3.1 ABSTRACT
The Breast Cancer Metastasis Suppressor 1 (BRMS1) is a nucleo-cytoplasmic protein
that suppresses cancer metastasis without affecting the growth of the primary tumor.
Previous work has shown that it decreases the expression of protein mediators involved in
chemoresistance. This study measured the biomechanical and biochemical changes in
BRMS1 expression and the responses of BRMS1 to drug treatments on cancer cells in vitro.
The results show that BRMS1 expression affects biomechanical properties by decreasing the
Young’s modulus and adhesion force of breast cancer cells after doxorubicin (DOX)
exposure. Raman spectral bands corresponding to DNA/RNA, lipids and proteins were
similar for all cells after DOX treatment. The expression of cytokines were similar for cancer
cells after DOX exposure, although BRMS1 expression had different effects on the secretion
of cytokines for breast cancer cells. The absence of significant changes on apoptosis, reactive
oxygen species (ROS) expression and cell viability after BRMS1 expression shows that
BRMS1 has little effect on cellular chemoresistance. Analyzing cancer protein expression is
critical in evaluating therapeutics. Our study may provide evidence of the benefit of
metastatic suppressor expression before chemotherapy.
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3.2 INTRODUCTION
The most deadly feature of cancer cells is their metastatic property, which is
controlled by metastasis suppressors. Clinical studies have reported that Breast Cancer
Metastasis Suppressor 1 (BRMS1) affects disease progression and prognosis [1, 2]. BRMS1
is part of an expanding class of proteins called metastasis suppressors that stifle cancer
metastasis without affecting the primary tumor growth [3]. A loss of BRMS1 is correlated
with poor prognosis among cancer patients [4-6]. BRMS1 decreases the expression and
activity of numerous mediators of chemoresistance such as NF-κB activity [7] and AKT
phosphorylation [8] in several cancer models [9-11]. Some reports studied BRMS1’s effect
on cellular biophysical and biocomponents differences [12, 13], but little research evaluates
these biophysical and biochemical changes in response to drug treatments in presence of
BRMS1. Thus, we compared the responses of cancer cells with and without BRMS1 to a
therapeutic agent using multiple approaches.
Atomic force microscopy (AFM) is a scanning analytical technique that can measure
the biomechanical and topographical characteristics of a sample at nanoscale resolution [14,
15]. Attractive or repulsive forces between tip and sample surface will cause a positive or
negative bending of the cantilever. This alteration is detected by a laser, and reflected by a
position photodetector [15, 16]. AFM has been used to detect biomechanical differences
between human lung adenocarcinoma epithelial cell (A549) and human primary small airway
epithelial cell (SAECs) after exposure to anticancer drugs [17]. Therefore, AFM was selected
to study the biomechanical properties of cells.
Raman microspectroscopy (RM) is a spectroscopic technique based on inelastic
scattering when a laser impinges upon a molecule, interacting with the electron cloud and
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the bonds of that molecule. RM provides chemical information in the vibrational system, so it
can identify chemical molecular compositions through characteristic fingerprints in living
cells [18]. RM is used to study cells in near physiological conditions, without labeling or
fixation [19], and has been applied to investigate the interaction between pharmaceuticals
and living cells in toxicology studies [20]. Thus, RM is a suitable technique to collect the
biochemical information of cells.
Apoptosis, ROS expression and cell viability tests were also applied to detect
BRMS1’s effect on cellular chemoresistance. Apoptosis is a universal and efficient suicide
pathway in cells, and it might enhance a death cascade by a drug [21]. ROS, generated during
cellular metabolism, are oxygen-containing molecules that can damage DNA, proteins, and
lipids [22]. The viability of cancer cells will change according to the interaction conditions
with anticancer drugs. Comparing the results of apoptosis, ROS expression and cell viability
between parental and BRMS1-expressing cells though doxorubicin (DOX) exposure can
reflect BRMS1 effect on chemosensitivity. In this work, using five different cell lines:
metastatic MDA-MB-231 (231), metastatic MDA-MB-435 (435), non-metastatic MDA-MB231/BRMS1 (231/BRMS1), non-metastatic MDA-MB-435/BRMS1 (435/BRMS1) and A549.
We investigated the biomechanical and biochemical changes induced on BRMS1 expression
when treated with the chemotherapeutic agent DOX. Knowledge of these differences could
improve the understanding of metastasis suppressors and be of significant clinical benefit in
human cancer therapy.
3.3 HYPOTHESIS
BRMS1 expression has limited impact on cellular physiological conditions when
cancer cells were treated with anti-cancer drugs (DOX).
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3.4 MATERIALS AND METHODS
3.4.1 Cell culture
To express BRMS1 cDNA, 231 and 435 cells were transfected with a lentiviral vector
construct under a cytomegalovirus promoter. 231, 231/BRMS1, 435 and 435/BRMS1 cells
were cultured in a 1:1 mixture of Dulbecco’s-modified eagle’s medium (DMEM) and Ham’s
F-12 medium supplemented with 5% fetal bovine serum (Thermo Fisher Scientific, Waltham,
MA, USA). A549 cells (ATCC, Manassas, VA, USA) were cultured in F-12k medium
containing 10% fetal bovine serum at 37 °C with 5% CO2 in a humidified atmosphere. All
cells were passaged at 80-90% confluency using 0.5% Trypsin-EDTA solution (Thermo
Fisher Scientific).
3.4.2 Drug preparation and treatment
DOX was dissolved in deionized water. Stock solutions of DOX (8 µM) were stored
at 4 °C according to instructions (Sigma-Aldrich, St. Louis, MO, USA). For final drug
concentrations, solutions were serially diluted. The dose of DOX treatment for A549 is 71
nM, referring to the study of Kashkin et al [23]. Meantime, the IC50 concentration of DOX
corresponding to 231, 231/BRMS1, 435, and 435/BRMS1 cell is 49 nM, 71 nM, 122 nM,
and 114 nM, respectively, referring to the research from Danney et al [24].
3.4.3 Immunofluorescence for detection of BRMS1 localization
435 and 435/BRMS1 cells were plated on cover slips (Thermo Fisher Scientific),
washed with cold PBS (Thermo Fisher Scientific), fixed with 4% para-formaldehyde
(Electron microscopy sciences, Hatfield, PA, USA) and permeabilized with 0.2% Triton X-
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100 in PBS. After blocking with 5% Bovine serum albumin (BSA) in PBS for one hour, cells
were incubated with anti-BRMS1 monoclonal antibody (1:100 dilution) in 5% BSA solution
overnight at 40C. After washing thrice with PBS, Alexa Fluor 488-labeled anti-mouse IgG
(1:400 dilution, Thermo Fisher Scientific) was added and incubated at room temperature for
1 hour. After washing the cells thrice with PBS, the cover slips were mounted (Vector
laboratories Inc., Burlingame, CA, USA) and observed under an Olympus IX-70 inverted
fluorescence microscope (Olympus America Inc., Center Valley, PA, USA).
3.4.4 Raman spectroscopy
To avoid high near infrared (IR) Raman scattering and fluorescence background,
magnesium fluoride (MgF2, United Crystals Co., Port Washington, NY, USA) substrates
were used. The cells were seeded on MgF2 in culture medium overnight and treated with
corresponding IC50 concentration of DOX. Before measurements, cells were rinsed thrice in
PBS, and maintained in EBSS (Thermo Fisher Scientific) for Raman spectra collection.
Before experiments began, LIVE/DEAD viability experiments were conducted to
verify if the cells were alive on MgF2. Raman spectra were recorded using a Renishaw inVia
Raman spectrometer (Renishaw, Wotton-under-Edge, Gloucestershire, UK) equipped with a
63 × 0.9NA water immersion objective (Leica DMLM, Leica Microsystems, Buffalo Grove,
IL, USA) and a 300 mW 785 nm near-IR laser. Spectra were collected in static mode for 1
accumulation at 10 s laser exposure over a wavenumber range of 600-1800 cm-1. Eight cells
per treatment were analyzed with micro-Raman spectroscopy. Cosmic rays of Raman spectra
were removed by Renishaw WiRE 3.3 software (Renishaw).
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3.4.5 Atomic force microscopy
Cells were detected by a contact mode PicoPlus AFM controlled by Picoview
software (Agilent Technologies, Santa Clara, CA, USA). Biomechanical properties were
calculated from in situ force-distance curve measurements in medium at room temperature.
The radius of silicon nitride tips was 20 nm. Its spring constant was calibrated to 0.10~0.11
N/m by Thermo K Calibration (Agilent Technologies) and its corresponding deflection
sensitivities were 45~50 nm/V. More than 10 cells were detected, collecting at least 15 force
curves on the central area of different cells to avoid spurious detections [25, 26]. Scanning
Probe Image Processor (SPIP) software (Image Metrology, Hørsholm, Denmark) was used to
calculate Young’s modulus by fitting the Sneddon variation of Hertz model [27-29].
Adhesion force (the force between tip and cellular surface during tip retracting) was
calculated from deflection (nm) vs. distance (nm) curves by SPIP. The half cone-opening
angle of tip was 36◦, and cellular Poisson’s ratio was 0.5. The detection was accomplished
within 2 hours (h) to approximate physiological conditions.
Ecell = 4 · F (∆Z) · (1 – η2cell)/3 · (∆Z1.5) · tan θ, where Ecell: Young’s modulus; F:
loading force; ηcell: Poisson ratio; ∆Z: indentation; θ: tip half cone opening angle.
3.4.6 Cytokine and chemokine analysis
A total of 25 cytokines and chemokines were selected to analyze their expression.
The samples were centrifuged at 250 × g for 5 min, the supernatant was collected and stored
at −80 °C prior to the assay. The samples were tested as single batches on Q-Plex ArrayTM
kits (Quansys Biosciences, Logan, UT, USA).
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3.4.7 ROS and apoptosis assay
The ROS expression was detected by a Muse™ Oxidative Stress kit (EMD Millipore
Co., Billerica, MA, USA), and apoptosis level was determined by a Muse™ Annexin V and
Dead Cell kit (EMD Millipore Co.). Cells were cultured in 6-well plates to about 70%
confluence, then the medium was replaced with DOX containing medium. Every treatment
had three replicates. At each time point, the cells were collected and analyzed using a Muse
Cell Analyzer (EMD Millipore Co.).
3.4.8 Cell viability assay
Cell viability was analyzed using LIVE/DEAD Viability/Cytotoxicity Assay Kit
(Thermo Fisher Scientific). Calcein AM is retained within live cells producing green
fluorescence; whereas, EthD-1 enters damaged membrane and binds to nucleic acids,
producing red fluorescence. Every treatment has three replicates. After staining, cells were
imaged using fluorescence microscope with DP30BW CCD camera (Olympus America Inc.)
to analyze the relative proportion of live/dead cells.

3.5 RESULTS
3.5.1 BRMS1 distributed mainly in nucleus with some expression observed in the
cytosol
To assess the biophysical and biochemical differences of breast cancer cells with and
without BRMS1, it is important to pinpoint the distribution of BRMS1. Figure 3.1 shows the
immunofluorescence images for 435 and 435/BRMS1 cells. BRMS1 is highly expressed
(green) in (Figure 3.1B) 435/BRMS1 cells compared to 435 cells (Figure 3.1A). Further, it is
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observed that BRMS1 is mainly distributed within cellular nucleus, which is consistent with
previous research [30].

Figure 3.1 BRMS1 mainly distributed around the nucleus. Immunofluorescence images of
(A) 435 and (B) 435/BRMS1 cells stained with anti-BRMS1 antibody (blue: nucleus; green:
expression of BRMS1).

3.5.2 BRMS1 affects the biomechanical properties and the response of cancer cells to
DOX
AFM was employed to quantify the biomechanical properties. The results are shown
after 4 h DOX exposure where A549, 231 and 435 cells showed similar changes as both
Young’s modulus (Figure 3.2A) and adhesion forces increased (Figure 3.2B). However, both
biomechanical properties of 231/BRMS1 and 435/BRMS1 moderately decreased. For 231
and 231/BRMS1 cells, the differences in the Young’s modulus and adhesion force
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corresponded to 7.5 kPa and 0.30 nN respectively. While for the 435 and 435/BRMS1 cells,
the differences were 11.6 kPa and 0.29 nN respectively. However, after incubation with
DOX, both the Young’s modulus and adhesion forces decreased for both cell lines. The
difference amounts to 2.8 kPa and 0.04 nN for 231 and 231/BRMS1 and, 2.6 kPa and 0.07
nN for 435 and 435/BRMS1.
These results suggest that BRMS1 expression affects the biomechanical properties of
cancer cells and also induces a differential response when interacting with DOX.

Figure 3.2 BRMS1 expression alters the biomechanical properties and the response of cancer
cells to DOX. (A) Young’s modulus and (B) adhesion force of 231, 231/BRMS1 (231/B),
435, 435/BRMS1 (435/B) and A549 cells without DOX treatment and treated with 4 h DOX
group. Error bars are standard deviation of the mean (N ≥ 10, **p < 0.01; B represents
BRMS1).
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3.5.3 BRMS1 has little effect on the biochemical changes of cancer cells to DOX
To compare the differences in biochemical information, Raman spectra of cells with
and without DOX treatment were collected. A representative Raman video images of 231,
231/BRMS1, 435, 435/BRMS1 and A549 are shown in Figure 3.3A-E. The average Raman
spectra were collected from over 24 spectra for each individual group, and all those spectra
exhibited similar spectral peaks.
To identify the spectral differences, the spectrum of corresponding control group was
subtracted from the average Raman spectra of different DOX groups (4 h, 12 h and 24 h) as
shown in Figure 3.3A’-E’. Raman peaks at 786 cm-1, 937 cm-1, 1006 cm-1, 1095 cm-1, 1313
cm-1, 1450 cm-1, 1608 cm-1 and peak range from 1200-1300 cm-1 show significant differences
when BRMS1 is expressed. The peak at 786 cm-1 arises from pyrimidine ring breathing mode.
Raman peak at 937 cm-1 is assigned to α-helix and C-C stretching in the protein backbone.
The peak at 1006 cm-1 belongs to the symmetric ring breathing mode of phenylalanine (Phe).
Raman peak at 1095 cm-1 can be assigned to lipid, and the peak at 1313 cm-1 corresponds to
guanine (G). The bands at 1450 cm-1 can be assigned to the CH2 deformation (def) of lipid
whereas the 1608 cm-1 corresponds to tryptophan (Tyr). The spectral region of 1200-1300
cm-1 belongs to Amide III. Table 3.1 lists the other major cellular biopolymers, i.e. nucleus
acids, proteins, lipids and carbohydrates.
The Raman intensities were extracted as shown in Figure 3.4. Most of the peak
intensities from BRMS1-expressing cells are larger than parental cells (Figure 3.4A-G).
Meanwhile, these spectral intensities displayed a similar trend from control to 24 h DOX
group.
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Figure 3.3 Similar Raman peaks corresponding to DNA/RNA, lipids and proteins between
cell lines have noticeable changes for all cancer cells after DOX treatment. The
representative Raman video images of (A) 231, (B) 231/BRMS1, (C) 435, (D) 435/BRMS1
and (E) A549 (inset in each image is the average Raman spectra from nucleus of control and
treated with DOX for 4 h, 12 h and 24 h). Spectra difference between different time (4h, 12h
and 24h) of DOX treated cells and control cells of (A’) 231, (B’) 231/BRMS1, (C’) 435, (D’)
435/BRMS1 and (E’) A549 (B represents BRMS1).

The peak intensity at 786 cm-1 (Figure 3.4A) gradually reduces in all cell lines from
control group to 24 h DOX exposure. After 24 h DOX exposure, the intensity at 786 cm-1 for
231, 231/BRMS1, 435, 435/BRMS1 and A549 slightly decreases 1.2, 1.2, 1.1, 1.1 and 1.2
folds respectively, compared to the corresponding control group. Interestingly, the intensity
of 1313 cm-1 (Figure 3.4B) increases for all cells from control to 24 h DOX exposure. In the
control group, the intensity of 1313 cm-1 for BRMS1-expressing cells is slightly larger than
that of cells without BRMS1. All cells increase 1.1 fold at 1313 cm-1 after 24 h DOX
treatment compared to control. Similarly, the peaks at 1095 cm-1, 1450 cm-1, 937 cm-1 and
1006 cm-1 (Figure 3.4C-F) all exhibit increasing intensity for all cells when compared to the
control. However, the intensity at 1608 cm-1 of 231, 231/BRMS1, 435, 435/BRMS1 and
A549 at 24 h group reduces 7%, 19%, 5%, 4% and 15% respectively compared to control.
The spectral region of 1200–1300 cm−1 (Figure 3.4H) fluctuates over DOX exposure time,
and the band areas of 12 h and 24 h DOX groups increase compared to control group for all
cancer cell lines due to an alteration of proteins secondary structure. The band area ratios
between the 1450 cm−1 and 1006 cm−1 in Figure 3.4I, A1450/A1003, can reveal a structural
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modification [40]. Most of the cells have the largest mean ratio at 24 h DOX treatment,
indicating the largest relative content of lipids at 24 h DOX incubation.
Overall, although BRMS1 expression changes the biochemical information of cancer
cells, all cancer cells respond to DOX similarly over time.

Table 3.1 Tentative Raman band assignments of cells.
Raman shift (cm-1)
Band assignment
624
Phenylalanine
717
CN− (CH3 )3 (lipids)
719
C-C-N+ symmetric stretching in phosphatidylcholine
720
DNA
760
Tryptophan
786
DNA & phosphdiester bands DNA
813
Phosphodiester bands RNA
832
PO−
2 stretch nucleic acids
854
Ring breathing tyrosine (proteins)
937
C-C stretching, α-helix (proteins)
961
Phosphate of HA; Calcium-phosphate stretch band
1006
Phenylalanine
1031
Phenylalanine
1057
Lipids
−
1066
PO2 stretching; chain stretching; C-O, C-C stretching
1084
Phosphodiester groups in nucleic acids
1095
Lipid
1200-1300
Amide III (proteins)
1313
Guanine
1317-9
Guanine (B,Z-marker)
1335/6
Guanine
1400-30
γ(C=O) O- (amino acids aspartic & glutamic acid)
1450
CH2 deformation (lipids)
1579
Pyrimidine ring (nucleic acids)
1608
Phenylalanine, Tryptophan
1658/9
Amide I band (protein band)
1740
Collagen III
Band assignments refer from literature [31-39].
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Figure 3.4 BRMS1 expression has little impact on the biochemical changes of cancer cells to
DOX. Raman intensity analysis of five cancer cell lines at (A) 786 cm-1 (pyrimidine), (B)
1313 cm-1 (guanine), (C) 1095 cm-1 (lipid), (D) 1450 cm-1 (CH2 deformation of lipid), (E)
937 cm-1 (α-helix), (F) 1006 cm-1 (phenylalanine) and (G) 1608 cm-1 (phenylalanine and
tryptophan) at different DOX exposure times (control, 4 h, 12 h and 24 h). Error bars are
standard deviation of the mean. The band area of 1200-1300 cm-1 (H) and the intensity ratio
(I) between the 1450 cm-1 and 1006 cm-1 bands (A1450/A1006) of 231, 231/BRMS1, 435,
435/BRMS1 and A549 cells at different DOX exposure times (N ≥ 6, **p < 0.01, B
represents BRMS1).
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3.5.4 BRMS1 affects the expression of cytokine and chemokine
Multiplex ELISA was applied to analyze a total of 25 human cytokines and
chemokines, and the majority of them were undetectable. However, several cytokines (IL-8,
IL-15, RANTES, MCP-1, GROα, GMCSF, IL-2 and TNFα) showed prominent expression
levels after DOX treatments (Figure 3.5).
All cells expressed IL-8, IL-15, RANTES and MCP-1, while some of these cells did
not release GROα, GMCSF, IL-2 and TNFα. For 231 and 231/BRMS1, the expressions of
IL-8, IL-15, RANTES and IL-2 are very similar from control to 24 h DOX group. However,
the average expression of GROα is 1041 and 5282 pg/mL for 231 and 231/BRMS1
respectively from control to 24 h DOX group, and 231 and 231/BRMS1 secrete an average of
135 and 9 pg/mL for GMCSF correspondingly. Similar to 231 and 231/BRMS1, these
cytokines fluctuate from control to 24 h DOX group for 435 and 435/BRMS1. Among the
eight cytokines 435 releases more than 435/BRMS1 except IL-2 that is undetectable. On
average, 435 cells express about 2-fold more IL-15, 9-fold more RANTES, 85-fold higher
MCP-1, 87-fold more IL-8, 93-fold higher TNFα, and 6308-fold more GROα than the
435/BRMS1 from control to 24 h DOX group. Meanwhile, the average expression of
GMCSF is 1687 pg/mL for 435 cells, while that of 435/BRMS1 is undetectable. For A549
cells, cytokine expression also varies. A549 cells express low level of IL-15, RANTES,
GMCSF, IL-2 and TNFα (each one is less than 9 pg/mL on average) comparing to IL-8,
MCP-1 and GROα (83142, 975 and 27650 pg/mL on average, respectively) from control to
24 h DOX group.
Overall, different cell lines release different cytokines at varying levels from control
to 24 h DOX group. Among the 25 cytokines and chemokines, many are expressed at a
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negligible level. The eight cytokines discussed here indicate that 231 and 231/BRMS1
release similar levels of IL-8, IL-15, RANTES and IL-2, while 435 cells express cytokines at
a much higher level than the 435/BRMS1 (except IL-2).

Figure 3.5 The expression of cytokine and chemokine was affected by BRMS1. Cytokines
and chemokines analysis of (A) IL-8, (B) IL-15, (C) RANTES, (D) MCP-1, (E) GROα, (F)
GMCSF, (G) IL-2 and (H) TNFα released from 231, 231/BRMS1, 435, 435/BRMS1 and
A549 cells. Cells were exposed to DOX for 0h (control), 4 h, 12 h and 24 h before
measurement. Unit of Y-axis: pg/mL. Error bars are standard deviation of the mean (N = 3,
**p < 0.01, B represents BRMS1).
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3.5.5 BRMS1 expression has little effect on apoptosis, ROS expression and cell viability
of cancer cells from DOX
When DOX interacts with cancer cells, an apoptotic response, an increase in ROS,
and reduced viability is triggered. These results also show that apoptosis, ROS expression
and cell viability tests are all time-dependent, and the percentage variations of these three
tests follow similar changes across all cell lines. In Figure 3.6A, there is a large increase in
the number of apoptotic cells after 24 h DOX exposure, with a pronounced increase in 435
and 435/BRMS1 cells. For instance, at 12 h exposure, both 435 and 435/BRMS1 have a
similar apoptosis percentage (ca. 5~6%); after 24 h exposure, the percentage of apoptotic
cells increases to 24 % for 435, and 27% for 435/BRMS1. Plus, both are significantly higher
than ~17% for both 231 and 231/BRMS1 at the same exposure time. Similarly, the
production of ROS in five cells grew with the increase of DOX exposure time (Figure 3.6B).
The overall level of ROS production for A549, 231, and 231/BRMS1 after 24 h DOX
exposure was larger than those for 435 and 435/BRMS1 cells. For cell viability (Figure 3.6C),
the viable cell percentages of 231, 231/BRMS1, 435, 435/BRMS1 and A549 decreased after
DOX treatment, changing into 72.7%, 72.4%, 74.8%, 70.7% and 74.5% respectively after 24
h DOX incubation. After 4 h and 12 h DOX exposure, the differences of viability percentage
between cancer cells and cancer cells with BRMS1 are ~3% and ~2.8%, correspondingly.
The apoptosis, ROS expression and cell viability changes of five cells display a
similar pattern from control to 24 h DOX exposure, reflecting the similar responses between
cancer cells and BRMS1-expressing cells to DOX treatment.
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Figure 3.6 BRMS1 expression has little influence on apoptosis, ROS expression and cell
viability of cancer cells from DOX. The representative (A) Apoptosis, (B) ROS expression
and (C) cell viability images and the histogram of (A’) Apoptosis, (B’) ROS expression and
(C’) cell viability percentage from 231, 231/BRMS1, 435, 435/BRMS1 and A549 cells
without DOX treatment and treated with 4 h, 12 h and 24 h DOX (Error bars are standard
deviation of the mean; N = 3, **p < 0.01, B represents BRMS1).
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3.6 DISCUSSIONS
Studies were conducted to understand the effects of metastasis suppressors on cellular
biomechanical and biochemical properties and its responses to chemotherapeutic drugs. To
perform these studies, a representative metastasis suppressor, BRMS1, was selected.
Immunolocalization experiments using BRMS1 antibody confirmed the high expression and
localization of BRMS1 predominantly to the nucleus of MDA-MB-435/BRMS1 cells.
BRMS1 is an important part of the SIN3-HDAC complexes, critical for deacylating histone
proteins and condensing the chromatin machinery leading to reduced transcription of several
genes [41, 42]. BRMS1 was also found, albeit at lower levels, in the cytosol, which is
consistent with earlier reports categorizing BRMS1 as a nucleo-cytoplasmic protein [43].
It is reported that in BRMS1-expressing cells, the activation of focal adhesion kinase
and β1 integrin were reduced, leading to a decrease level of cellular adhesion and
cytoskeletal reorganization [44]. Our results demonstrate that BRMS1 could affect cellular
biomechanical properties. The Young’s moduli of metastatic cancer cells (231, 435) are
lower than that of non-metastatic cells (231/BRMS1, 435/BRMS1), which is consistent with
reported studies [26, 45-47]. This distinction in cell elasticity is attributed to altered
cytoskeletal organization, in particular the intermediate filament and actin filament structures,
which have been identified as the main determinants of cell elasticity [48]. Furthermore,
interaction with DOX results in an increase in Young’s modulus for cancer cells; while
decreasing it in BRMS1 expressing cells. Metastatic cancer cells (231, 435) possessed lower
adhesion forces than BRMS1 expressing non-metastatic cells. In addition, interaction with
DOX led to increased cell adhesion in metastatic A549, 231 and 435 cells, whereas a
decrease was seen in non-metastatic 231/BRMS1 and 435/BRMS1 cells. The measured
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adhesion force is associated with cell-surface biomolecules [49]. Alterations in cell adhesion
after DOX treatment may be caused by cellular response to chemical stimulus leading to the
variation of cell-surface macromolecules.
The Raman spectral results demonstrate that BRMS1 expression has an effect on
cellular biochemical properties. However, after DOX treatment, the spectral changes of
cancer cells with BRMS1 are similar to those without BRMS1. DOX incubation time also
plays a critical role in changing spectral intensities.

The results suggest that BRMS1

expression changes the cells’ biochemical makeup without affecting chemotherapeutic
sensitivity of these in vitro cancer cells. It is reported that the expression of BRMS1 largely
enhances major histocompatibility complex (MHC) genes and significantly reduces the
expression level of some genes related to protein localization and secretion [50]. This
phenomenon is more obvious between 435 and 435/BRMS1, as shown in Figure 3.5.
Although 231 and 231/BRMS1 secrete similar level of IL-8, IL-15, RANTES and IL-2, the
level of GMCSF for 231/BRMS1 is much less than that of 231. This result may indicate that
the expression of BRMS1 in different cell lines has different effects on secretion of cytokines.
In addition, the expression values of cytokines and chemokines for five cell lines are at
similar magnitude comparing control to DOX treated groups, suggesting that DOX has
similar influences on cancer cells with and without BRMS1. The results from apoptosis, ROS
expression and cell viability reflect similar patterns for five cell lines upon DOX treatments,
confirming that DOX has similar impacts on cancer cells with and without BRMS1.
In conclusion, this study demonstrates the distribution of BRMS1 within cells. It is
also observed that BRMS1 has an influence on cellular biomechanical and biochemical
properties. However, the effect on cellular biomechanical and biochemical information from
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BRMS1 does not affect the chemotherapeutic sensitivity of cells with BRMS1 compared to
cells without BRMS1. These findings have provided critical clues on the biomechanical and
biochemical changes from BRMS1 expression and the following drug treatments, and
confirmed that the drug treatment of breast cancer remains effective in the presence of
BRMS1. Our future work is to study more metastasis suppressors and their effects on cellular
levels, providing clinical cues for drug treatments.
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CHAPTER 4
DIESEL EXHASUT PARTICLES (DEP) INDUCED HUMAN LUNG CANCER CELLS
DAMAGE AND THE STRUCTURE PROTECTIVE EFFECT OF RESVERATROL (RES)
4.1 ABSTRACT
In this study, scanning electron microscopy (SEM), confocal laser scanning
microscopy and atomic force microscope (AFM), Raman spectroscopy (RM), multiplex
ELISA, flow cytometry, were applied to analyze the biochemical and biophysical responses
of in vitro human lung carcinoma epithelial cells (A549) treated with or without resveratrol
(RES), followed by different time points (from 0 h to 48 h) of diesel exhaust particles (DEP)
exposure. SEM identified the elements and size of DEP and the morphology of cells treated
with DEP and RES. Confocal microscope and AFM results confirmed that DEP destroyed
cellular structure and the protective effect from RES. AFM topography showed that RES
protected cells from DEP-induced damage to cytoskeleton and cell architectures. Also, AFM
force-distance measurements indicated that RES treatments attenuated DEP-induced
alterations in cell elasticity and surface adhesion force over DEP incubation time. RM
monitored the changes of characteristic Raman peak intensities of DNA and protein over
DEP exposure time for both RES and non-RES treated groups. The cytokine and chemokine
changes quantified by Multiplex ELISA revealed that the inflammatory responses were
enhanced with the increase in DEP exposure time, and that RES attenuated the expression
levels of cytokine and chemokine. In addition, DEP and RES changed the plasma membrane
potential (PMP) and cell cycle of A549 cells. This work demonstrated that significant
biophysical and biochemical changes induced by DEP may be relevant to early pathological
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changes induced by DEP damage, and that the pretreatment of RES protected cellular
damage and increased cellular sensitivity to DEP exposure, revealing the importance of
antioxidant on the prevention of respiratory diseases.
4.2 INTRODUCTION
A relationship between lung cancer incidence, cardiopulmonary deaths, respiratory
and cardiovascular diseases for adults living in metropolitan areas and the level of particulate
matter (PM) has been reported [1-4]. One specific type of PM significant to public health is
the diesel exhaust particle (DEP), which is characterized by a carbonic nucleus, in which
some 18,000 high-molecular-weight organic compounds are adsorbed [5]. The mechanisms
of DEP causing adverse health effects are involved with reactive oxygen species (ROS)
generation, oxidative stress and inflammation [6], and these repsonses can lead to DNA
damage [7].
Resveratrol (trans-3, 4, 5-trihydroxystilbene, RES) is a phenolic natural component of
Vitis vinifera L, mainly abundant in the skin of the grapes and found to be present in higher
concentration in red than in white wines. This natural compound has been found to show
many pharmacologic effects, including lipoprotein metabolism modulation, platelet
antiaggregation, anti-inflammation, anti-fungal, cancer chemopreventive, and anticancer
properties [8-11]. Studies have shown RES can effectively inhibit oxidative damage [12, 13]
and has been shown to scavenge free radicals such as lipid hydroperoxyl, hydroxyl (•OH),
and superoxide anion (O2•-) radicals [14].
It is clinically important to study cellular responses when cells are exposed to DEP
with or without RES because people are under the condition of taking up antioxidants by
daily diet and being exposed to potential DEP-containing environment. The investigation of
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DEP and RES on cellular biophysical and biochemical changes is needed to better
understand the mechnisms of DEP and RES on mammalian cells. Atomic force microscopy
(AFM) has proven to be a valuable tool to study single cells. With AFM measurement,
cellular topography and mechanics properties (adhesion force and elasticity) can be measured
and statistically analyzed [15-17], allowing researchers to better understand biophysical
responses of mammalian cells under the different treatments. Previous applications of AFM
in human lung carcinoma epithelial cells (A549) studies include elasticity modulus
measurements [18, 19], recognition of surface heparin sulphate proteoglycan receptors [20],
and photodynamic and sonodynamic effects [21, 22], demonstrating the feasibility and utility
of AFM to detect cellular biophysical properties. Raman microspectroscopy (RM) is a
spectroscopic technique that can be utilized to identify characteristic fingerprints of living
cells based on chemical compositions and molecular structures [23]. When the light is
scattered from a molecule, a small fraction of light (approximately 1 in 107 photons) is
scattered at lower optical frequencies than the frequency of the incident photons. Raman
scattering can occur with a change in vibrational, rotational or electronic energy of a
molecule, Thus RM is a sensitive method to measure compounds in biological system and
can provide supplementary information on cellular composition. Previous applications of RM
were mainly focused on physical and structural investigations; more recently, it has gained
popularity in the field of cellular biology [24, 25], suggesting that RM can provide cellular
biochemical information for analysis.
The primary target tissue of inhaled DEP is lung epithelial cells, so this experiment
was conducted by exposing A549 cells - as model of alveolar epithelial cells - to DEP and
RES. The purpose of this work is to improve understanding of the cellular biomechanical and
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biochemical changes and the connection with cellular responses by which DEP cause damage
to the airway epithelium and the potential protection from RES to those DEP damaged cells.
In order to address this, the effects of DEP and RES on cellular topograpy, cytoskeleton,
biomechanics, biocomponents, inflamatory responses, plasma membrane potential and cell
cycle of the human epithelial A549 cell line were investigated.
4.3 HYPOTHESIS
DEP could destroy cellular structure, and induce cellular inflammatory responses,
while RES could alleviate DEP-induced destructive effect on cytoskeleton and enhance the
inflammatory responses of cells.
4.4 MATERIALS AND METHODS
4.4.1 Preparation of human lung carcinoma epithelial A549 cells
Human lung carcinoma A549 cells (ATCC, Manassas, VA, USA) were cultured in
F-12k medium containing 10% fetal bovine serum (Thermo Fisher Scientific, Waltham, MA,
USA) at 37 °C with 5% CO2 in a humidified atmosphere. Cells (approximately 106 cells/mL)
were passaged at 70-90% confluency and used for experiments.
RES was dissolved in complete cell growth media, and sonicated for 3 min at room
temperature. Then 10 µM RES culture media was added directly into A549 cells for 24 hours.
DEP was generously given by Dr. M. Ian Gilmour of the National Health and Environmental
Effects Research Laboratory, U.S. Environmental Protection Agency (Research Triangle
Park, NC, USA). DEP was suspended in complete cell growth media and underwent vortex
for 10 s, and subsequently sonicated for 20 min at room temperature. Then 400 µg/mL DEP
suspension was added 50 µL directly into 2 mL culture media. One group of cells was treated
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with the DEP suspension for 0 hour (h) (no DEP treatment), 4 h, 8 h, 16 h, 24 h and 48 h,
respectively. And the other group of cells was treated with RES for 24 hours in advance and
then added the DEP suspension for 0 h, 4 h, 8 h, 16 h, 24 h and 48 h, respectively, at a final
concentration of 10 µg/mL DEP. DEP were characterized by scanning electron microscopy
(SEM) and energy-dispersive X-ray spectra (EDX), which was recorded by FEI Quanta FEG
650 equipped with a FEG source (FEI Quanta FEG 650, FEI Company, Hillsboro, OR,
USA). Cell samples of different treatments were stained for cytoskeletal (Alexa Flour® 488
phalloidin) and nuclear architecture (DAPI) according to manufacturer’s protocol (Thermo
Fisher Scientific), and were imaged by an LSM 710 confocal laser scanning microscopy
(Carl Zeiss, Thornwood, NY, USA).
4.4.2 Raman Microspectroscopy
To minimize background in RM, a density of 1x105 cells per 2 mL of media was
seeded on a sterilized magnesium fluoride (MgF2) optical window (United Crystals Co., Port
Washington, NY). Raman spectra were acquired with a Renishaw inVia Confocal Raman
System coupled a Leica microscope (Leica DMLM, Leica Microsystems, Buffalo Grove, IL,
USA) with a 63  water immersion objective. The Raman system (Renishaw, Wotton-underEdge, Gloucestershire, UK) was equipped with a thermoelectrically cooled Renishaw
RenCam NIR enhanced charge-coupled device (CCD) detector and a 785 nm near-IR laser
was employed as excitation source. The Raman microscope was equipped with a motorized
XYZ positioning stage (Prior Scientific, Cambridge, UK) with integrated position sensors on
the X and Y axes with a 0.1 m displacement capacity. Instrument control and data
collection was performed with Renishaw WiRE 3.3 software. The confocal configuration
placed a physical block or “pinhole” in the laser path and reduced the illuminated laser area
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to a ~3 × 3 m laser spot. Additional high confocality software settings allowed largely
improved signal-to-noise in the final data. The spectrometer was calibrated with silicon at a
static spectrum centered at 520.5 cm-1 for 1 s. Cells were cultured on 13 mm MgF2 with ~70%
confluency, then placed in a 50 mm glass Petri dish lined with a reflective metal substrate,
with Earle’s Balanced Salt Solutions (EBSS) as the imaging medium. Spectra were collected
in a static mode for two accumulations at 20 s laser exposure over a wavenumber range of
600  1800 cm-1 for cells and culture medium at the same focal plane [26]. If necessary,
Cosmic Ray Removal (CRR) was performed. Four spectra per location and three locations
for each cell were imaged (16 total spectra per location): nucleus, cytoplasm and cell
membrane. The diffraction limited optical resolution for the 63  objective was calculated by
the Abbe equation [23]. In this experiment, 48 spectra (4 replicates per location × 3 locations
per cells × 4 individual cells) for each time treatment point were collected. Raman spectra are
affected by the physical properties of the samples and background noise, so it is necessary to
perform mathematical processes to reduce systematic noise, and enhance resolution of
chemical compositions from target cells. Firstly, Raman spectra were smoothed by moving
average smoothing to filter high-frequency noise. Then, second derivative of smoothed
spectra was performed to eliminate baseline drifts and background interference. This method
of data processing helps to distinguish overlapping peaks and improve resolution and
sensitivity of spectra [27].
4.4.3 Measurement of cytokines and chemokines secretion by multiplex ELISA
To analyze the secretion of cytokines and chemokines, cell supernatants with
different treatments were collected and centrifuged at 250 × g for 5 min to remove cells and
then centrifuged at 2500 × g for 5 minutes to remove DEP prior to storage at -80°C. The
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samples were tested as single batches on Quansys Biosciences’ (Logan, UT, USA) Q-Plex
ArrayTM kits for human cytokines and chemokines. The data were reported as mean ± SD
(standard deviation of the mean), and the statistical difference was analyzed by one-way
ANOVA.
4.4.4 Flow Cytometry
Flow cytometry was performed with BD FACSAria II (BD Biosciences, San Jose,
CA, USA), and data analysis was conducted by FACSDiva version 6.1.3 (BD Biosciences).
Protocol of Plasma membrane potential. The dye bis-(1, 3-Dibarbituric acid)trimethine oxanol (DiBAC4(3)) (Ex/Em: 493/516 nm; Enzo Life Sciences, Farmingdale, NY,
USA) was applied to detect the alterations in plasma membrane potential of A549 in the
absence and presence of 10 µM RES and 10 µg/mL DEP. DiBAC4(3) serves as an indicator
for the changes in membrane potential. An increase in fluorescence intensity indicates
depolarization of cells, while a decrease in fluorescence intensity is indicative of cell
hyperpolarization. The harvested DEP-treated cells were incubated in 5 µM dye-PBS
solution in 37oC incubator with 5% CO2 for 30 min. Then stained cells were immediately
tested by flow cytometry.
Protocol of Cell cycle. The floating and adherent cells were collected, washed twice
with PBS before centrifuged. The pellet was fixed in 70% (v/v) ethanol for 24 h at 4 °C. The
cells were washed once with PBS and resuspended in cold propidium iodide (PI; 50 µg/ml)
containing RNase A (0.1 mg/mL) in PBS (pH 7.4) for 30 min in the dark. Cellular DNA
content was analyzed by flow cytometry. Forward light scatter characteristics were used to
exclude cell debris from the analysis. At least 10,000 cells were used for each analysis.
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4.4.5 Atomic Force Microscopy
The cells were seeded on poly-L-lysine coated glass bottom Petri dishes (MatTek
Corp., Ashland, MA, USA) at a density of 1x105 cells per 2 mL of media. Cells with
different treatments were then measured by AFM. For AFM measurements, the in situ
approach was used to visualize cell topography and measure the mechanical properties such
as adhesion force and Young’s modulus; that is, cells grown on poly-D-lysine-coated glass
bottom Petri dishes were directly transferred onto AFM scanner stage for measurements
without any pretreatment, and whole measurements were conducted in culture media at room
temperature within 2 h; the acquired imaging and data thus reflected the morphology and
physiological status of the observed living cells.
The contact mode Picoplus AFM controlled by software PicoView 1.14 (Agilent
Technologies, Santa Clara, CA, USA) was applied to perform measurements directly in cell
culture media. The spring constant of the cantilever was calibrated at 0.06 ~ 0.11 N/m using
the Thermal K Calibration Kit (Agilent Technologies). The length of tip with pyramid shape
is approximately 3 µm, and the curvature radius of the Si3N4 tip is around 10 nm. Meanwhile,
the approach/retract velocity applied throughout the experiments of deflection (nm) vs.
distance (nm) curve acquirement was 6 µm/s. The values for the adhesion force (the
detachment force between bare AFM tip and cell surface in the process of AFM cantilever
retracting, which reflects alteration of cell membrane adhesion behavior/property or
denaturation of membrane surface adhesion molecules) were extracted from curves of
deflection (nm) vs. distance (nm) via the Scanning Probe Image Processor (SPIP) software
(Image Metrology, Hørsholm, Denmark). Over 10 cells were measured, collecting at least 50
force curves of each individual cell. By applying the AFM tip to the cell surface, the

98

elasticity modulus of cells can be evaluated based on the slope of compliance portion of the
deflection-distance curves. To analyze alterations in cell elasticity, Young’s modulus was
calculated according to the formula [15, 28, 29]:

Ecell 

2
4  F( Z )  (1   cell
)

3  z 2  tan 

(1)

Where, Ecell, cellular Young’s modulus; F, loading force; ηcell, Poisson ratio (assuming 0.5);
Δz, indentation; 𝜃 is the tip half opening angle that equals to 36o.
Young’s modulus and adhesion force were calculated based on hundreds of
deflection-distance curves acquired for each group. Furthermore, to assess statistically
significant differences in biomechanical properties including adhesion force and cellular
elasticity between the two groups, the data were reported as mean ± SE (standard error of the
mean), and the statistical difference was analyzed by a Student’s t-test. The data used to
graph histogram were measured from the whole cell body, and the histograms were plotted
by OriginPro 9.0 (OriginLab Corp., Northampton, MA, USA).

4.5 RESULTS
4.5.1 Characterization of DEP by SEM
From the EDX spectrum (Figure 4.1A), the DEPs used in this study consisted of nonmetal element, metal and metal oxide compounds [30]. DEP size in culture medium ranged
from nanometers to as large as micrometers (Figure 4.1A (inset)), which is similar to
previous report [31].
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Figure 4.1(B-D) illustrates the representative SEM images of A549 cells without
treatment, treated with 24 h DEP, and treated with 24 h RES first and then 24 h DEP (black
arrow points to DEP), respectively. It was found that after 24 h DEP exposure (Figure 4.1C)
the filaments of the cells decreased compared to control (Figure 4.1B). However, the group
of cells treated with 24 h RES first and followed by 24 h DEP exposure (Figure 4.1D)
exhibited more well-defined filaments than that of 24 h DEP group (Figure 4.1C), suggesting
that RES may play an important role in protecting cellular structure.

Figure 4.1 Energy-dispersive X-ray spectroscopy of DEP (A) used in this study (inset is the
representative SEM image of DEP). Representative SEM images of A549 cells without
treatment (B), treated with 24 h DEP (C) and treated with 24 h RES and 24 h DEP (D) (black
arrow points to DEP).
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4.5.2 Morphological comparison by confocal laser scanning microscopy
To further detect cytoskeletal alterations of A549 treated with DEP for different
exposure times before and after RES pre-treatment, laser scanning confocal microscopy was
applied to visualize cellular structure, as shown in Figure 4.2 (green fluorescence). DEP can
be easily found in DIC images (black dots). It was observed that cytoskeleton was gradually
obscure after 16 h DEP exposure in non-RES group (Figure 4.2A). Additionally, cell shape
and cell architectures especially lamellipodia structures became obviously contracted over
longer DEP exposure time. In contrast, cytoskeletal structures arranged in parallel can be
readily seen in RES group (Figure 4.2B) under similar DEP exposure time (e.g., 16 h
exposure timepoint), and the RES group possessed more cellular filamentous cytoskeleton or
filopodia. These observations revealed the damage effect from DEP on cellular structures and
protective effect of RES on cytoskeleton, confirming the findings from AFM results below.
4.5.3 RES attenuated DEP-induced biomechanical alterations of A549 cells by AFM
AFM was applied to imaging cellular topography and detect cell biomechanics for the
cells under DEP and/or RES exposures, as shown in Figure 4.3. Figure 4.3(A-B) displayed
cellular deflection topography images from different treatment times (from 4 h to 48 h) and
the corresponding 3D view images (row 1 and row 2), respectively. Morphological changes
due to DEP exposure were found in Figure 4.3A, and it was observed that cell size gradually
reduced over DEP exposure time, compared to control cells. However, the RES treated group
(Figure 4.3B) exhibited well-defined cytoskeleton and more cellular surrounding structures
in comparison with non-RES treated group under similar DEP exposure time. For example,
after 8 h exposure, RES/DEP treatment group presented more flat and filamentous
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cytoskeleton than non-RES groups, suggesting that the presence of RES may maintain
cellular morphology even under DEP exposure.

Figure 4.2 Differential interference contrast (DIC) images (row 1 and row 3) and
corresponding fluorescence (FL) confocal images (row 2 and row 4) of A549 cells treated
with DEP for different time and treated with RES and DEP for different time (scale bar: 10
µm; DEP: black spot in DIC images; nucleus: DAPI, blue; cytoskeleton: fluorescein
phalloidin, green).

After observing the cytoskeletal changes, it was of interest to investigate the
biomechanical properties of A549 in the absence and presence of RES, which would offer
new insights into assessments of DEP cytotoxicity and RES role in protecting cells from DEP
induced damage. Therefore, AFM was also used to quantify mechanical property changes
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(including Young’s modulus and membrane adhesion force) of A549 cells in culture medium,
as shown in Figure 4.3(C-D). Furthermore, a statistical analysis of alterations of adhesion
force and Young’s modulus (cell elasticity) obtained from multiple cells was conducted.
Both histograms of Young’s modulus (Figure 4.3C) and adhesion force (Figure 4.3D)
fluctuated over DEP exposure time in both non-RES and RES groups, and they both had
peak values at 24 h DEP (19.16 kPa for non-RES group; 17.17 kPa for RES group). In
addition, it was observed that Young’s modulus in presence RES increased slightly over the
exposure time except 16 h and 24 h (which slight decrease). In general, the presence of RES
lead to the slight increase in adhesion force across all exposure time (Figure 4.3D), indicating
that RES made cell tougher and difficult to migrate. For example, at 0 h DEP (control group)
the value of Young’s modulus and adhesion force for RES group was 1.3-fold and 1.2-fold
than those of non-RES group, respectively; while at 48 h DEP treatment, the value of
Young’s modulus and adhesion force for RES group was 1.2-fold and 1.2-fold than those of
non-RES group, respectively. The AFM results indicated that DEP damage lead to the
changes of cytoskeleton and biomechanical properties, and RES may play a protective role in
cellular structures from the DEP induced damage.
4.5.4 RES affected DEP-induced biochemical changes of A549 cells by Raman
microspectroscopy
Raman representative bright-field images and the corresponding spectra of four time
points (0 h, 4 h, 16 h and 48 h DEP exposure) with or without RES treatments were shown in
Figure 4.4(A-B). Raman bright-field images exhibited the morphologic changes of A549
cells (labelled with white dash line) treated with different time points of DEP. Three
averaged spectra (under each bright-field image) correspond to three locations on a single
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cell were presented in color: nucleus (black), cytoplasm (red), and cell membrane (blue).
Each spectrum was the averaged spectrum from four randomly selected cells. It was observed
that the spectra of non-RES group and RES group are similar at 0 h and 48 h DEP. Both
groups exhibited well-define spectral peaks at 0 h DEP, while these characteristic peaks
disappeared after 48 h DEP treatment, indicating the destructive effect from DEP. However,
it was found that RES group displayed more spectral peaks than non-RES group at 4 h and
16 h DEP incubation, suggesting that RES may protect cellular biocomposition against DEP.
To further compare these spectral differences, characteristic peaks were extracted for analysis.
A representative Raman spectrum of A549 cells without treatment is shown in Figure
4.4C. Two characteristic peaks at 786 cm−1 (DNA and phosphodiester) and 1660 cm−1
(Amide I) are selected to compare the spectral changes of cellular biopolymers due to DEP
and RES exposure, and the change in peak intensities (normalized to the highest peak in the
spectrum) from three cell locations is displayed in Figure 4.4(D-F). It was found that these
peak intensities at nucleus, cytoplasm and cell membrane decreased with the increase of DEP
exposure time. The peak intensity decrease of 786 cm-1 at nucleus (Figure 4.4D) indicated
that extended DEP exposure could damage cellular DNA. Also, DEP could suppress the
presence of Amide I at cytoplasm and membrane, as seen from Figure 4.4(E-F). In addition,
RES treatment attenuated the decrease of the DEP-induced peak intensities, suggesting RES
affects the cellular biocomponents of exposed cells.
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Figure 4.3 Representative AFM deflection images and corresponding 3-D images of A549
treated with 10 µg/mL DEP (A) and treated with 10 µM RES and 10 µg/mL DEP (B) for
different times. Histograms of Young’s modulus (C) and adhesion force (D) of A549 cells
treated with different groups. The data of histograms were obtained from multiple individual
cells (Error bars are standard deviation of the mean; N ≥ 10, **p < 0.01).
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Figure 4.4 Raman bright-field images and spectra of A549 cells with 0 h, 4 h, 16 h and 48 h
DEP treatment (A) and treated with 24 h RES in advance, followed by 0 h, 4 h, 16 h and 48 h
DEP treatment (B). In row 1 of (A) and (B) white dash line illustrates cellular morphology;
black arrow points to nucleus; red arrow points to cytoplasm; blue arrow points to
membrane. Row 2 of (A) and (B) is the corresponding confocal Raman spectra at different
cellular locations as assigned by different color: nucleus (black); cytoplasm (red) and cell
membrane (blue). A representative Raman spectrum of A549 cells without treatment (C).
Raman peak intensity changes for nucleus (D), cytoplasm (E) and membrane (F) at Raman
peaks 786 and 1660 cm−1 (Error bars of (D–F) are standard deviation of the mean; N ≥ 4, **p
< 0.01).
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4.5.5 Cytokine and Chemokine analysis of DEP-induced A549 cells before and after
RES treatment
Seven human cytokines and chemokines (IL-6, IL-8, MCP-1, RANTES, GROα, GMCSF and Eotaxin) assayed by multiplex ELISA were selected to compare the inflammatory
changes among different treatments, as shown in Figure 4.5. It was noticed that the increase
of DEP exposure time resulted in the elevated inflammatory responses, which were reflected
by the increasing level of some important cytokines and chemokines secretion. As an
example, from to 0 h DEP to 48 h DEP exposure, it led to the expression of IL-6, IL-8,
MCP-1, RANTES, GROα, GM-CSF and Eotaxin increased 44.4%, 74.3%, 62.7%, 43.2%,
21.5%, 49.7% and 116.7%, respectively. As comparison, it was found that RES treatment
increased the secretion of cytokines and chemokines of DEP-induced cells (even for control
group), especially for IL-6, IL-8, MCP-1, RANTES and GROα (Figure 4.5(A-E)). In control
cells (0 h DEP), RES treatment exhibited an increase of 4.3-fold for IL-6, 3.3-fold for IL-8,
2.5-fold for MCP-1, 3.5-fold for RANTES, 2.0-fold for GROα, 1.1-fold for GM-CSF, and
1.7-fold for Eotaxin than those of non-RES treatment.
Overall, the cytokines and chemokines levels for A549 cells were found to be
elevated over DEP exposure time. Compared to non-DEP treated groups, A549 released
higher levels of cytokines and chemokines in presence of RES. This observation suggested
that the presence of RES seems to make the DEP damaged cells become “worse” with
enhanced inflammatory responses, and it is possible that RES may play a different role in the
regulation of cytokines/chemokines levels than the regulation of cell biomechanics over DEP
exposure.
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Figure 4.5 RES induced cytokines and chemokines release from A549 cells. Histograms of
IL-6, IL-8, MCP-1, RANTES, GROα, GM-CSF and Eotaxin (A-G) showed mean values of
three independent experiments of both types of cells. Cells were exposed to 10 µM RES for
24 h and 10 µg/mL DEP for 0 h (no DEP treatment), 4 h, 8 h, 16 h, 24 h and 48 h, or only
treated by 10 µg/mL DEP 0 h (no DEP treatment), 4 h, 8 h, 16 h, 24 h and 48 h for before
measurement (Error bars are standard deviation of the mean; N = 3, **p < 0.01).

108

4.5.6 Plasma membrane potential and cell cycle analysis
To further evaluate the biophysical responses, flow cytometry was applied to
investigate the effect of RES on plasma membrane potential (PMP) and cell cycle of DEP
exposed A549 cells (Figure 4.6). These histograms of statistical analysis were based on three
independent experiments of just DEP treated cells and RES combined with DEP treated cells.
In PMP measurement, the fluorescence of the dye DiBAC4(3) reflects the level of
PMP. In depolarized cells, DiBAC4(3) can easily bind to intracellular proteins or membrane
to exhibit higher fluorescence intensity, which corresponds to high PMP. Conversely, a
decrease in fluorescence (low PMP) is indicative of cell hyperpolarization. The PMP of both
cells with and without RES groups fluctuated over DEP exposure time (Figure 4.6A). NonRES group (DEP only) showed the increasing trend up to 8 h at which PMP reached the
largest (2.0-fold of 0 h DEP), and then decreased gradually till reached stable at 24 h through
48 h exposure time (67.9% of 0 h DEP) . However, the presence of RES maintained the PMP
stable in first 8 h of DEP exposure, then decreased till 16 h; slightly increased PMP (~9% of
0 h DEP) after 24 h DEP exposure was then observed. It was noticed that the PMP value of
non-RES group was 2.0-fold at 8 h DEP and 1.9-fold at 16 h DEP than those of
corresponding RES group. However, the PMP values of non-RES group at 24 h and 48 h
DEP became 61.3% and 61.1% of those corresponding RES group. The fluctuation of PMP
revealed that DEP can lead to cellular depolarization and hyperpolarization at different times
of DEP exposure, and RES can decrease DEP-induced PMP over the first 16 h of DEP
exposure, followed by the increase in PMP from 24 h to 48 h.
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Figure 4.6 Changes of plasma membrane potential (A) (control group was normalized as 1)
and cell cycle (B) of A549 cells treated with 10 µg/mL DEP and treated with 10 µM RES
and 10 µg/mL DEP assayed by flow cytometry. Results represent the means of three separate
experiments, and error bars represent the standard error of the mean. All experimental groups
significantly differs from control group (Error bars are standard deviation of the mean; N = 3,
**p < 0.01).

The regulation of the cell cycle plays an important role in cell survival because it can
repair genetic damage and prevent uncontrolled cell division. To study the effect from RES
on the cell cycle progression of A549 cells, the cells were stained with PI and then flow
cytometry was performed on cells incubated with 10 μM RES for 24 h in advance then
treated without DEP or treated with 10 µg/mL DEP for 4 h, 8 h, 16 h, 24 h and 48 h (Figure
4.6B). It was observed that most of cells from non-RES and RES groups were resting cells
(over 80% of cells for all treatments in G1 stage except cells treated with RES and 16 h DEP
(79% of cells in G1)), and G2 stage had the least percentage of cells for all treatments. Cells
treated with RES and 16 h DEP were significantly increased in the S phase. The percentages
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of cells in G2 stage for both non-RES and RES groups decreased over DEP exposure time
except the group of RES and 16 h DEP. In non-RES group the cells, G2 stage percentage
decreased 75.9%, 60.2%, 81.4%, 42.4% and 50.9% at 4 h, 8 h, 16 h, 24 h and 48 h DEP,
compared to control group, respectively. Similarly, compared to control group, G2 stage
percentages in presence of RES also decreased 78.1%, 74.5%, 61.6%, 31.7% and 32.6% at 4
h, 8 h, 16 h, 24 h and 48 h DEP respectively. In comparison, it was found that the non-RES
group had 1.6-fold, 1.6-fold, 1.3-fold, 2.1-fold, 2.2-fold and 2.6-fold more cells in G2 than
the RES group at 0 h, 4 h, 8 h, 16 h, 24 h and 48 h DEP, respectively. These cell cycle results
indicated that most of A549 cells from both non-RES and RES groups were arrested in the
G1 phase of cell cycle over DEP exposure time. The percentages of cells in G2 phase
decreased over DEP exposure time for both non-RES and RES groups, and RES group had
less percentage of G2 stage cells than that of non-RES group at each DEP exposure time
point.
4.6 DISCUSSION
Cytotoxicity of DEP evokes increasing concerns with adverse effects on human
health, especially on the respiratory system. Antioxidant is an effective approach for
protection against environmental factor-induced damage. RES has been well known for its
antioxidant role and protective effects against oxidative damage [32]. Previous approaches to
study cytotoxicity associated with DEP exposure and test the protective ability of RES were
based mainly on traditional molecular biology methods (e.g., Microarray; microRNA;
western blotting). However, very little information from these traditional methods can be
provided with cell biophysical properties (cytoskeleton, cell architectures and cell
biomechanics) and biochemical properties (biochemical components, cell surface
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biomacromolecules/biopolymers), especially analysis of these properties at the single living
cell level. Thus, investigations of such biophysical and biochemical information using our
proposed instrument techniques would further elucidate the role of RES in potential
protection of DEP induced cell damage.
Inspired by this motivation, first SEM was applied to confirm the localization of DEP
on A549 cells and distinguish their structural differences (Figure 4.1). It was noticed that the
size of DEP was not uniform and distributed randomly around the cells. There were obvious
morphological differences between DEP group and RES/DEP combined treatment group: the
later displayed more filaments and well-defined surrounding cellular structures. Confocal
fluorescence microscopy images (Figure 4.2) showed that changes of cytoskeletal
organization induced by DEP can be distinguished. The cytoskeletal structures of DEP
treated cells became obscure and decreasing F-actin filaments after 8 h DEP exposure,
implying denaturation of membrane molecules occurred at these time points, whereas cells of
combined RES and DEP treatment group possessed a clear and intact cytoskeleton structures
in the first 16 h.
Furthermore, AFM was utilized to detect biophysical changes at single cell level in
the absence and presence of RES, and besides visualization of possible rearrangement and
even destruction of cytoskeleton induced by DEP. Observations of membrane cytoskeleton
indicated that DEP treatment induced significant alterations in cell architectures after 16 h
treatment, and the topographical images revealed that the cell lamellipodia structures became
obviously contracted over DEP exposure time. However, the group treated with combined
RES/DEP possessed more cellular filamentous cytoskeleton or filopodia than the group
treated with DEP only at the same DEP treatment duration (e.g., after 8 h DEP exposure),
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and the topography images of combined RES with DEP group were similar to non-treatment
group (Figure 4.3). Such observations and analyses revealed that 10 µg/ml of DEP
intervention could induce obvious changes in cell membrane cytoskeleton and cell
topography, and 10 µM RES of 24 h incubation (before DEP exposure) could prevent the
structural damage from DEP. In addition, cellular biomechanics (Young’s modulus and
adhesion force) were generally increased after treated with RES at most of DEP exposure
timepoints, compared to non-RES group. It was reported that cancer cells normally have
lower cellular biomechanics (cell stiffness and adhesion) than that of their normal
counterparts, and these biomechanical differences can be indicative of early diagnosis of
cancers [33, 34]. When first treated with RES before DEP exposure, the biomechanical
properties of A549 cells were larger than these of non-RES group, which means RES treated
A549 cells became less cancerous and would be more difficult to migrate. These
observations implied that RES plays a significant role in the regulation of cellular
cytoskeleton and prevention of cancer migration. Characterizations of these biophysical
properties demonstrated the competence and utility of AFM as a force-sensitive
nanotechnique in the study of DEP induced cellular damage and the potential protective
effect of RES. Our work here supports the conclusion that cell nanomechanics [17] such as
elasticity [35] could be a promising “biomarker” to reveal cellular phenotypic events [36]
associated with cytoskeleton arrangement [15] and the decomposition of membrane surface
molecules.
To assess how RES treatment affects the biochemical composition of A549 cells over
DEP exposure time, RM was then used to evaluate spectral changes that directly reflect the
biochemical alterations of individual A549 cell under various DEP treatment times (Figure
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4.4). The Raman spectra from three locations (cell nucleus, cytoplasm, cell membrane) were
selected to compare spectral changes in some characteristic peak intensities, as a function of
DEP exposure time. It was noticed that Raman spectra at each location were distinctive with
reproducible band differences. Spectra of non-DEP group (Ctrl and RES in Figure 4.4)
illustrated well-defined Raman bands. Peak assignments of RM spectra of A549 cells have
been given previously [37-41]. For RM spectra of cells treated with only DEP and DEP
combined with RES, these characteristic peaks were significantly suppressed in all five DEP
exposure timepoints (4, 8, 16, 24 and 48 h), suggesting DEP had destructed cellular surface
structures. Statistical analysis of Raman characteristic peaks at 786 cm-1 (DNA) at nucleus
and 1660 cm-1 (protein) at cytoplasm and membrane revealed that biochemical changes were
time-dependent (Figure 4.4(D-F)). The gradual decrease of peak intensity at 786 cm-1 and
1660 cm-1 clearly indicated that DEP can damage cellular DNA and protein, which is
consistent with previous studies that DEP exposure leads to DNA damage [42, 43].
Meantime, the DNA and protein decrease induced by DEP were attenuated for RES-treated
cells, indicating A549 cells became more sensitive to DEP exposure after 24 h RES pretreatment. It was reported that RES has the functions of chemopreventive and
chemotherapeutic for lung cancer by inhibiting cancer cells growth and inducing
considerable physiologic alterations (apoptosis, cell cycle, cell proliferation, etc.) [44, 45],
which may account for the biophysical and biochemical differences between RES group and
no-RES group. Our previous study found that normal cells are more sensitive to DEP
exposure [46], suggesting RES treatment may turn cancer cells (A549) to less malignant
cancer cells. Additionally, the higher expression of pro-inflammatory responses
(cytokines/chemokines) in Figure 4.5 confirmed that RES treated cancer cells actually led to
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more secretion of typical cytokines/chemokines, especially IL-6, IL-8, MCP-1, RANTES and
GROα. Higher levels of such cytokines and chemokines also implied greater protein changes
in cells, which is supported by the RM results which showed that RES treated cells had larger
change of characteristic protein peak intensities than those of non-RES treatment.
It was reported that among normal cells cellular depolarization and hyperpolarization
can induce a decrease and an increase in cellular stiffness respectively [47, 48]. From AFM
measurements (Figure 4.3.(C-D)), it was noticed that cellular Young’s modulus at 8 h and 24
h DEP exposure was the least and largest within DEP treated groups, which can match with
the largest and the least value of PMP at 8 h and 24 h DEP exposure (Figure 4.6(A)).
However, it was difficult to find similar relationship in other groups. Although the changes of
PMP measured by flow cytometry cannot fully match with the trend of cellular Young’s
modulus measured by AFM, our measurements still provide complimentary cell
biomechanics information (cell elasticity) in addition to other biophysical properties (PMP).
In Figure 4.6B cell cycles of both RES group and non-RES group arrest in the G1 phase,
which can delay cell proliferation and migration. This observation is different from previous
report that RES can cause an arrest cells in S phase of cell cycle [49], and this difference may
come from different RES treatment conditions (time, concentration and so on), and the
chemical structure difference between RES and RES analogue.
In summary, SEM, confocal, and AFM results confirmed the destructive effect of
DEP on cellular structures and the protective role of RES in cytoskeleton. We successfully
observed the biophysical and biochemical differences of cells under different DEP exposure
duration with and without RES. DEP treatments can change cell stiffness and adhesion force,
which is beneficial for the study of respiratory diseases at sub-cellular scale. RES can
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strengthen cellular biomechanical properties, inhibiting cellar metastasis and making cell
more sensitive to DEP. Characteristic Raman peak intensity changes revealed that DEP can
decrease DNA and protein, and the presence of RES attenuated the decease of DNA and
protein induced by DEP. Cytokines and chemokines analysis indicated that RES pretreatment can enhance the DEP-induced inflammatory responses of exposed cells, making
cells more sensitive to DEP by secreting higher level of cytokines and chemokines.
Combined RM and AFM measurements allowed us to quantitatively assess biochemical and
biomechanical changes due to DEP-induced cytotoxicity and the effect from RES at single
cell level. These findings indicated that DEP exposure induces significant biophysical and
biochemical alterations that are relevant to early pathological development. Meantime, RES
plays a protective role in DEP-induced lung cell structure damage. This work evaluates
cellular biomechanical and biochemical changes, and provides an insightful information on
the interaction between environmental pollution and antioxidant on a single cell, which is
important for the research area of respiratory diseases.
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CHAPTER 5
IN-VITRO BIOMECHANICAL PROPERTIES, FLUORESCENCE IMAGING, SURFACEENHANCED RAMAN SPECTROSCOPY, AND PHOTOTHERMAL THERAPY
EVALUATION OF LUMINESCENT FUNCTIONALIZED CaMoO4:Eu@Au HYBRID
NANORODS ON HUMAN LUNG ADENOCARCINOMA EPITHELIAL CELLS
5.1 ABSTRACT
Highly dispersible Eu3+-doped CaMoO4@Au-nanorod hybrid nanoparticles (HNPs)
exhibit optical properties, such as plasmon resonances in the near-infrared region ~790 nm
and luminescence 615 nm, offering multimodal capabilities: fluorescence imaging, surfaceenhanced Raman spectroscopy (SERS) detection and photothermal therapy (PTT). HNPs
were conjugated with a Raman reporter (4-mercaptobenzoic acid), showing desired SERS
signal (enhancement factor ~4.76105). The HNPs have heat conversion efficiency 25.6%,
and hyperthermia temperature ~42 °C could be achieved by adjusting either concentration of
HNPs, or laser power, or irradiation time. HNPs were modified with antibody specific to
cancer biomarker epidermal growth factor receptor (EGFR), then applied to human lung
cancer (A549) and mouse hepatocyte cells (AML12), and in-vitro PTT effect was studied. In
addition, the biomechanical properties of A549 cells were quantified using atomic force
microscopy. Together, this study shows the potential applications of these HNPs in
fluorescence imaging, SERS detection, and PTT functionalities with good photostability and
biocompatibility.
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5.2 INTRODUCTION
Development of novel nanostructured materials with desired properties of
luminescent, surface-enhanced Raman spectroscopy (SERS) and photothermal therapy (PTT)
have drawn significant interest in clinical diagnosis and therapeutic monitoring in biological
systems [1-5]. Ultrasensitive and non-invasive detection of specific bioanalytes in living cells
can be achieved by SERS through increasing the weak inelastic scattering signal into a
structurally sensitive probe [6]. To realize this SERS function with good stability and
biocompatibility, the gold nanorods (GNRs) are conjugated with Raman reporter molecules
followed by protective polymers (e.g., PEG) [7]. PTT reagents such as GNRs absorb nearinfrared (NIR) photons which can be converted into heat energy (hyperthermia temperature
~42 °C) to destroy the cancer cells [8]. Hybrid nanoparticles (HNPs) exhibit fluorescence
emission (~615 nm), good photothermal stability, and high biocompatibility are the potential
good candidates for cancer therapy. Also, GNRs have high tissue penetration in the NIR
region (700–850 nm). Recently, PTT agents such as GNRs [9], Au nanoshells [10], zinc
ferrite spinel reduced graphene oxide (ZnFe2O4–rGO) [11], palladium nanostructures [12],
CuS nanoparticles (NPs) [13], Cu9S5 nanocrystals [14], and other inorganic NPs have been
intensively investigated. However, none of these nanostructured materials have fluorescence
properties. It is also known that the proximity of GNRs on the surface of luminescent NPs
(ex. lanthanide ion doped NPs) significantly enhances the luminescence efficiency [15].
HNPs were synthesized and can be used as prospective materials for killing tumor cells and
diagnostic imaging applications.
The cellular biomechanics (Young’s modulus and adhesion) can be considered as an
indicator of early diagnosis of cancers, where cancer cells have lower Young’s modulus than
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their normal counterparts [16]. When the NPs interact with cells, the proteins present in the
cell membrane bind to the surface of NPs and form a coating known as the protein corona.
Rapid corona formation affects NPs uptake and the death of endothelial cell at an early stage
[17]. Although many NPs for therapeutic applications have been studied, a little is known
about the morphological and biomechanical changes of cancer cells induced by NPs.
Moreover, attaining specific targeting of NPs in tumor site is particularly important. It can be
achieved by conjugating antibodies (Ab) to the HNPs. Epidermal growth factor receptor
(EGFR), one of the cell surface biomarkers for targeting in Ab-based cancer therapy, is a
transmembrane receptor protein embedded in the plasma membrane of many types of cancer
cells. Overexpression of EGFR (>50%) is observed in lung cancer patients [18, 19]. Recent
studies have shown that NPs labelled with anti-EGFR Ab could effectively kill the target
cancer cells when irradiated by laser light with a wavelength around the nanoparticle
absorption peak [20, 21].
Herein, we demonstrate the potential use of CaMoO4:Eu@GNR (CMO:Eu@GNR)
HNPs as multi-functional probes for optical imaging, and SERS and as a PTT agent. The
specificity of anti-EGFR Ab coated CMO:Eu@GNR is used for the enabled targeting of
EGFR over-expressing human lung cancer cells (A549 cell). Also, the effect of
CMO:Eu@GNR on cellular biomechanics and biocompatibility of the cancer cells were
studied. The SERS enhancement factor (EF), photothermal responses and efficiency of lightto-heat conversion of the CMO:Eu@GNR were evaluated. Also, we investigated the
influence of HNPs on the PTT of A549, AML12, and white blood cells (WBC) cells
illuminated at an 808 nm laser for in-vitro cancer killing study.

125

5.3 HYPOTHESIS
The synthesized NPs could specifically image, detect and kill A549 cells by the
mechanism of antibody-receptor binding.
5.4 MATERIALS AND METHODS
5.4.1 Materials
Calcium nitrate tetrahydrate, (Ca(NO3)2.4H2O, 99%, Alfa Aesar, Ward Hill, MA,
USA), ammonium molybdate (H8MoN2O4, 99.99%, Alfa Aesar), europium(III) nitrate
hydrate (Eu(NO3)3 · xH2O, 99.99%, Sigma Aldrich), oleic acid (Alfa Aesar), 1-octadecene
(95%, Alfa Aesar), NaOH pellet (Merck & Co., Kenilworth, NJ, USA), hydrochloric acid
(HCl, Sigma-Aldrich, St. Louis, MO, USA), HS-PEG-COOH (MW = 5000, Nanocs Inc.,
New York, NY, USA), mPEG-SH (MW = 5000, Nanocs Inc.), N-(3-dimethylaminopropyl)N-ethylcarbodiimide hydrochloride (C8H17N3HCl, MW = 191.7 g/mol, Sigma-Aldrich)
(EDC), N-hydroxysuccinimide (C4H5NO3, Sigma-Aldrich, MW = 115.09 g/mol) (NHS), 4mercaptobenzoic acid (MBA, Sigma-Aldrich), anti-human epidermal growth factor
receptor (EGFR) antibody (Thermo Fisher Scientific, Waltham, MA, USA), and
phosphate buffered saline (1X) (PBS) (Thermo Fisher Scientific) were used for HNPs
synthesis. Human (homo sapiens) lung carcinoma (A549 cells) (ATCC, Manassas, VA,
USA), Mouse hepatocyte cells (AML12, normal hepatocyte from liver tissue), 0.5%
trypsin-EDTA solution (Thermo Fisher Scientific), LIVE/DEAD Viability/Cytotoxicity
Assay Kit (Thermo Fisher Scientific), Earle’s balanced salt solution (EBSS, Thermo
Fisher Scientific) and PBS were used for cell experiments.
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5.4.2 Coating GNRs on CaMoO4:Eu NPs
Twenty mg of the CMO:Eu NPs were dispersed in 5 mL of 0.1 M HCl, and the
mixture was sonicated for 1 h. To this, 2 mL of diethyl ether was added and sonicated for 30
min. The resulting solution was centrifuged at 6000 rpm for 15 min. The obtained precipitate
was washed twice with ethanol and redispersed in 5 mL of PBS solution. To this, 20 mg of
HS-PEG-COOH was added and sonicated for 1 h. The PEGylated capped NPs were collected
by centrifugation and washed with PBS solution for three times to remove the excess of HSPEG-COOH present in the sample. The final precipitate obtained was redispersed in a PBS
solution. For the synthesis of HNPs, GNRs with 10 nm in diameter and 35 nm in length were
purchased from Nanopartz. First, 4 mL of the GNRs was centrifuged at 13,000 rpm for 30
min and then redispersed in PBS. Centrifugation was repeated for three times to reduce the
excess of cetyltrimethylammonium bromide (CTAB) present on the surface of the GNRs.
Four mL of GNRs dispersed in PBS was added to 1 mL of the PEGylated CMO:Eu NPs
under continuous stirring and then sonicated for 1 h. The resulting solution was centrifuged,
and the HNPs precipitated was collected. These particles were washed with a PBS solution
for three times and redispersed in PBS.
5.4.3 Raman reporter labeling and antibody conjugation
The synthesized NPs were labeled with MBA by adding 200 µL of a MBA
solution (2 mM) into 1 mL of the synthesized NPs solution. After 30 min sonication,
the MBA-labelled CMO:Eu@GNR NPs were collected. For conjugating the antihuman EGFR antibody with the MBA-labelled CMO:Eu@GNR NPs, 10 µL HS-PEGCOOH of 1 mg/mL concentration was added into the MBA-labelled NPs. After 15
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min sonication, 40 µL mPEG-SH of 1 mg/mL was added for 2 h incubation followed
by 30 min sonication. The prepared NPs were centrifuged for 15 min at 13,000 rpm
and then resuspended in water. Next, 10 µL EDC (10 mM) and 10 µL NHS (25 mM)
were added and sonicated for 30 min. The prepared NPs were centrifuged for 15 min
of 13,000 rpm and then resuspended in PBS. Then, the prepared NPs were labelled
with antibody (20 µL, 0.2 mg/mL) with 1 h sonication. After 15 min centrifugation at
13,000 rpm, the prepared NPs were resuspended in PBS and stored at 4 °C for further
experiments.
5.4.4 Characterization of synthesized NPs
Transmission electron microscopy (TEM) images and energy-dispersive X-ray
spectroscopy spectrum (EDX) were collected using an FEI Titan 80–300 kV (S) TEM
equipped with a spherical aberration (Cs) image corrector. All the images were collected at
300 kV. For the TEM measurements, the powder samples were ground and dispersed in
methanol. A drop of the dispersed particles was placed over a carbon-coated copper grid and
evaporated to dryness at room temperature.
UV-visible spectra were recorded using a Multiskan UV-visible spectrophotometer.
All the luminescence spectra were recorded using a Horiba FluoroMax-3 fluorescence
spectrophotometer. A zeta potentiometer (ZetaPALS, Brookhaven Instrument, Holtsville, NY,
USA) was used to measure the surface charge of the particles. Hydrodynamic diameter and
particle size distributions of the HNPs were determined by dynamic light scattering (DLS)
measurements using a DynaPro NanoStar (Wyatt Technology Corp., Santa Barbara, CA,
USA) instrument at 25±0.1 °C. Disposable cuvettes were used for the measurements.
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The temperature changes of the CMO:Eu@GNR solutions irradiated by an 808 NIR
laser (Xi’an Sampling Laser Technik Institute, Xi’an, Shanxi, China) were collected by a
portable fiber optic thermometer (Qualitrol, Fairport, NY, USA). The photothermal images
of the CMO:Eu@GNR solutions were recorded using an FLIR A20 camera (FLIR Systems,
Inc., Wilsonville, OR, USA), and the laser power was measured using a handheld laser
power meter (Edmund Optics, Barrington, NJ, USA).
5.4.5 Calculation of Raman enhancement factor (EF) of CMO:Eu@GNR-MBA
𝐸𝐹 =

𝐼𝑆𝐸𝑅𝑆
𝑁𝑅𝑆
×
− − − −(1)
𝐼𝑅𝑆
𝑁𝑆𝐸𝑅𝑆

Using the above equation, NSERS was calculated from the results of TEM and concentration
analyses. First, the laser-activated volume (Vlaser) in the micro-Raman experiment was
calculated from the laser spot diameter [dspot = 0.61λ/NA = 1.2 μm; λ = 785 nm, NA
(numerical aperture) = 0.9] and the penetration depth (pd = x μm), resulting in a Vlaser value of
0.942x μm3. From the commercial sample, the surface area and weight of one GNR (length =
38 nm, diameter = 10 nm) were determined as 1350×10−6 μm2, and 5.2×10−14 g, respectively.
The concentration of the CMO:Eu@GNR-MBA solution was about 20 Au μg/mL, which
corresponds to 3.85 × 108 GNRs/mL = 3.85×10-4 GNRs/μm3. Therefore, the
CMO:Eu@GNR-MBA solution in Vlaser contained 3.62×10-4 GNRs, which indicates that the
SERS spectra were generated by 3.62×10-4 CMO:Eu@GNR-MBA molecules. On the other
hand, the surface area of the MBA was 0.33 nm2 as a monolayer [22] and therefore the
number of MBA molecules absorbed onto one GNR was approximately 4091 and
consequently 1.5x MBA molecules, which is NSERS in the above equation, were absorbed onto
the GNRs present in Vlaser.
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The density of MBA used in regular Raman detection was approximately 3.1×10-6
g/mL. Thus, the number of MBA molecules in Vlaser for regular Raman detection was
1.13×104 MBA. Finally, we determined the Raman enhancement factor (EF) as
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5.4.6 Heat transfer efficiency of synthesized NPs
The change in the temperature of the HNPs was estimated by the heat input from the
NIR laser via GNRs and heat dissipated into the ambient atmosphere, which can be
expressed as follows:
∑ 𝑚𝑖 𝐶𝑖
𝑖=2

𝑑𝑇
= 𝑄𝑖𝑛 − 𝑄𝑜𝑢𝑡
𝑑𝑡

(2)

where mi and Ci are the mass and specific heat capacity of sample i, respectively. T is the
temperature of the HNPs on NIR irradiation at time t. The mass of HNPs is significantly
smaller than that of water (1 g), and the specific heat capacity of GNRs and water are ~0.129
Jg1K1 and 4.18 Jg1K1, respectively [23]. By neglecting the specific heat capacity of GNR,
eq. (i) can be modified as follows:
𝐶𝑖

𝑑𝑇
= 𝑄𝑖𝑛 − 𝑄𝑜𝑢𝑡
𝑑𝑡

(3)

where Qin = (I0Itr)η and Qout = ∑hS[T(t)To], I and Itr are the NIR laser power before and
after transmitting through the HNPs, h is the heat transfer efficiency, and S is the surface area
of the interference between the HNPs and external environment. The increase in the
temperature of the HNPs at any time t can be estimated as follows:
𝑇(𝑡) = 𝑇0 +

(𝐼0 − 𝐼𝑡𝑟 )𝜂
(1 − 𝑒 −𝐵𝑡 )
𝑚𝐶𝐵

(4)
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where Tm is the maximum stable temperature of the HNPs at which laser is turned off, η is
the photothermal conversion efficiency, and B is the heat dissipation constant.
The dissipation constant (B) was calculated using the temperature decay profile after
the laser was turned off as follows:
𝑇(𝑡) = 𝑇0 + (𝑇𝑚 − 𝑇0 )𝑒 −𝐵𝑡

(5)

In thermal equilibrium condition, Qin= Qout
∆𝑇

i.e., 𝜂 = 𝑚𝐶𝐵 ∆𝐼 − − − −(6) , all symbols have their usual meanings.
5.4.7 Cell culture and NPs treatment
A549 cells (ATCC) were cultured in F-12k medium containing 10% fetal
bovine serum at 37°C with 5% CO2 in a humidified atmosphere. Mouse hepatocyte
cells (AML12, normal hepatocyte from liver tissue) purchased from American Type
Culture Collection (ATCC) were cultured in a 1:1 mixture of Dulbecco's modified
Eagle's medium and Ham's F12 medium (ATCC) with 0.005 mg/ml insulin, 0.005
mg/ml transferrin, 5 ng/ml selenium, 40 ng/ml dexamethasone (Sigma-Aldrich) and
10% fetal bovine serum (ATCC) at 37°C with 5% CO2 in a humidified atmosphere.
Both cells were passaged at 70–90% confluency using 0.5% Trypsin-EDTA
solution, and the cell number was estimated by a hemocytometer to be ∼1×105
cells/mL. A549 and AML12 cells (∼1×105 cells/mL) were treated with 100 μL
prepared NPs (20 μg/mL) for two hours incubation at 37 °C. Then, cells were washed
to remove non-bound NPs. The binding of the NPs onto the cells was verified by
fluorescence and SERS spectra. The fluorescence images were captured under a
fluorescence microscope with DP30BW CCD camera (Olympus IX71, Olympus
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America Inc., Center Valley, PA, USA) with an excitation at 450 nm and an emission at
630 nm.
5.4.8 Atomic force microscopy
A549 cells were detected by AFM contact mode controlled by Picoview
software (Picoplus, Agilent Technologies, Santa Clara, CA, USA). AFM probe was
applied silicon nitride with 20 nm tip radius (Bruker Corp., Billerica, MA, USA), and
its spring constant was calibrated as 0.06–0.10 N/m and deflection sensitivities were
30–40 nm/V. The biomechanical properties (Young’s modulus and adhesion force) of
cells were calculated using a Scanning Probe Image Processor (SPIP) software (Image
Metrology, Hørsholm, Denmark) by Sneddon’s modification of the Hertz model from the
force curves for the elastic indentation in a soft sample [24, 25]. The model describes the
relationship between applied loading force F and indentation depth 𝛿:

𝐹=

2
𝐸𝑐𝑒𝑙𝑙
× 𝑡𝑎𝑛 (𝛼) ×
× 𝛿2
𝜋
1 − 𝛾2

where Ecell: Young’s modulus; F: loading force; 𝛾: Poisson ratio (its value was 0.5);
and α: tip half cone opening angle (its value was set to 36). The force was obtained
by the cantilever deflection d(z) and the spring constant of the cantilever k: F = k×d(z).
The indentation depth was calculated from the z-height and the cantilever deflection:
𝛿 = z-d(z). The Young’s modulus were obtained from the force curves transformation
and the linear regression fitted by the Hertz model [26]. For each group, at least 25
force curves of each cell (the total cells are over 20) were detected, and the detection
was accomplished within 2 h to approximate cellular physiological conditions. For
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deflection and 3D view images, the AFM images were imported into a WSXM
software (Nanotec Electrónica S.L., Tres Cantos, Madrid, Spain).
5.4.9 SERS measurements of cells treated with synthesized NPs
SERS spectra were recorded using a Renishaw inVia Raman spectrometer
(WIRE 3.3 software, Renishaw, Wotton-under-Edge, Gloucestershire, UK) equipped with
a 300 mW, 785 nm NIR laser. Cells were cultured on magnesium fluoride (MgF 2,
United Crystals Co., Port Washington, NY, USA) and imaged in EBSS through a 63 ×
(NA = 0.90) water immersion objective (Leica DMLM, Leica Microsystems, Buffalo
Grove, IL, USA). For Raman streamline mapping, the data were acquired at 1
accumulation with 10 s exposure, and the peak at 1078 cm1 from MBA was selected
for mapping. On each group, the cells were detected within 2 h at room temperature.
Renishaw Wire 3.3 software (Renishaw) performed for Raman spectra baseline
corrected, spectral smoothed, and normalized at maximum peaks. The processed
spectra were imported to OriginPro 9 software (OriginLab Corp., Northampton, MA,
USA) for analysis.
5.4.10 NIR photothermal therapy on cells
For NIR PTT, A549 and AML12 cells (∼1 × 105 cells/mL) were incubated
with about 100 μL prepared NPs (20 μg/mL CMO:Eu@GNR-MBA-Ab and
CMO:Eu@GNR-MBA, respectively) for two hours incubation at 37 °C. Next, the
cells were rinsed with PBS thrice and then exposed to the 808 nm laser irradiation at 1
W/cm2 power densities for 5 min. For cell viability test, the cells with triplicates were
stained using a LIVE/DEAD viability/cytotoxicity Assay Kit (Thermo Fisher Scientific)
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according to the instruction. After staining, the cells were imaged using a fluorescence
microscope equipped with a DP30BW CCD camera (Olympus IX71) at 10× objective
to analyze the relative proportion of live/dead cells.
5.4.11 Zeta Potential and DLS studies
The colloidal stability of the NPs was estimated using a zeta potential (the potential
close to the particle surface and thus the electrostatic stabilization) in PBS solvent. The
average zeta potential of the GNR particles in a CTAB solution was found to be ~41.12 mV.
The value slightly decreased when the particles were dispersed in PBS (~35.5 mV), whereas
the PEGylated CMO:Eu NPs showed a negative zeta potential of ~29.5 mV. The
CMO:Eu@GNR HNPs showed a zeta potential of ~27.6 mV. This indicates that
positive charge is present on the surface of HNPs. It confirms the high stability of the
particles in PBS.
5.4.12 White blood cell (WBC) count experiment
EDTA stabilized human whole blood were freshly obtained from Innovative Research
(Novi, MI, USA). Whole blood and serum were used for white blood cell (WBC) count
analysis.
5.4.13 Statistics analysis
Data are presented as mean ± standard deviation of error. Differences were
considered significant at p <0.01. The OriginPro 9 software (OriginLab Corp.) was
used for one-way ANOVA for significance test.
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5.5 RESULTS
5.5.1 Characterization of HNPs
Transmission electron microscopy (TEM) and high-resolution transmission
electron microscopy (HRTEM) images of the CMO:Eu@GNR NPs and selected area
electron diffraction pattern (SAED) are shown in Figure 5.1(A–D). The TEM image
confirms the formation of hybrid nanostructures where GNRs are attached to the
surface of CaMoO4:Eu NPs (Figure 5.1(B)). The average sizes of CaMoO4:Eu found
to be ~10~15 nm and GNRs with an average diameter of ~8–12 nm and a length of
~40 nm. The distance between lattice planes ~2.283 Å corresponding to the lattice
spacing in the (211) plane of tetragonal CaMoO4, JCPDS card No. 29–0351(Figure
5.1(C)) was calculated using ImageJ Software v1.47. The bright circular spots in the
SAED patterns confirms the presence of both CaMoO4 and GNRs phases in the
CMO:Eu@GNR (Figure 5.1(D)). Furthermore, the energy dispersive X-Ray analysis (EDX)
spectrum confirms the presence of Ca, Mo, O, Eu, and Au elements in the hybrid sample.
Figure 5.1(E) shows the UV-visible spectra of CMO:Eu@GNR with and without Ab
between 200–1000 nm. Three characteristic peaks were observed ~260, 530, and 790 nm.
The absorption band ~260 nm was assigned to the Mo–O charge-transfer band (CTB) [27],
and the bands ~530 and 790 nm can be attributed to the surface plasmon resonance (SPR) of
GNRs [3]. The inset of Figure 5.1(E) shows the comparison of the normalized SPR
absorption

spectrum

between

400–1000

nm.

Figure

5.1(F)

depicts

the

photoluminescence spectra of the CMO:Eu@GNR with and without Ab coating at a fixed
excitation of 464 nm (7F05D2) and show a strong red luminescence ~612 nm. Inset shows
a digital photograph of HNPs under UV light. HNPs show a strong excitation spectrum at
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~275 nm, which is assigned to OMo CTB (Mo–O CTB), and two sharp peaks at ~394 and
464 nm are assigned to the 7F05L6 and 7F05D2 transitions of Eu3+, respectively [8].
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Figure 5.1 (A) TEM and (B) HRTEM images of CMO:Eu@GNR. (C) HRTEM image
of CaMoO4:Eu NPs and (D) SAED pattern for (A). (E) UV–visible and (F)
photoluminescence (λex = 464 nm) spectra of CMO:Eu@GNR without (black) and with
Ab (red). Inset in (E) shows the comparison of normalized absorption spectrum at an
SPR of ~790 nm. Digital photograph of the CaMoO4:Eu NPs dispersed in PBS under a
UV-lamp (λex = 254 nm), shown in the inset of (F).

5.5.2 Photothermal properties of HNPs
The PTT abilities of HNPs were investigated using 808 nm NIR laser irradiation.
Figure 5.2(A) shows a thermal image of phosphate buffered saline (PBS) and
CMO:Eu@GNR solution placed in a 1 cm quartz cuvette using a forward looking infrared
(FLIR) thermal imaging camera on irradiation with a NIR laser (~1 mm spot size, 1 W/cm 2)
after 900 s at room temperature. As the irradiation time increased, the color of the thermal
images of HNPs is gradually changed from dark blue to bright yellow (high temperature). In
contrast, the thermal images for the PBS solution changed slightly over time as compared to
those HNPs. Thermal images confirms that the NIR light could be absorbed by the
CMO:Eu@GNR and converted to heat energy. It consists of a fiber-optic thermocouple
temperature sensor (accuracy ±0.1 C) for temperature measurement, a FLIR thermal
imaging camera, and an 808 nm NIR laser.
Figure 5.2(B, C) show the temperature kinetic curves at different concentrations. The
bright circular spots in the SAED patterns (0 ~28 µg/mL of GNRs) and excitation powers (0
~1.1.2 W/cm2) of the CMO:Eu@GNR irradiated with NIR laser for 900 s (ΔT is the
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temperature change, sample temperature ~27 C). The temperature of the HNPs solution
exponentially increases with the concentration of GNRs, and the similar temperature
increasing profile is observed with the increase of excitation power. CMO:Eu@GNR
achieved a PTT temperature of ~42 C (ΔT = 15 C) in ~210, 258, 377, and 481 s for 28, 21,
14, and 7 µg/mL of GNRs, respectively (Figure 5.2(B)). In the case of 0 µg/mL of GNRs
(pure PBS), ΔT was found to be ~4.4 C in 900 s, which is ~87.5% lesser than PTT
temperature obtained using CMO:Eu@GNR (28 µg/mL GNRs). The heating ability of the
CMO:Eu@GNR at various laser irradiation powers for ~28 µg/mL of GNRs concentration, is
shown in Figure 5.2(C). The required PTT temperature of ~42 C (ΔT = 15 C) was
obtained in ~136, 237, 351, and 673 s for 1.2, 1.0, 0.8, and 0.6 W/cm2 of NIR laser power,
respectively. Thus, by increasing the NIR laser power, the time required for the desired PTT
temperature can be decreased. Moreover, the increase in the temperature of the PBS solution
was significantly less than required PTT temperature.
Heat conversion efficiency (η) can be determined by plotting ΔT vs. ΔI as reported by
Pinchuk and co-workers (Eq. 2-6) [23]. The value of heat dissipation rate constant (B) was
further analyzed using the cooling temperature profile when the laser was turned off. The
natural log of (T(t)–T0)/(Tm–T0) as a function of time after the laser was turned off. The
average value of B was found to be ~1.58103 s1 with R2 = 0.99923. Recently, Pinchuk and
co-workers reported a B value of ~4.66103 s1 for spherical Au particles with an SPR of
530 nm. It was reported that the value of B depended on the volume of the NPs in the
cuvette and was almost independent of the amount of the NPs present in the sample [23]. The
η value was found to be ~25.6%. However, a slight deviation in the ΔT was observed at a
higher NIR laser irradiation power.
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Figure 5.2 (A) Infrared images of PBS and CMO:Eu@GNR aqueous solutions
exposed to 808 nm laser (1 W cm-2) for 900 s recorded at different time intervals. (B)
Photothermal responses of CMO:Eu@GNR NPs at different concentrations in
aqueous solution for 900 s NIR laser (808 nm, 1 W/cm2). (C) Photothermal responses
of 808 nm laser irradiation with different power densities for 900 s at fixed
CMO:Eu@GNR NP concentration (28 μg/mL GNR). (D) Temperature change of
CMO:Eu@GNR solution at 1 W/cm2 808 nm laser irradiation over six LASER
ON/OFF cycles. Experiment was carried out at room temperature.
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To understand the photostability of HNPs, six cycles of ON/OFF NIR laser
irradiations were performed (~1 W/cm2 for 300 s (laser ON), followed by naturally cooling
for 900 s (laser OFF) (Figure 5.2(D)). It was found that the temperature (ΔT) increased by
17.6 C in the first laser ON condition of the CMO:Eu@GNR (GNR concentration ~28
µg/mL). During six cycles of laser ON/OFF, the temperature elevations remained almost the
same as in the first cycle within the limits of error bar, indicating the good photostability of
HNPs. Furthermore, the effect of laser ON/OFF on luminescence emission was measured (λex
= 464 nm) on the start and end of each cycle. A slight decrease in the emission of ~<2% was
observed at the end of the sixth cycle.
The biocompatibility of the HNPs was investigated using the LIVE/DEAD
viability/cytotoxicity assay kit. Cells has high viability (>90%) at lower concentrations of the
CMO:Eu@GNR (2.5–20 μg/mL) incubated for 24 h and decreased to ~84% as the
concentration increased to 40 μg/mL. The decrease in cell viability at high concentration of
CMO:Eu@GNR can be attributed to the production of hydroxyl radicals from CaMoO4:Eu
[28]. Hydroxyl radicals can generate reactive oxygen species (ROS), causing cellular
apoptosis [29, 30].
5.5.3 Cell biomechanical properties
To investigate the interactions between cells and the HNPs (without and with
Ab), the cellular morphological effects were observed by atomic force microscopy
(AFM) and compared with control cells (Figure 5.3). In case of control group (Figure
5.3(A-A’)), its surrounding cytoskeleton structures were less visible than the NPs
treated groups (Figure 5.3(B-B’, C-C’)). The short black arrows in these treated groups
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indicate the filamentous actin bundles, which suggests that the mechanical properties of
cells vary with the interaction of HNPs.
The comparison of biomechanical properties of different groups were shown in
Figure 5.3(D, E). The control group has the largest Young’s modulus ~13.7±8.3 kPa,
while the CMO:Eu@GNR-Ab group has the least Young’s modulus ~11.3±6.2 kPa.
Furthermore, the CMO:Eu@GNR-Ab group has the largest adhesion force ~0.53±0.20
nN and control group has the least adhesion force ~0.34±0.22 nN. These results
implied that the CMO:Eu@GNR-Ab has significant effects on the cellular
biomechanics. One-way ANOVA for significance test was applied.
5.5.4 Fluorescence imaging of HNPs treated cells
To

investigate

the

bioimaging

application,

CMO:Eu@GNR

and

CMO:Eu@GNR-Ab were incubated with A549 cells for 2 and 16 h, respectively. Red
fluorescence from the CMO:Eu@GNR (λem=615 nm) was observed from A549 cells
on excitation ~464 nm (5D2 level of Eu3+ ion). Figure 5.4 shows phase contrast,
fluorescence, and overlay of phase contrast and fluorescence images of control, A549
cells incubated with CMO:Eu@GNR NPs for 2 and 16 h (with and without Ab). It was
found that the fluorescence intensity from the cells after 16 h incubation is larger than
that of 2 h incubation; and no fluorescence was observed from the control cells under
similar conditions. The increase in the fluorescence intensity with time may be due to
more uptake of the CMO:Eu@GNR by the A549 cells. The Ab-conjugated
CMO:Eu@GNR after 16 h incubation showed the strongest fluorescence compared to other
groups. This result showed the specificity of CMO:Eu@GNR-Ab as compared to the
control and CMO:Eu@GNR groups. The fluorescence emission from Eu3+ doped NPs was
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similar to previous studies that used Ab-coated NPs for enhanced fluorescence imaging [3133].

Figure 5.3 Atomic force microscopy detection of A549 cells (A) without treatment,
(B) treated with CMO:Eu@GNR, or (C) CMO:Eu@GNR-Ab for 2 h: (A–C) are 3D
view images of (A–C); (D) Young’s modulus and (E) adhesion force of cells. Error
bar: standard deviation of the mean; N ≥ 20, **P <0.01.
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Figure 5.4 Phase, fluorescence, and overlay images of A549 cells without treatment
and treated with CMO:Eu@GNR or CMO:Eu@GNR-Ab for 2 h and 16 h. Scale bar:
100 μm.
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5.5.5 SERS measurement
Gold nanomaterials have been widely applied as Raman signal enhancement
substrates due to their good biocompatibility and strong SERS signal [34, 35]. 4mercaptobenzoic acid (MBA) was selected as the Raman reporter molecule to evaluate the
SERS ability of the CMO:Eu@GNR for its well-established strong Raman peak ~1078 cm1
(aromatic ring vibration) [36]. To estimate the EF, we calculated the EF per MBA molecule
as the ratio of the intensity of 1078 cm1 obtained from the CMO:Eu@GNR-MBA NPs and
the Raman intensity of the MBA without NPs under excitation 785 nm laser by eq. (1) in
Materials and Methods part. SERS signals are enhanced by many orders of magnitude
stronger than intrinsic cellular Raman signals. The average EF of the CMO:Eu@GNR
calculated using eq. (1) was ~4.76105, demonstrating the SERS capability of the
CMO:Eu@GNR (the EF calculation was based on the SERS signal of MBA on the
CMO:Eu@GNR NPs).
The HNPs were conjugated with Ab for the enhancement of specificity. Figure 5.5
shows the Raman bright-field image, Raman streamline mapping and Raman spectrum (900–
1250 cm1) from SERS negative (black cross) and SERS positive (red cross) sites on a
single live A549 cell incubated with CMO:Eu@GNR. Raman mapping for a live cell was
performed by selection of 1078 cm1 (a characteristic peak from Raman reporter
molecule MBA). The Raman spectra obtained from SERS positive and negative spots are
shown in Figure 5.5(C). The SERS positive spectra from both CMO:Eu@GNR-MBA and
CMO:Eu@GNR-MBA-Ab groups show a strong characteristic peak from MBA at
1078 cm1. The order of strong Raman mapping pixel intensity is found to be control <
CMO:Eu@GNR-MBA < CMO:Eu@GNR-MBA-Ab. The bright color spots in the Raman
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mapping indicates the distribution of EGFR biomarkers on single live cell (Figure 5.5(B)).
The high pixel intensity in Raman mapping for CMO:Eu@GNR-MBA-Ab group confirms
the higher cellular distribution of HNPs compared to non-Ab group. A few CMO:Eu@GNR
were still distributed around the cellular membrane edges in CMO:Eu@GNR-MBA
group due to nonspecific binding. In contrast, more NPs were bound to the cells in
CMO:Eu@GNR-MBA-Ab group. As expected, no SERS signal was detected from the
control group (no NPs treatment) except a lowest intensity characteristic peak ~1004
cm1, which is assigned to the phenylalanine from the cell [37]. CMO:Eu@GNR were
also applied to the AML12 cells (EGFR negative) for SERS detection, as shown in
Figure 5.6. It was found that a few NPs were distributed around AML12 live cell
membrane of both CMO:Eu@GNR-MBA and CMO:Eu@GNR-MBA-Ab groups,
indicating nonspecificity binding of NPs. The spectra from Figure 5.6(C) confirmed
these Raman positive spots were CMO:Eu@GNR due to presence of the characteristic
peak from Raman reporter MBA molecule. These SERS results compared the spectral
differences among the three groups, illustrating the specificity of the Ab-conjugated
NPs and the distribution of these NPs.
5.5.6 Photothermal treatment of cells
NPs with strong NIR absorption are considered to be a relatively noninvasive and
effective treatment of cancer compared to the current cancer treatments (chemotherapy,
radiotherapy, surgery, and so on), which usually result in severe adverse effects and cancer
recurrence [38-41]. In PTT, the malignant cells were killed by localized hyperthermia
generated by the conversion of absorbed light to heat. The distribution of cancer biomarker
EGFR (via CMO:Eu@GNR) into A549 cells was confirmed by Raman results (Figure 5.5),
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cells were treated with CMO:Eu@GNR (without and with Ab) and irradiated by a NIR laser
for 5 min (1 W/cm2). Figure 5.7(A) shows the fluorescence images of phase, live
(green), and dead (red) cells with and without NPs treatments. Most of the cells were
alive in control group, whereas a few dead in CMO:Eu@GNR groups, but complete
cell death was observed in CMO:Eu@GNR-Ab group within the external 808 nm laser
exposure area. Moreover, there was no significant difference in the cell viability
between no-laser and laser control groups, suggesting that 808 nm NIR laser has
negligible effect on the cells under similar conditions. Besides being tested on cancer
cells A549, noncancerous hepatocyte AML12 cells were also treated with
CMO:Eu@GNR (with and with Ab).

Figure 5.5 (A) Raman bright-field images of A549 cells without treatment and treated
with CMO:Eu@GNR-MBA or CMO:Eu@GNR-MBA-Ab for 2 h (peak at 1078 cm-1
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from MBA was selected for mapping). Scale bar: 10 μm (horizontal), 5 μm (vertical).
(B) Raman streamline mapping and (C) corresponding Raman spectra of A549 cells
without treatment and treated with CMO:Eu@GNR-MBA or CMO:Eu@GNR-MBAAb NPs for 2 h.

Figure 5.6 (A) Raman Bright-field images of AML12 cells without treatment and
treated with 2-h CMO:Eu@GNR-MBA or CMO:Eu@GNR-MBA-Ab (peak at 1078
cm-1 from MBA was selected for mapping). Scale bar: 10 μm (horizontal), 5 μm
(vertical). (B) Raman streamline mapping (Black cross: SERS negative; red cross:
SERS positive) and (C) the corresponding Raman spectra of AML12 cells without
treatment and treated with 2-h CMO:Eu@GNR-MBA or CMO:Eu@GNR-MBA-Ab
NPs at 63 water immersion objective.
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Figure 5.7 (A) Photothermal therapy. A549 cells were incubated without NPs (control),
with CMO:Eu@GNR or CMO:Eu@GNR-Ab for 2 h; after that, cells were irradiated under 1
W/cm2 808 nm laser for 5 min (green: live cells; red: dead cells. Scale bar: 100 μm). (B) Cell
viability of A549 cells without treatment and treated with CMO:Eu@GNR or
CMO:Eu@GNR-Ab for 2 h; after that, irradiation for 5 min under 1 W/cm2 808 nm laser.
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Inset shows the fluorescence image of A549 cells treated with CMO:Eu@GNR-Ab NPs for 2
h, then irradiated without/with laser; Error bar: standard deviation of the mean; N = 3, **P
<0.01.

As shown in Figure 5.8, it was also found that the CMO:Eu@GNR have no
PTT effect on AML12 cells, suggesting the HNPs with conjugated anti-EGFR
antibodies are specific to cancer cells that overexpressed EGFR. The quantitative cell
viability of A549 cells without and with treated (CMO:Eu@GNR and CMO:Eu@GNRAb) groups for 2 h was studied on 5 min 1 W/cm2 808 nm laser irradiation (Figure
5.7(B)). The CMO:Eu@GNR group shows a slight toxicity (viability ~90.2±7.6%),
compared to control group. However, CMO:Eu@GNR-Ab group shows the least
percentage of viability (~4.6±1.7%), indicating the high PTT effect from the Ablabelled NPs. Inset of the Figure 5.7(B) shows the fluorescence images of the A549
cells incubated with the CMO:Eu@GNR-Ab NPs where the laser spot edge (white
dashed line) shows a boundary between green (no laser) and red (laser) fluorescence
regions. Within the laser spot, almost all cells were killed and displayed red color
(dead cells). These results demonstrated that the CMO:Eu@GNR-Ab NPs could effectively
and specifically kill A549 cells. This was because the CMO:Eu@GNR-Ab CMO:Eu@GNR
can target the A549 cells via the interactions between the Ab and EGFR on the cancer cell
surface. Thus, the CMO:Eu@GNR with high specificity and PTT efficiency may be of great
importance for cancer treatments and have a potential to apply in clinical cancer therapy.
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Figure 5.8 Fluorescence images of A549 and hepatocyte cells control without laser
and with 5 min 1 W/cm2 808 nm laser irradiation and treated with 2 h
CMO:Eu@GNR or CMO:Eu@GNR-Ab, then for 5 min 1 W/cm2 808 nm laser
irradiation (Green: live cells; red: dead cells. Scale bar: 100 µm).

5.6 DISCUSSION
Hybrid nanomaterials with fluorescence in red region with NIR–SPR properties
are increasingly attractive in theranostics of cancer that combines both diagnostic and
therapeutic functions in recent years. NIR radiation is used as emerging tool in the
fight against cancer [42]. We synthesized CaMoO4:Eu NPs having a strong
luminescence at ~615 nm and conjugated with GNRs having NIR absorption at ~790
nm. When these HNPs are uptaken at the tumor site, the temperature increase (~42 °C)
on NIR irradiation can kill the cancer cells. HNPs synthesized in this way have a great
advantage in PTT tumor ablation. The HNPs were coated with anti-EGFR Ab for the
selectively targeting of A549 cancer cells. Antibody conjugation to HNPs was further
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confirmed by redshift in Mo–O CTB (~15 nm) and SPR band (~0.5 nm) (Figure 5.1(E)).
The decrease in SPR band absorption for the Ab-conjugated NPs implies that the surface
of the GNRs has different environment than Ab free NPs. EI-Sayed and his co-workers
studied the in detailed analysis of with and without anti-EGFR conjugated Au NPs to
distinguish between cancerous and noncancerous cells using red shift [43]. Moreover, Ab
conjugated Au NPs were specifically and homogeneously bind to the surface of the cancer
cells 600% greater affinity than to the noncancerous cells [43]. Furthermore, a slight decrease
in the luminescence intensity of Eu3+ ion was observed after Ab conjugation (Figure 5.1(F)).
Asymmetric ratio (A21 = ∫5D07F2/∫5D07F1) values for without and with Ab coated NPs are
found to be ~8.6 and 5.3, respectively. The luminescence of HNPs is slightly higher than
CaMoO4:Eu, this is due to proximity effect of GNRs [15]. The high colloidal stability
(zeta potential) and uniform hydrodynamic size distribution of the HNPs were shown in
Figure 5.9 and Figure 5.10. Indeed, the HNPs are good candidates for the development
of PTT and imaging agents due to its easy access, simple conjugation procedures and
low toxicity.

Figure 5.9 Zeta potentials of different samples at pH ~7.
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Figure 5.10 DLS data of CMO:Eu@GNR NPs.

HNPs with plasmon-enhanced fluorescence properties have attracted much
attention as imaging nanoprobes for PTT due to its small size and deeper tumor
permeation. Our HNPs have PTT conversion efficiency of ~25.6% and a sharp
luminescence peak at ~615 nm. Recently, Sun and co-workers synthesized GNRs and gold
nanostars (GNSs) with strong NIR absorption 800 nm [44]. They concluded that pure GNRs
show a higher η value, which varies in the range 69.7–94.2%. It is well known that pure gold
particles exhibit strong PTT activity. Self-assembled WO3−x hierarchical nanostructures
ranging from 700–1400 nm were prepared with η ~28% by Hu and co-workers [45], and the
same research group prepared CuS NPs with η ~38% [13]. Although various nanostructures
have been evaluated as PTT agents, HNPs offer additional favorable properties that enable
their use for cancer therapy. More importantly, the HNPs synthesized here not only have a
high η value, but also have good NIR photostability (Figure 5.2(D)) and fluorescence
properties (Figure 5.1(F)). These results demonstrate that the CMO:Eu@GNR could be used
as a photothermal and imaging agent for cancer therapy applications.
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Biomechanical properties played important roles in cellular morphogenesis,
focal adhesion, motility, and metastasis [46-48], but also useful in medicine to
understand the formation and stage of tumor development. The biomechanical
properties of the cancer cells were investigated at singular cell level on incubation
with HNPs. The biomechanical values of the control group were similar to our
previous studies [49, 50]. Our AFM results (Figure 5.3) revealed that the interaction of
HNPs with cells showed more surrounding cytoskeleton structures, much softer cell
membrane and increased surface adhesion force compared to control cells. These
alterations in cell topography and biomechanics indicate that the HNPs affected the
cellular biophysical properties within a short time (2 h) under similar experimental
conditions.
HNPs-MBA shows high sensitive SERS properties which arises from the interaction
of MBA molecules with GNRs. Several factors (e.g., substrate types, aspect ratios, plasmon
absorption, reporter molecules, excitation source) [51] may affect the value of EF. The
average EF value (4.76105) of our HNPs was similar to previous reports [51, 52]. Raman
streamline mapping in Figure 5.5 and Figure 5.6 consist of over 1000 spectra detected over
80% of the cell area. HNPs without Ab are partly attached to the cellular surface, suggesting
that there was still nonspecific binding to cells due to long incubation time. Nevertheless, the
nonspecific cellular binding of CMO:Eu@GNR NPs was significantly less than that of
CMO:Eu@GNR-Ab with high specificity. To confirm this both cancerous (A594) and
noncancerous cells (AML12) were treated with HNPs (with and without Ab) and
irradiated with 808 nm NIR laser for 5 min (Figure 5.8). it was found that most of the
cancer cells were killed and noncancerous cells were still alive. Furthermore, WBC
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were treated with HNPs to evaluate their biocompatibility. WBC count demonstrates
that HNPs treated groups (HNPs, HNPs-Ab, HNPs + laser, HNPs-Ab + laser) show a
slight decrease in count by ~9% as compared to control group (Figure 5.11). The
decrease of WBC count for NPs treated groups largely comes from the immune
function of WBC to protect cells against foreign invaders (HNPs). However, the
numbers of WBC for HNPs treated groups are still within normal range (~4000–
11,000 white blood cells/µL) [53] after this slight decrease, indicating the good
biocompatibility of HNPs. These results indicate that rationally engineered HNPs having
fluorescence in red region (λex = 464 nm) and PTT conversion efficiency (λex = 808 nm) can
be used as efficient PTT agents. Meantime, the HNPs stand out because of its efficient NIR
light absorption between 700–850 nm and their small size leading to the higher possibility of
deeper tumor penetration. These properties of HNPs make them favorable for in vivo study in
future experiments.

Figure 5.11 The effect of different treatments on the WBC counts (NPs: CMO:Eu@GNR;
**p < 0.01, N = 3, error bar: standard deviation of the mean).
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In summary, multifunctional HNPs were synthesized for in vitro fluorescence
imaging, SERS detection, and PTT cancer therapy applications. Fluorescence images
show the fluorescent function of the HNPs with fluorescence at 615 nm (5D07F2) on
excitation 464 nm. Ab was coated on the surface of the HNPs to enhance the cellular
uptake. The biomechanical experiments shows that the Young’s modulus of the A549
cells decreased whereas the adhesive force increased with the interactions between the
HNPs and cells, and these changes further increased in the group of HNPs combined
with Ab (CMO:Eu@GNR-Ab). Raman mapping confirmed the distribution of HNPs
around the nucleus and membrane region using SERS characteristic peak of MBA at
1078 cm1, and the EF was found to be 4.76  105. Moreover, these HNPs effectively
suppressed A549 cell viability upon 808 nm laser irradiation. However, no significant
decrease in cell viability of noncancerous cells (AML12) was observed. The PTT
efficiency of CMO:Eu@GNR were found to be ~25.6%. Thus, a combination of
fluorescence imaging, SERS and the NIR photothermal ablation of targeted tumor cells
would allow multimodal imaging and PTT in vivo for the future applications.
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CHAPTER 6
NEAR-INFRARED PHOTOTHERMAL THERAPY OF PRUSSIAN BLUE COATED
MULTIFUNCTIONAL CaMoO4:Eu@SiO2/Au NANOSTRUCTURES FOR TARGETING
HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 EXPRESSING CANCER
CELLS
6.1 ABSTRACT
Here we report the synthesis, characterization and application of Prussian blue (PB)
functionalized

CaMoO4:Eu@SiO2@Au-nanorod

hybrid

nanoparticles

(NPs)

having

multimodal capabilities such as fluorescence imaging, surface-enhanced Raman spectroscopy
(SERS) detection and photothermal therapy (PTT). The average size of CaMoO4:Eu@SiO2
nanoparticles was found to be ~206 nm. Hybrid particles are highly dispersible in water for
several weeks without settling and show a strong absorption in NIR region which is overlap
of Prussian blue absorption between 600–1000 nm and surface plasmon resonance of Au
nanorods around 800 nm. Upon 808 nm laser excitation particles shows hyperthermia
temperature (43 °C). Also, PB NPs can be used in clinical trials for treatment of radioactive
exposure, and PB acts as a Raman reporter molecule (2152 cm-1 characteristic peak) with
good biosafety and stability in the human body. In addition, using both SiO2 NPs and Au
nanorods to coat on the surface of CaMoO4:Eu nanoparticles increases the biocompatibility.
Furthermore, the PTT efficiency of HER2 (human epidermal growth factor receptor 2)
antibody conjugated hybrid nanoparticles on MDA-MB-435 cancerous cells is
significantly higher than and hepatocyte cells (non-cancerous). This is due to more uptake
of hybrid nanoparticles in cancerous cells than non-cancerous cells. Together, this study
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shows the potential applications of these HNPs in fluorescence imaging, SERS detection, and
PTT functionalities with good photostability and biocompatibility.
6.2 INTRODUCTION
The combination of diagnostic and therapeutic functions into a single construct is an
emerging field to further promote clinical diagnosis and therapeutic processes. This construct
can image and detect a specific target, measure the biological changes and conduct the
therapeutic processes. In this way, specificity and selectivity can be significantly facilitated
followed by high therapeutic efficacy while decreasing deleterious side effects. Recently, we
developed hybrid materials with the properties of fluorescence, surface-enhanced Raman
spectroscopy (SERS) and photothermal therapy (PTT) potential. Different from traditional
fluorophores restricted by the limitation of photobleaching and short lifetime [1], the
synthesized inorganic hybrid materials do not experience these problems. In addition, the
hybrid materials exhibit enhancement in luminescence intensity (λem: ~615 nm) due to metal
(GNR) proximity effect [2], and this luminescence feature is from Eu3+ ion (5D2 level of
Eu3+ ion). Moreover, the Raman-labeled hybrid materials can be applied as sensitive SERS
probes for Raman imaging in living cells. Similarly, Raman imaging techniques are not
limited by photobleaching or solvent and environmental effects because of the need for only
one irradiation source and the narrow spectral peaks [3]. When the absorption band of a
Raman-labeled construct overlaps with the laser excitation, the SERS signal can be greatly
intensified [4]. Furthermore, the hybrid materials have the property of PTT potential, which
is a non-invasive laser-based approach applied to ‘burn’ tumor cells by converting the photon
energy into thermal energy (hyperthermia temperature ~42 °C) [5]. Therefore, the
combination of fluorescence, Raman imaging and PTT might be important for increasing the
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curative rates of cancer treatments and has a potential for application in clinical cancer
therapy.
Mesoporous silica nanoparticles (NPs) with the features of high surface area,
adjustable pore size and chemically modifiable surfaces have been widely applied as efficient
drug delivery carriers with good biocompatibility [6, 7]. Prussian blue (PB) is not only an
inorganic pigment containing ferric ferrocyanide, but it is also an antidote for heavy metal
poisoning [8]. Moreover, PB is very useful as an FDA approved treatment for radioactive
exposure [9]. In addition, recent studies have indicated that PB could efficiently transform
irradiation laser into heat for cancer treatment [10, 11], and its low price promotes its use in
practical applications. The soluble PB is loaded onto silica NPs as well as the surface of
GNR through electrostatic interactions. The conjugation of PB can greatly increase the PTT
efficacy because the absorption bands of PB and GNR used in this work are both close to the
NIR laser wavelength. Meantime, PB can be applied as a Raman reporter molecule for SERS
imaging. The synergistic PTT effect from PB and GNR could provide us with new insight in
fighting against cancer.
The HER2 (human epidermal growth factor receptor 2) protein is over-expressed in
25% to 30% of human breast cancers [12]. A monoclonal antibody (mAb), anti-HER2, was
conjugated onto the external surface of PB modified CaMoO4:Eu@SiO2@GNR (HNP-PB) to
selectively recognize HER2/neu glycoproteins that are usually overexpressed on breast
cancer cells. The specific targeting capability of HNP-PB-Ab is strongly affected by the mAb
density on the outer surface of HNP-PB, and the mAb was modified with a polyethylene
glycol (PEG) spacer to reduce non-specific binding to other cells without the receptor.
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Herein, the synthesized hybrid materials are characterized first, then applied for
imaging and PTT with an enhanced specificity when conjugating HER2 antibodies, and their
biocompatibility is also evaluated.
6.3 HYPOTHESIS
The developed silica coated NPs could effectively visualize, detect and treat human
breast cancer cells by the mechanism of antibody-receptor binding with enhanced
biocompatibility.
6.4 MATERIALS AND METHODS
6.4.1 Materials
Calcium nitrate tetrahydrate, (Ca(NO3)2.4H2O, 99%, Alfa Aesar, Ward Hill, MA,
USA), ammonium molybdate (H8MoN2O4, 99.99%, Alfa Aesar), europium(III) nitrate
hydrate (Eu(NO3)3 · xH2O, 99.99%, Sigma-Aldrich, St. Louis, MO, USA), oleic acid (OA,
Alfa Aesar), 1-octadecene (95%, Alfa Aesar), NaOH pellet (Merck & Co., Kenilworth, NJ,
USA), hydrochloric acid (HCl, Sigma-Aldrich), HS-PEG-COOH (MW = 5000, Nanocs Inc.,
New York, NY, USA), mPEG-SH (MW = 5000, NANOCS), N-(3-dimethylaminopropyl)-Nethylcarbodiimide hydrochloride (C8H17N3HCl, MW = 191.7 g/mol, Sigma-Aldrich) (EDC),
N-hydroxysuccinimide (C4H5NO3, Sigma-Aldrich, MW = 115.09 g/mol) (NHS), Prussian
blue (PB) (Sigma-Aldrich, USA), human epidermal growth factor receptor 2 (HER2)
antibody (Santa Cruz Biotechnology Inc., Dallas, TX, USA), and phosphate buffered
saline (1X) (PBS) (Thermo Fisher Scientific, Waltham, MA, USA) were used for HNPs
synthesis. MDA-MB-435 human breast carcinoma (435 cells), mouse hepatocyte cells
(AML12, normal hepatocyte from liver tissue, ATCC, Manassas, VA, USA), 0.5%
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trypsin-EDTA

solution

(Thermo

Fisher

Scientific),

LIVE/DEAD

Viability/Cytotoxicity Assay Kit (Thermo Fisher Scientific), Earle’s balanced salt
solution (EBSS, Thermo Fisher Scientific) and PBS were used for cell experiments.
6.4.2 Synthesis of CaMoO4:Eu@SiO2@GNR core/shell Nanoparticles
CaMoO4:Eu (2 at.%; CMO:Eu) nanoparticles were synthesized by a
thermolysis process. A detailed method of synthesis was discussed elsewhere
[submitted for publication]. To remove the unwanted oleic acid (OA) capped on the
surface of the particles, 20 mg of the CMO:Eu nanoparticles were dispersed in 5 mL
of 0.1 M HCl, and the mixture was sonicated for 1 h. To this, 2 mL of diethyl ether
was added and sonicated for 30 min. The resulting solution was centrifuged at 6000
rpm for 15 min. The obtained precipitate was washed four times with ethanol. For the
silica-coating on the surface of CaMoO4:Eu nanoparticles, 200 mg of CMO:Eu
nanoparticles was added to 100 mL of deionized water and 25 mL of NH4OH aqueous
solution added and sonicated for 30 min. To this 8 ml of Tetraethyl orthosilicate
(TEOS) added drop wise and the reaction mixture was vigorously stirred for 24 h.
Resulting precipitate was collected by centrifugation and washed with water to
remove the unwanted reactants present on the surface of the particles and redispersed
in 50 ml of distilled (DI) water.
For the synthesis of CMO:Eu@SiO2@GNR hybrid nanoparticles, we used
commercially available Au nanorods (GNRs; Nanopartz Inc., Loveland CO, USA)
with 10 nm in diameter and 43 nm in length. First, 4 mL of the GNR was centrifuged
at 13,000 rpm for 30 min and then redispersed in DI water. Centrifugation was
repeated for three times to reduce the excess of cetyltrimethylammonium bromide
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(CTAB) present on the surface of the GNR. Secondly, 10 mg of HS-PEG-COOH was
added to 10 ml of CMO:Eu@SiO2 and sonicated for 1 h and the resulting solution was
centrifuged three times with DI water to remove the excess of HS-PEG-COOH
present in the sample. The precipitate obtained was redispersed in a 10 ml of DI water
followed by sonication for 2 h. To this GNRs were added dropwise and stirred for 24
h.

Finally, CMO:Eu@SiO2@GNR hybrid nanoparticles (non-PEGylation) were

centrifuged at 13000 rpm for 15 min and redispersed in DI water. To this, 200 ml of
100 µM mPEG-SH was added and stirred for 12 h. Finally, nanoparticles solution was
centrifuged and redispersed in DI water. This step is used to control the surface charge
on the particles.
6.4.3 Prussian blue labeling and antibody conjugation
The synthesized NPs were labeled with PB by adding 100 µL PB solution (2
mM) into 1 mL of non-PEGylated NPs solution. After 30 min sonication, the PBlabelled CMO:Eu@SiO2@GNR NPs were centrifuged for 15 min of 13,000 rpm to
remove extra PB molecule and then resuspended in PBS for antibody conjugation. For
conjugating the HER2 antibody (Ab) with the PB-labelled CMO:Eu@SiO2@GNR
NPs, 10 µL HS-PEG-COOH of 1 mg/mL concentration was added into the PBlabelled NPs. After 15 min sonication, 40 µL mPEG-SH of 1 mg/mL was added for 2
h incubation followed by 30 min sonication. The prepared NPs were centrifuged for
15 min at 13,000 rpm and then resuspended in water. Next, 10 µL EDC (10 mM) and
10 µL NHS (25 mM) were added and sonicated for 30 min. The prepared NPs were
centrifuged for 15 min of 13,000 rpm and then resuspended in PBS. Then, the
prepared NPs were labelled with antibody (20 µL, 0.2 mg/mL) with 1 h sonication.
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After 15 min centrifugation at 13,000 rpm, the prepared NPs were resuspended in PBS
and stored at 4 °C for further experiments.
6.4.4 Characterization of synthesized NPs
X-ray diffraction (XRD) patterns of the powder samples were examined at room
temperature using a PANalytical X’Pert X-ray diffractometer equipped with Ni filtered CuKa
(l = 1.54056 Å) radiation as the X-ray source. XRD patterns of the powder sample were
examined at room temperature. The microstructure and morphology of the nanoparticles
were analyzed using Scanning Electron Microscopy (SEM) (FEI Quanta FEG 650, FEI
Company, Hillsboro, OR, USA) integrated with the energy dispersive analysis of X-ray
(EDX) spectrometer operated at accelerating voltage of 20 kV.

Scanning transmission

electron microscopy (STEM) of single particles was measured using Titan TEM with
ChemiSTEM capability. Fourier transform infrared spectroscopy (FTIR) spectrum was
measured with a FT–IR spectrometer (Bomem MB 102, Agilent technologies, Santa Clara,
CA,

USA).

UV-visible

spectra

were

recorded

using

a

Multiskan

UV-visible

spectrophotometer (Thermo Scientific). All the luminescence spectra were recorded using a
Jobin Yvon Horiba Fluoromax-3 at room temperature. A zeta potentiometer (ZetaPALS,
Brookhaven Instrument, Holtsville, NY, USA) was used to measure the surface charge of the
particles. Hydrodynamic diameter of the HNPs was determined by dynamic light scattering
(DLS) measurements using a DynaPro NanoStar (Wyatt Technology Corp., Santa Barbara,
CA, USA) instrument at 25 ± 0.1 °C. Disposable cuvettes were used for the measurements.
The surface area and the total pore volume were evaluated using the BET (Brunauer–
Emmett–Teller) model and the pore size was evaluated using the BJH (Barrett–Joyner–
Halenda) model (Lucideon, Schenectady, NY, USA). The temperature changes of the
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CMO:Eu@GNR solutions irradiated by an 808 NIR laser (Xi’an Sampling Laser Technik
Institute, Xi’an, Shanxi, China) were collected by a portable fiber optic thermometer
(Qualitrol, USA), and the laser power was measured using a handheld laser power meter
(Edmund Optics, Barrington, NJ, USA).
6.4.5 Heat transfer efficiency of synthesized NPs
The change in the temperature of the HNPs was estimated by the heat input from the
NIR laser via GNRs and heat dissipated into the ambient atmosphere, which can be
expressed as follows:
∑ 𝑚𝑖 𝐶𝑖
𝑖=2

𝑑𝑇
= 𝑄𝑖𝑛 − 𝑄𝑜𝑢𝑡
𝑑𝑡

(1)

where mi and Ci are the mass and specific heat capacity of sample i, respectively. T is the
temperature of the HNPs on NIR irradiation at time t. The mass of HNPs is significantly
smaller than that of water (1 g), and the specific heat capacity of GNRs and water are ~0.129
Jg1K1 and 4.18 Jg1K1, respectively.[13] By neglecting the specific heat capacity of GNR,
eq. (i) can be modified as follows:
𝐶𝑖

𝑑𝑇
= 𝑄𝑖𝑛 − 𝑄𝑜𝑢𝑡
𝑑𝑡

(2)

where Qin = (I0Itr)η and Qout = ∑hS[T(t)To], I and Itr are the NIR laser power before and
after transmitting through the HNPs, h is the heat transfer efficiency, and S is the surface area
of the interference between the HNPs and external environment. The increase in the
temperature of the HNPs at any time t can be estimated as follows:
𝑇(𝑡) = 𝑇0 +

(𝐼0 − 𝐼𝑡𝑟 )𝜂
(1 − 𝑒 −𝐵𝑡 )
𝑚𝐶𝐵

(3)
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where Tm is the maximum stable temperature of the HNPs at which laser is turned off, η is
the photothermal conversion efficiency, and B is the heat dissipation constant.
The dissipation constant (B) was calculated using the temperature decay profile after the
laser was turned off as follows:
𝑇(𝑡) = 𝑇0 + (𝑇𝑚 − 𝑇0 )𝑒 −𝐵𝑡

(4)

In thermal equilibrium condition, Qin= Qout
∆𝑇

i.e., 𝜂 = 𝑚𝐶𝐵 ∆𝐼 − − − −(5) , all symbols have their usual meanings.
6.4.6 Cell culture and NPs treatment
435 cells were cultured in a 1:1 mixture of Dulbecco’s-modified eagle’s medium
(DMEM) and Ham’s F-12 medium supplemented with 5% fetal bovine serum (ThermoFisher
Scientific). Mouse hepatocyte cells (AML12, normal hepatocyte from liver tissue)
purchased from American Type Culture Collection (ATCC) were cultured in a 1:1
mixture of Dulbecco's modified Eagle's medium and Ham's F12 medium (ATCC) with
0.005 mg/ml insulin, 0.005 mg/ml transferrin, 5 ng/ml selenium, 40 ng/ml
dexamethasone (Sigma-Aldrich) and 10% fetal bovine serum (ATCC) at 37°C with
5% CO2 in a humidified atmosphere.
Both cells were passaged at 70–90% confluency using 0.5% Trypsin-EDTA
solution, and the cell number was estimated by a hemocytometer to be ∼1×105
cells/mL. 435 and AML12 cells (∼1×105 cells/mL) were treated with 100 μL prepared
NPs (20 μg/mL) for two hours incubation at 37 °C. Then, cells were washed with PBS
to remove non-bound NPs. 435 cells without treatment, treated with HNP-PB or HNP-PBAb were fixed first, then measured by scanning electron microscopy (SEM) and energy-

171

dispersive X-ray spectra (EDX), which was controlled by FEI Quanta FEG 650 equipped
with a FEG source (FEI Company). The fluorescence images were captured under a
fluorescence microscope with DP30BW CCD camera (Olympus IX71, Olympus
America Inc., Center Valley, PA, USA) with an excitation at 450 nm and an emission at
630 nm. EDTA stabilized human whole blood were freshly obtained from Innovative
Research (Novi, MI, USA). Whole blood and serum were used for white blood cell (WBC)
count analysis.
6.4.7 SERS measurements of cells treated with synthesized NPs
SERS spectra were recorded using a Renishaw inVia Raman spectrometer
(WIRE 3.3 software, Renishaw, Wotton-under-Edge, Gloucestershire, UK) equipped with
a 300 mW, 785 nm NIR laser. Cells were cultured on magnesium fluoride (MgF 2,
United Crystals Co., Port Washington, NY, USA) and imaged in EBSS through a 63 ×
(NA = 0.90) water immersion objective (Leica Microsystems, Buffalo Grove, IL, USA).
For Raman streamline mapping, the data were acquired at 1 accumulation with 10 s
exposure, and the peak at 2152 cm1 from PB was selected for mapping. On each
group, the cells were detected within 2 h at room temperature.
6.4.8 NIR photothermal therapy on cells
For NIR PTT, 435 and AML12 cells (∼1 × 105 cells/mL) were incubated with
about 100 μL prepared NPs (20 μg/mL CMO:Eu@SiO2@GNR-PB-Ab (HNP-PB-Ab)
and CMO:Eu@SiO2@GNR-PB (HNP-PB), respectively) for two hours incubation at
37 °C. Next, the cells were rinsed with PBS thrice and then exposed to the 808 nm
laser irradiation at 0.8 W/cm2 power densities for 5 min. For cell viability test, the
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cells with triplicates were stained using a LIVE/DEAD viability/cytotoxicity Assay
Kit (Thermo Fisher Scientific) according to the instruction. After staining, the cells were
imaged using a fluorescence microscope equipped with a DP30BW CCD camera
(Olympus IX71) at 10× objective to analyze the relative proportion of live/dead cells.
6.4.9 Apoptosis and reactive oxygen species (ROS) analysis
The apoptosis level was recorded by a Muse™ Annexin V and Dead Cell kit (EMD
Millipore Co., Billerica, MA, USA), and ROS level was measured by a Muse™ Oxidative
Stress kit (EMD Millipore Co.). Cells were cultured in 6-well plates to about 70% confluence,
and every treatment had three replicates. The cells were collected and analyzed using a Muse
Cell Analyzer (EMD Millipore Co.).
6.4.10 Statistics analysis
Data are exhibited as mean ± standard deviation of error. One-way ANOVA is
conducted for significance test by OriginPro 9 software (OriginLab Corp., Northampton,
MA, USA).
6.5 RESULTS AND DISCUSSIONS
6.5.1 Characterization of HNP-PB
Figure 6.1(A) shows the X-ray diffraction (XRD) pattern of CMO:Eu@SiO2 hybrid
NPs. All diffraction peaks are well matches with tetragonal structure of CaMoO4 (JCPDF No:
29–0351 having space group I41/a (88) and Z = 4) [14] and a broad peak between 15–30°
centered at ~23° was assigned to porous silica present on the surface of the CMO:Eu
nanoparticles [15]. The intensity of the diffraction peak centered at ~23° weak as
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compared to that of CaMoO4 due to the amorphous nature of SiO2 on the surface of
CaMoO4. No impurity phases were detected. In this way luminescence functionalized
CMO:Eu nanoparticles are capped by SiO2 shell. Similar results were reported on
mesoporous SiO2 functionalized with luminescent core or Fe 3O4 magnetic
nanoparticles [16, 17].
The structural and morphological properties of the CMO:Eu@SiO2 (Figure 6.1(B))
and CMO:Eu@SiO2@GNR (Figure 6.1(C)) nanoparticles were examined by SEM. A
mesoporous spherical SiO2 shell with uniform thickness was formed over CMO:Eu core.
The average diameter of CMO:Eu@SiO2 nanoparticles was found to be ~206 nm. However,
SEM micrographs were not able to resolve the thickness of SiO2 shell and CMO:Eu core. It
was confirmed by using STEM micrograph (inset of Figure 6.1(B)). Moreover, the
presence of SiO2 shell on the surface of CMO:Eu nanoparticles significantly enhanced the
dispersion ability of the nanoparticles in distilled water. Furthermore, all the particles were
spherical in shape and no irregular shaped particles were observed. Thickness of the SiO 2
shell can be varied simply changing the concentration of TEOS in the reaction [15]. The
obtained CMO:Eu@SiO2 nanoparticles possessed uniform pore size of ~2.2 nm and high
surface area 380 m2/g. SEM micrograph of CMO:Eu@SiO2@GNR hybrid nanoparticles was
shown in Figure 6.1(C). On average each CMO:Eu@SiO2 nanoparticles was surrounded by
~5 GNRs. The presence of elements in CMO:Eu@SiO2 nanoparticles was further confirmed
by Energy-dispersive X-ray spectroscopy (EDX) spectrum as shown in Figure 6.1(D). Inset
of Figure 6.1(D) shows the Fourier transform infrared spectroscopy (FTIR) spectra of (i)
CaMoO4:Eu3+ and (c) CMO:Eu@SiO2 nanoparticles. The absorption peaks at 1642 and 3450
cm−1 are attributed to bending and stretching vibrations water molecules present on the
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surface of nanoparticles [18]. The band at ∼816 cm−1 is attributed to asymmetric stretching
vibrations of O–Mo–O of MoO42− tetrahedral [14]. The absorption band ~1110 cm−1 is due to
stretching vibrations of Si–O–Si which arises from hybrid nanoparticles [16].
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Figure 6.1 (A) XRD (B) SEM of Silica coated CMO nanoparticles and (C) Silica coated
CMO nanoparticles conjugated with gold nanorods, Inset of (B) shows the STEM of
CMO@SiO2; Inset of (C) shows the SEM of single CMO@SiO2@GNR. (D) EDX spectrum
of CMO@SiO2. (E) Excitation, and (F) Luminescence spectra of CMO@SiO2@GNR-PB
nanoparticles

under

different

excitations.

(G)

UV–visible

spectra

of

GNR,

CMO@SiO2@GNR, PB and CMO@SiO2@GNR-PB. (H) Photothermal responses of 808
nm laser irradiation with different power densities for 900 s at fixed CMO@SiO2@GNR-PB
concentration (28 μg/mL GNR). (I) Temperature change of CMO@SiO2@GNR-PB solution
with 28 μg/mL GNR at 0.8 W/cm2 808 nm laser irradiation over seven LASER ON/OFF
cycles. Experiment was carried out at room temperature.

The excitation (monitoring emission at 615 nm) and emission (excitation at 265, 285,
300, 395 and 464 nm) spectra of CMO@SiO2@GNR-PB hybrid nanoparticles are shown in
Figure 6.1(E-F). Excitation consists of a strong and broad absorption in the range of 225–350
nm, peak centered at 285 nm is attributed to Mo–O charge transfer (CT). Inset of the Figure
6.1(E) shows the expansion the excitation spectrum between 350 to 480 nm. The sharp
absorption peaks ~395 (7F0→5L6) and 464 nm (7F0→5D2) are due to the f–f transitions of
Eu3+ ion [19]. Figure 6.1(F) shows the emission spectra of bare CMO@SiO2@GNR-PB
hybrid nanoparticles at different excitation wavelengths. Emission spectra consist of sharp
emission peaks which are assigned to 5D0,1→ 7Fi , i=0–4, transitions of Eu3+ ion. The
emission at 595 and 615 nm correspond to the magnetic (5D0→7F1) and electric dipole
transitions (5D0→7F2) of Eu3+ ion, respectively, where the emission intensity of the electric
dipole transition is significantly higher that other transitions. When Eu3+ ions occupy the
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Ca2+ lattice sites in CaMoO4 host, only the magnetic dipole transition should be allowed
according to Judd–Ofelt theory, but the non-inversion center leads to a dominant
hypersensitive electric dipole transition at 615 nm.

Moreover, there is a significant

enhancement in the luminescence intensity of CMO@SiO2@GNR-PB hybrid nanoparticles
as compared to CMO@SiO2. This may be due to proximity of GNRs on the surface of
luminescent NPs that significantly enhance the luminescence efficiency [2]. Figure 6.1(G)
shows the UV-visible spectra of GNR, CMO@SiO2@GNR, PB and CMO@SiO2@GNRPB between 200–1000 nm. Two characteristic peaks were observed ~530 and 808 nm, which
are assigned to surface plasmon resonance (SPR) of GNRs. Bare GNRs and
CMO@SiO2@GNR hybrid nanoparticles show almost no any absorbance around 680 nm
whereas Prussian blue shows a strong absorption at 680 nm which arises due to a chargetransfer absorption band from Fe(II) to Fe(III) peculiar to Prussian blue [20]. The
CMO@SiO2@GNR-PB hybrid nanoparticles show a broad absorption from 500–1000 nm
which arises due to overlap of PB absorption and SPR band of GNRs, which enable the use
of hybrid nanoparticles as a potential agent for NIR mediated PTT agent [21].

Figure 6.2 (A) Photothermal responses of PBS, GNR, PB, CMO@SiO2@GNR and
CMO@SiO2@GNR-PB for 900 s at fixed 0.8 W/cm2. (B) The photothermal response of the
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CMO@SiO2@GNR-PB solution (28 μg/mL GNR) was recorded for an NIR laser (808 nm,
0.8 W/cm2), and then the laser was turned off. (C) Temperature increase of synthesized
CMO@SiO2@GNR-PB solution as a function of laser power extinction.

The photothermal properties of CMO@SiO2@GNR-PB hybrid nanoparticles
were investigated by monitoring the temperature of 1 mL water containing
CMO@SiO2@GNR-PB NPs (28 μg/mL GNRs) under 808 nm NIR light for 900 s at
different irradiation powers (0.8–1.2 W/cm2) (Figure 6.1(H)). Temperatures increased
between 25 to 65 °C on NIR irritation (0.8 W/cm2) to the hybrid nanoparticles for 900
s. It was also found that the temperature of hybrid nanoparticles was exponentially
increased with time and laser irradiation power. The comparison of photothermal
responses of 808 nm laser irradiation at PBS, GNR, PB, CMO@SiO2@GNR and
CMO@SiO2@GNR-PB for 900 s at fixed 0.8 W/cm2 was shown in Figure 6.2(A). No
significant difference in temperature change was observed when PBS was irradiated
with an 808 nm NIR radiation. It was found that the order of PTT heating efficiency
follows

CMO@SiO2@GNR<PB<GNR<CMO@SiO2@GNR-PB.

To

understand

the

photostability of CMO@SiO2@GNR-PB hybrid nanoparticles, seven cycles of ON/OFF NIR
laser irradiations were performed (~0.8 W/cm2 for 300 s (laser ON), followed by naturally
cooling for 1800 s (laser OFF) (Figure 6.1(I)). It was found that the temperature increased to
43 C in the first laser ON condition of the CMO@SiO2@GNR-PB. After the seventh cycle
of laser ON/OFF, the temperature elevations remained almost the same as in the first cycle
within the limits of error bar. It confirms the excellent photothermal stability of
CMO@SiO2@GNR-PB hybrid nanoparticles. The PTT heat conversion efficiency (η) of
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CMO@SiO2@GNR-PB hybrid nanoparticles was determined using the previous report by
Pinchuk and co-workers (Eq. 1-5) [13]. PTT effect of CMO@SiO2@GNR-PB hybrid
nanoparticles on an 808 nm NIR laser, in which the irradiation lasted for 300 s, and then the
laser was shut off and allowed to cool the nanoparticles up to 1800 s (Figure 6.2(B)). Inset of
Figure 6.2(B) shows log of (T(t)–T0)/(Tm–T0) versus time obtained from cooling curve and
the value of heat dissipation rate constant (B) was calculated using the cooling temperature
profile when the laser was turned off. The average value of B was found to be ~1.61103 s1
by linear fitting to Figure 6.2(B) with R2 = 0.99883. Figure 6.2(C) shows the linear
relationship between ΔT and ΔI. The η value was found to be ~30.6%. Furthermore, there is
no significant difference in luminescence emission was measured on 464 nm excitation to the
hybrid nanoparticles at the start and end of each cycle (Figure 6.1(I)).
6.5.2 Zeta potential/hydrodynamic diameter properties
Moreover, for the cellular uptake of the hybrid nanoparticles, its surface charge and
dispersion ability play essential factors. Bare GNRs show a positive charge of ~43.9 mV.
CMO@SiO2 nanoparticles show a negative charge of –26.6 mV, this is may be due to the
presence of –OH groups present on the surface of nanoparticles. Further, zeta potential of
CMO@SiO2@GNR-PB hybrid nanoparticles shifted to +16 mV. This high value reveals the
good colloidal stability of the hybrid nanoparticles but minimum surface charge is required
for the better tumor penetration. Recently, Joshi and Halas group demonstrated that the
PEGylated gold nano-shell (–5.4 mV) and nanomatryoshkas (–4.4 mV) shows more tumor
uptake as compared to bare gold nano-shell (–57 mV) and bare nanomatryoshkas (–46.7 mV)
nanoparticles [22]. Also, mesoporous silica coated gold nanoparticles with zeta potential –
22.5 mV have been successfully tested for both in-vitro and in-vivo applications [23].
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6.5.3 Characterization of HNP-PB distributed on cells by SEM
To understand the distribution of nanoparticles in cell environment, 435 cells were
treated with HNP-PB and HNP-PB-Ab nanoparticles.

Figure 6.3(A) illustrates the

representative SEM images of 435 cells without treatment, treated with HNP-PB and treated
with HNP-PB-Ab (black arrow points to NPs) and its EDX spectra were displayed in Figure
6.3(B). The scale of HNP-PB and HNP-PB-Ab group in Figure 6.3(B) is slightly different,
which is caused by the distribution of NPs, but both groups confirm the distribution of NPs
on cells. After 2 h NPs incubation, cells treated with HNP-PB-Ab group exhibited a strong
EDX signal which confirms the presence of highest occupancy NPs distributed around the
cell surface as compared to control and HNP-PB groups, indicating the specificity of HNPPB-Ab. Few NPs were still observed on HNP-PB treated cells because of non-specific
binding.

Figure 6.3 (A) Representative SEM images of 435 cells without treatment, treated with
HNP-PB or HNP-PB-Ab (black arrow points to NPs). (B) Corresponding energy-dispersive
X-ray spectroscopy of 435 cells without treatment, treated with HNP-PB or HNP-PB-Ab.
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6.5.4 Fluorescence imaging of HNP-PB on cells
Figure 6.4 exhibits phase contrast, fluorescence, and overlay of phase contrast
and fluorescence images of 435 and AML12 cells without treatment (control), treated
with 2 h HNP-PB (with or without Ab). In 435 cells (Figure 6.4(A)) there was no
obvious fluorescence red color in the groups of control and 2 h HNP-PB; while a
strong red color was observed in the group of 2 h HNP-PB-Ab, demonstrating the
fluorescence function of synthesized NPs with strong specificity once conjugated with
antibodies. To further investigate the specificity of HNP-PB-Ab, non-cancerous cells
(AML12, HER2 negative) were treated with the same groups (Figure 6.4(B)). Still no
red fluorescence was detected under the groups of control and 2 h HNP-PB. However,
there was a slight red fluorescence color in the group of 2 h HNP-PB-Ab. When
compared to 435 cells of 2 h HNP-PB-Ab group with the group of AML12 cells, it
was evident that 435 cells possessed much more red color than AML12 cells,
indicating the over-expression of HER2 on 435 cells than AML 12 cells. This also
further confirmed the specificity of HNP-PB-Ab for 435 breast cancer cells.
The red fluorescence was observed in the group of 435 and AML12 cells
treated with HNP-PB-Ab by ~464 nm excitation and 615 nm emission, and this
fluorescence property is from Eu3+ ion (5D2 level of Eu3+ ion). Previous studies also
demonstrated the fluorescence emission from Eu3+ doped NPs for enhanced imaging
[15, 16]. Compared to 435 cells with AML12 cell line, 435 cells over-express HER2
[24], and AML12 cell line was derived from normal liver and is non-tumorigenic [25].
The 435 cells of 2 h HNP-PB-Ab group exhibited the strongest fluorescence compared
to other groups.
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Figure 6.4 Phase (PH), fluorescence (FL), and overlay images of 435 (A) and AML12
cells (B) without treatment and treated with HNP-PB or HNP-PB-Ab for 2 h. Scale bar:
100 μm.
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6.5.5 Distribution of HNP-PB on cells detected by SERS
HNP-PB possess SERS function due to GNR conjugation, and GNR has been
largely utilized to enhance Raman intensity [26, 27]. Prussian blue (PB) was selected
to evaluate the SERS ability as the Raman reporter molecule for its strong Raman
vibrational band at ~2152 cm-1 (stretching vibration of carbon nitrogen triple bond
group) [28]. Raman mapping for live 435 and AML12 cells was performed by
selection of 2152 cm-1 (a characteristic peak from PB). The HNP-PB were conjugated
with Ab for the enhancement of specificity. Figure 6.5 shows the Raman bright-field
image, the corresponding Raman streamline mapping and representative Raman spectrum
(2000–2300 cm-1) from SERS negative (green cross) and SERS positive (red cross) sites of
single living 435 (Figure 6.5(A)) and AML12 cell (Figure 6.5(B)). It was observed
that 435 cells treated with HNP-PB-Ab illustrated the strongest distribution of NPs
(bright yellow color indicated), suggesting the specificity of synthesized HNP-PB-Ab.
Few NPs were still distributed around the 435 cells treated with HNP-PB due to nonspecific binding. NPs were also applied to the AML12 for comparison (Figure 6.5(B)).
It was found that few NPs were located around AML12 cells in both HNP-PB and
HNP-PB-Ab groups, indicating non-specific binding of NPs. These SERS results
verified the specificity of HNP-PB-Ab and the distribution of these NPs on cancerous
cells (e.g., 435 cells) but not on non-cancerous cells (e.g., AML 12 cells).
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Figure 6.5 Raman streamline mapping of 435 (A) and AML12 cells (B) without treatment
and treated with HNP-PB or treated with HNP-PB-Ab for 2 h (peak at 2152 cm-1 from PB
was selected for mapping). Scale bar: 10 μm.

184

Figure 6.6 (A) Photothermal effect and biocompatibility. 435 and AML12 cells were
incubated without NPs (control), with HNP-PB or HNP-PB-Ab for 2 h; after that, cells were
irradiated under 0.8 W/cm2 808 nm laser for 5 min (green: live cells; red: dead cells. Scale
bar: 100 μm). (C) Cell viability of 435 and AML12 cells (Error bar: standard deviation of the
mean; N = 3, **P <0.01). (D) Human white blood count.
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6.5.6 Photothermal effect and biocompatibility of HNP-PB
The photothermal effect of HNP-PB and HNP-PB-Ab NPs on HER2 positive 435
cells and HER2 negative cells is presented in Figure 6.6. Cells were treated with HNP-PB
(without or with Ab) and irradiated by an 808 nm NIR laser for 5 min (0.8 W/cm2). Figure
6.6(A-B) exhibits the fluorescence images (live cells: green; dead cells: red) of 435
and AML12 cells without or with NPs treatments (HNP-PB or HNP-PB-Ab). Cells
were alive in the control group, whereas a few dead cells were observed in the HNPPB group when treated to both types of cells. As expected, almost all cells were dead
when HNP-PB-Ab was applied to 435 cancer cells (Figure 6.6(A)). However, only
few dead AML12 cells in HNP-PB-Ab group were observed (Figure 6.6(B)),
indicating that HNP-PB-Ab can specifically target and kill 435 cancer cells that
overexpressed HER2.
The quantitative cell viability of 435 and AML12 cells without and with treated
(HNP-PB or HNP-PB-Ab) groups for 2 h was studied on 5 min 0.8 W/cm2 808 nm laser
irradiation (Figure 6.6(C)). There was no significant viability differences for AML12
cells among these three group. However, 435 cells treated with HNP-PB-Ab had the
least percentage of viability (~4.0±2.8%) comparing to control and HNP-PB group,
demonstrating the specificity and high PTT efficiency from HNP-PB-Ab. Moreover,
HNP-PB with or without Ab were treated with WBC to evaluate their biocompatibility,
as shown in Figure 6.6(D). WBC count reveals that there was no significant viability
differences among these three groups, and the numbers of WBC for all treated groups
were within normal range (~4000–11,000 white blood cells/µL) [29], indicating the
good biocompatibility of synthesized HNP-PB.
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Figure 6.7 Cytotoxicity of synthesized HNP-PB. (A) The histograms show the percentages
of ROS- (M1) and ROS+ (M2) for one experiment. 435 cells were incubated without NPs
(control), with HNP-PB or HNP-PB-Ab for 2 h; after that the formation of ROS was
measured using the Muse flow cytometry-based oxidative stress assay™. (B) The scattered
apoptosis blots represent one experiment. 435 cells were incubated without NPs (control),
with HNP-PB or HNP-PB-Ab for 2 h; after that apoptosis was evaluated after staining with
FITC-annexin-V/7ADD. (C) The graph displays the summary ROS+ cells from three
independent experiments. (D) The graph represents the summary mean percentages ± SD of
apoptosis (early and late apoptosis) of three independent experiments. (E) Cell viability of
435 and AML12 cells: control and treated with different concentrations of HNP-PB for 24 h
(Error bars are standard deviation of the mean; N = 3, **P <0.01).
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The PTT results indicated that the HNP-PB-Ab could kill 435 cells with high
specificity, PTT efficiency and biocompatibility. The high specificity comes from the
binding interactions between the Ab and HER2 on the cancer cell, the advanced PTT
efficiency is from the synergistic effect of GNR and PB that can convert light to heat
effectively, and the good biocompatibility of HNP-PB-Ab is caused by the inert
property of SiO2 and GNR and the stability of PB. Therefore, the HNP-PB-Ab with high
specificity, PTT efficiency and biocompatibility could be used as a potential approach for
cancer treatment and may apply in clinical cancer therapy.
6.5.7 Cytotoxicity of synthesized HNP-PB
To evaluate the cytotoxicity of synthesized HNP-PB, ROS, apoptosis and cell
viability were measured for the cells exposed to these NPs. Figure 6.7(A) is the
representative result of ROS expression from flow cytometry, and Figure 6.7(C) compares
ROS+ cells from three independent experiments. The representative apoptosis result is shown
in Figure 6.7(B), and Figure 6.7(D) exhibits the summary mean percentages of apoptotic
cells of three independent experiments. Figure 6.7(E) analyzes the cell viability of 435 and
AML12 cells incubated with HNP-PB for 24 h at different concentrations (from 0 to 400
µg/mL). In Figure 6.7(C) the cell population with ROS+ cells in control group is 3.33 ±
0.72%, and there is a slight increase in HNP-PB without (3.81 ± 0.38%) or with antibody
(4.48 ± 1.63%) groups. There is no significant difference among them for ROS expression.
Similarly, there is no significant difference in NPs-induced apoptosis among the three
groups (Figure 6.7(D)): control group (5.70 ± 1.01%), cells treated with HNP-PB (5.77 ±
1.46%) and HNP-PB-Ab (6.03 ± 1.14%), respectively.
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The effect of HNP-PB on cell viability (Figure 6.7(E)) was evaluated using the
LIVE/DEAD viability/cytotoxicity assay kit. Even though cell viability decreased slightly
with the increase of HNP-PB concentration, it still remains >90% up to 400 μg/mL of the
HNP-PB incubated for 24 h. This observation is similar to previous study that mesoporous
silica nanoparticles have little impact on cellular activities (viability, mitochondrial activity,
membrane integrity) with good biocompatibility [30]. The slight decrease of cell viability at
high concentration (400 μg/mL) of HNP-PB may be attributed to CMO:Eu, which has been
reported to produce hydroxyl radicals at high concentration [31]. Hydroxyl radicals can
generate ROS which induces cellular apoptosis [32, 33]. However, the concentration of
HNP-PB used in this study is under 50 μg/mL, so the impact of cytotoxicity of higher NP
concentration is limited.
Overall, the cytotoxic effect of HNP-PB on cancerous and non-cancerous cells was
negligible, further demonstrating the good biocompatibility of synthesized NPs.
6.6 CONCLUSION
In summary, PB coated CaMoO4:Eu@SiO2@Au-nanorod hybrid nanoparticles were
prepared and used as a fluorescence, SERS and PTT probe for biomedical applications. The
nanostructures were heated up to hyperthermia temperature (43 °C) on excitation with NIR
light and can be used to kill cancer cells. Also, electric dipole transition of Eu3+ ion (615 nm)
can be used for imaging cancer cells on excitation with 464 nm. Surface functionalized
GNRs and SiO2 shell make hybrid particles more biocompatible. Core/shell features of the
particles were demonstrated by STEM. Finally, in-vitro results suggest that HER2 antibody
functionalized hybrid nanoparticles may induce more cell death as compared to bare
nanoparticles on 808 nm laser excitation. Also, the porous SiO2 structure may useful for
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loading drug and NIR fluorophores into the porous structure. This method can be used to
prepare various other upconversion core functionalized mesoporous nanostructures decorated
with GNRs and could be used for different biomolecules in biological and biomedical
applications. In addition, the ROS generation, apoptosis level and cell viability changes
induced from

the synthesized construct

were evaluated, confirming the

good

biocompatibility of synthesized materials. Thus, this work demonstrates the promising
potential of CMO:Eu@SiO2@GNR-PB nanocomposites that potentially benefit the area of
cancer therapy.
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CHAPTER 7
TROPHOBLAST DERIVED CELLS BIOPHYSICAL AND BIOCHEMICAL CHANGES
ON TiO2 NT ARRAYS COATED WITH GOLD NANOPARTICLES (TiO2 NTs-Au)
7.1 ABSTRACT
Trophoblast derived cells (TE) are interesting model of stem-like cell research for
their regenerative properties, indefinite passage, and foreign DNA receptivity. In this work,
vertically orientated TiO2 nanotube (NT) arrays coated with gold nanoparticles were
fabricated, and trophoblast cells were grown on the surface of these TiO2 NT fabricated
substrates. Fluorescence microscopy, Raman spectroscopy, and scanning electron
microscopy were applied to study cell viability, cellular biochemical information and
morphology of TE cells grown on TiO2 NTs surface up to 30 days. This study will benefit
efforts to design and fabricate new biomimetic materials for regenerative medicine, and
provide new insight into the nature of trophoblast cells-nanotopography interaction.
7.2 INTRODUCTION
Titanium surfaces have been widely applied in clinical implantations for the purpose
of bone, joint, or tooth replacements [1]. Compared with a non-textured titanium surface, a
thin TiO2 nanotube (NT) layer formed on Ti substrate has desirable bioactive (bone-growth)
properties [2]. In recent years TiO2 NT arrays have gained much attention as a potential
biomaterial for their superior biocompatibility to induce specific cell responses.
TiO2 NT surfaces with nanoscale spacing models can be utilized for size-dependent
cellular response [3]. The nanostructure also offered nanoscale cues to enhance cellular
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probing, cell sensing, and cell migration. For bovine aortic endothelial cells (BAECs) grown
on TiO2 NT, it is of benefit to probe the surface and interlock cellular extensions.
Extracellular matrix (ECM) deposition and a more natural “vascular bed” were stimulated by
TiO2 NT, which also induced unidirectional cytoskeletons and more organized lamellipodia,
indicating the TiO2 nanotopography facilitated endothelialization and endothelial cell
migration, evidenced especially in the raised formation of ECM and increased level of nitric
oxide/endothelin ratio [4]. The size of TiO2 NT also can regulate the differentiation of human
mesenchymal stem cell (hMSC) towards an osteoblast lineage without osteogenic inducing
factors. In a relatively confined diameter range (30 nm ~ 100 nm), TiO2 NT size is correlated
with the hMSC oriented differentiation vs. adhesion and growth [5]. Nanoscale TiO2 surface
topography is associated with the proliferation, vitality, and motility of mesenchymal stem
cells (MSCs) and their differentiation to bone-forming cells was associated specifically with
NT with diameters between 15 and 100nm [6]. It was reported that 15-nm TiO2 NT can
maximally induce the adhesion, proliferation, migration, and differentiation of MSCs, while
100-nm NT have the opposite effect, inducing cell death [3].
Cellular interactions with the extracellular matrix and other cells, are induced by
integrins that regulate all major cellular activities including adhesion, differentiation, cellular
shape changes, proliferation, migration, gene expression, and apoptosis in a synergistic
approach with hormones and growth factors [7, 8]. Due to cell adhesion to the extracellular
matrix, integrins cluster into focal adhesion complexes, causing activation of intracellular
signaling cascades into the cytoskeleton and to the nucleus [9, 10]. Various kinds of proteins
such as FAK, paxillin, tensin, p130Cas, and others are recruited by functional focal adhesion
complexes, which grow in size and complexity with time of adhesion [9, 11]. On 15 nm TiO2
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NT the phosphorylation of focal adhesion kinase FAK and the ERK kinase was highest in
growing stem cells, while lowest on 100 nm NT. The concentration and topography of cell
adhesion sites in the extracellular matrix are critical for integrin clustering and activation [6].
Porcine trophoblast derived cells have possessed a feature of stem cell - self-renewal,
and they are valuable tools for studying the molecular basis of early embryo physiology. In
serum-free medium these cells grow in colonies that form domes, self-regenerate, and can be
passaged indefinitely, but in serum medium these cells fail to self-regenerate, undergo wideranging morphological changes, and ultimately senesce. In this study, we designed and
synthesized three-dimensional TiO2 NT coated with gold nanoparticles (Au) to study the
biochemical and morphological alterations of trophoblast-derived stem-like cells treated with
serum and serum-free media grown on this substrate at different time points. This study
provided the new insight into the trophoblast cell-nanotopography interaction that would be
of benefit in the design and fabrication of new biomimetic materials for regenerative
medicine.
7.3 HYPOTHESIS
Three-dimensional nanostructures have stronger effects on the morphological and
functional development of TE cells over two-dimensional Petri dishes.
7.4 MATERIALS AND METHODS
7.4.1 Synthesis of TiO2 and TiO2 NT coated with gold nanoparticles
Anodization methods were applied to prepared TiO2 NT arrays substrate. First
titanium foils (0.5 mm thick, 99.6% purity, 1 cm × 1 cm, Alfa Aesar, Ward Hill, MA, USA)
were immersed into acetone and ethanol for 30 min ultrasound in order to thoroughly
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degrease. Then a solution consisting of HF:HNO3:H2O = 10:30:60 (vol%) was used to
chemically polish titanium foils. The anodization solution was prepared with a mixture
(90:10 vol%) of glycerol and deionized water (18.2 MΩ cm−1). The cleaned titanium foils
were anodized for 3 h using a two electrode electrochemical system with a platinum foil as
the cathode at a constant potential (20 V) with a direct current power supply (Agilent
Technologies, Santa Clara, CA, USA). After that the TiO2 NTs substrate was annealed for 2
h at 400 °C.
To attach gold nanoparticles, the prepared TiO2 NTs substrate was immersed in a
0.02 M SnCl2 solution with concentrated HCL and deionized water for 5 min. After being
rinsed with deionized water and ethanol, respectively, the air dried TiO2 NTs substrate was
immersed in a 0.02 M HAuCl4 solution three times (each time 2 min) to deposit Au seeds
onto the substrate by reduction. 0.10 M cetyltrimethyl ammonium bromide (CTAB), 2.5 ×
10−4 M HAuCl4 and 0.10 M freshly prepared ascorbic acid were mixed to make the growth
solution. The treated substrate was immersed into growth solution for 2 min, then exposed to
30 min UV irradiation. After that the substrate was re-immersed into the growth solution in a
38 °C water bath for 16 h. Finally the substrates with gold particles were ready to be prepared
for characterization and cell growth experiments.
7.4.2 Trophoblast-derived stem-like cell preparation
Porcine trophoblast-derived stem-like cells were processed as described previously
[12]. Though no animals were used in the current experiments, the authors can assert that the
cells utilized herein were collected in strict accordance with the animal welfare guidelines
reviewed and approved by the Institutional Animal Care and Use Committee at Utah State
University (Protocol #2239). Briefly, cells were harvested from pig embryos on gestational
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day 13, dissociated into small clumps of cells using mechanical (vortex) and enzymatic
(trypsin) means, and cultured in a defined (fetal bovine serum-free) medium at 39 °C with
5% CO2 in air. The detailed formula of medium is in Table 7.1. The serum-free medium
consists of 49% (v:v) Dulbecco’s Modified Eagle Medium (DMEM; Corning/Mediatech;
Manassas, VA, USA), 49% (v:v) Ham’s F12 Nutrient Mixture (Corning), and 2% (v:v) B-27
Supplement (50X; Invitrogen, Carlsbad, CA, USA) supplemented with 20 ng/ml Epidermal
Growth Factor (Sigma-Aldrich, St. Louis, MO, USA), 40 ng/ml FGF2 (Sigma-Aldrich), and
20 μg/ml gentamicin. Cells were cultured under these conditions until utilized for the
experiments detailed here. Upon initiation of the current work, cells were subpassaged and
plated onto the prepared TiO2 NTs or TiO2 NTs-Au substrate cell culture well inserts in
either the serum-free medium mentioned earlier, or a presumptive ‘differentiation’ medium
that consists of 85% (v:v) DMEM base medium, 15% (v:v) fetal bovine serum, 2 ng/ml
FGF2, and 20 μg/ml gentamicin.
7.4.3 Fluorescence microscopy
Bright field and fluorescence images were collected by an Olympus IX71 inverted
fluorescence microscope (Olympus America Inc., Center Valley, PA, USA) equipped with an
Olympus DP30BW CCD camera using Olympus DP-BSW Controller and Manager
Software.

Images

were

acquired

via

a

10×

lens

(Olympus).

LIVE/DEAD

Viability/Cytotoxicity Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA) was used
to image cell viability.
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7.4.4 Raman microspectroscopy
Raman spectra were recorded using a Renishaw inVia Raman spectrometer
(Renishaw, Wotton-under-Edge, Gloucestershire, UK) equipped with a 63 × 0.9NA water
immersion objective (Leica Microsystems, Buffalo Grove, IL, USA) and a 785 nm near-IR
laser. Cells cultured onto TiO2 NT coated with gold nanoparticles were placed under the
Raman microspectrometer. Cells were maintained in medium during Raman measurements.
The wavenumber of 520.5 ± 0.1 cm-1 with silicon at a static spectrum was the standard
calibration for the spectrometer. Spectra were then collected in static mode for 1
accumulation at 10 s laser exposure over a wavenumber range of 600–1800 cm-1.
Cosmic rays of Raman spectra were removed by Renishaw Wire 3.3 software. Due to
the interferences from background and other factors, mathematical approaches were
employed to reduce systematic noise and amplify the signal of biochemical compositions in
target cells.
7.4.5 Scanning electron microscope
The substrates were characterized by a Hitachi S4000 scanning electron microscopy
(SEM, Hitachi America Ltd, Tarrytown, NY, USA). X-ray photo-electron spectroscopy
(XPS) was performed with a Kratos Axis Ultra DLD instrument using a monochromatic Al
K-α source. Powder X-ray diffraction (XRD, X’PertPRO/cubix PRO, PANalytical) was
obtained using Cu K-α radiation.
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7.5 RESULTS AND DISCUSSION
7.5.1 Characterization of TiO2 NTs and TiO2 NTs-Au substrates
The synthetic TiO2 NTs had around 63 nm inner diameter (Figure 7.1A) and a 540
nm length (Figure 7.1B). It is reported that TiO2 NTs with small diameter (~ 30 nm) can
promote the adhesion of hMSC without affecting differentiation, while TiO2 NTs with large
diameter ((~ 70 to 100 nm) can induce hMSC selective differentiation into osteoblast-like
cells [5]. In this study, TiO2 NTs with ~63 nm diameter were selected to study the effect of
3D substrate on the growth of trophoblast cells.
Gold nanoparticles have been considered as biocompatible in vitro [13], and they are
suitable candidates for nanomedicine because of their noncytotoxic, nonimmunogenic and
good biocompatible properties. In addition, gold nanoparticles can be applied to enhance the
Raman signal of reporter molecule [14]. To increase the biocompatibility and Raman signal,
gold nanoparticles were coated onto the surface of TiO2 NTs. It was found that the gold
nanoparticles, randomly distributed on the surface of TiO2 NTs (Figure 7.1C), were mainly
hexagonal in shape with ∼140 nm diameter (Figure 7.1D). The gold nanoparticles and gold
cluster covered most of the TiO2 NTs surface area. TiO2 NTs-Au substrates were sterilized
before culturing trophoblast-derived stem-like cells for further detection.
7.5.2 Biochemical analysis of trophoblast-derived stem-like cells grown on TiO2 NTs-Au
substrates
To evaluate cellular biochemical information on three-dimensional substrates,
trophoblast-derived stem-like cells were seeded on TiO2 NTs-Au substrates. TiO2 NTs-Au
substrates were chosen because gold nanoparticles on the surface of TiO2 NTs could enhance
the Raman signal from cells, while cells grown on TiO2 NTs substrates only displayed the
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signal from TiO2 NTs substrates, as shown in Figure 7.2. For example, the Raman peak at
639 cm-1 was from the TiO2 NTs substrate (labelled with black dash line). However, cells
grown on TiO2 NTs-Au substrates exhibited the enhanced Raman peaks from cells.

Figure 7.1 (A) The SEM top view of TiO2 NTs, (B) cross section of TiO2 NTs, (C) the top
view of TiO2 NTs-Au, (D) the enlarged top view of TiO2 NTs-Au.
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Figure 7.2 Raman spectra of trophoblast-derived stem-like cells grown on TiO2 NTs-Au NPs,
TiO2 NTs and MgF2 substrates (black dash line indicates the peak from TiO2).

The smallest size of trophoblast cell was around 20 µm under undifferentiated status,
so the cells of all groups covered the area coated with gold nanoparticles to receive enhanced
Raman signal from cells. Raman average spectra of cells on TiO2 NTs-Au at day 3, 5, 7, 10,
15 and 30 on serum-free and serum media were illustrated in Figure 7.3. The characteristic
Raman peaks were labelled, and Raman signal was intensified because of the surface
plasmon resonance effects from gold nanoparticles. The Raman spectra of both serum-free
and serum groups at different days exhibited the characteristic peaks at 720 cm-1 (DNA), 854
cm-1

(Tyrosine),

1006

cm-1

(Phenylalanine),

1129

cm-1

(C-C

skeletal

stretch

transconformation), 1158 cm-1 (Lipids and nucleic acids), 1213 cm-1 (Tyrosine,
phenylalanine), 1260 cm-1 (Protein band), 1341 cm-1 (CH deformation (proteins and

204

carbohydrates)), 1374 cm-1 (Ring breathing modes of DNA/RNA), 1490 cm-1 (nucleic acids),
1582 cm-1 (Phenylalanine).
The difference between serum and serum-free groups was the Raman peak at 1446
cm-1 (CH2 deformation (proteins & lipids)) as shown in Figure 7.3B. There was no Raman
peak at 1446 cm-1 from day 3 to day 30 for cells with serum-free media groups. However, at
day 7, 10 and 15 the Raman peak at 1446 cm-1 was more apparent on serum groups than
serum-free groups, but decreased at day 3, 5 and 30 on serum groups. This Raman peak
could be a potential biochemical marker to distinguish undifferentiated and differentiated
trophoblast cells from day 7 to day 15.
Raman spectroscopy is able to monitor the biopolymer changes of trophoblast cells in
situ and in real-time. It is reported that the Raman intensity of nucleic acids can be indicative
of stem cells differentiation that the intensity of nucleic acids for differentiated stem cells is
significantly less than that of undifferentiated cells [15, 16]. In this study, the most
significant difference between differentiated and undifferentiated cells was the CH2
deformation (proteins & lipids) indicated by Raman peak at 1446 cm-1. This observation was
different from above reported stem cells research, and the reasons may be accounted for the
differences in cell type and the effect of substrate (TiO2 NTs-Au) used in this study.
7.5.3 Cell viability analysis of trophoblast-derived stem-like cells grown on TiO2 NTsAu substrates
As shown in Figure 7.4, viabilities of the TE cells grown on TiO2 NTs-Au at day 3, 5,
7, 10, 15 and 30 on serum and serum-free media (green: live; red: dead; scale bar: 100 µm)
were compared. Firstly the cells on both media were alive among 30 days, suggesting the
good biocompatibility of TiO2 NTs-Au substrates. Secondly the size of cells in serum-free
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medium (Figure 7.4A) was less than that of cells in serum medium (Figure 7.4B), suggesting
that cells in serum-free media still maintained undifferentiated state up to 30 days. However,
the size of cells in serum medium was larger and more stretched over time as compared with
cells in serum-free medium.

Figure 7.3 Raman spectra of trophoblast-derived stem-like cells on TiO2 NTs-Au at day 3, 5,
7, 10, 15 and 30 on (A) serum-free and (B) serum media.
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Previous study reported that the adhesion of hMSC grown on TiO2 NTs with small
diameter can be increased, and the differentiation of hMSC grown on TiO2 NTs with large
diameter can be facilitated [5]. In this study the TiO2 NTs-Au substrates affected little on
cellular morphology and differentiation, and the reasons may be the diameter of TiO2 NTs
used in this work which was between 30 nm to 100 nm, gold nanoparticles coating, cell line
differences or the role of culture medium. Thus, these observations indicated the good
biocompatibility of substrate and limited impact on cellular morphology and differentiation.
7.5.4 Morphological characterization of trophoblast-derived stem-like cells grown on
different substrates
To compare the influence from substrates on cellular structure, three substrates (TiO2
NTs-Au NPs, TiO2 NTs and flat Petri dish substrate as control), one time point (3 days) and
one medium type (serum-free medium) were selected. Trophoblast cells with similar cell
density were seeded on these three substrates with serum-free medium. After three days, cells
were fixed first and then imaged by SEM to visualize the morphological changes.
Figure 7.5 illustrated the SEM images of trophoblast cell grown on TiO2 NTs-Au NPs
(A), TiO2 NTs (B) and Petri dish (C). Firstly it was observed that cells grown on threedimensional TiO2 NTs-Au NPs and TiO2 NTs substrates presented more cellular structures,
like more filaments, compared to cells grown on flat Petri dish. In addition, there were lots of
cytoskeleton structures expanded along the substrates for cells grown on three-dimensional
substrates. Together, these observations from SEM images indicated that cells grown on
three-dimensional substrates may undergo more aggressive proliferative process as compared
with cells on flat Petri dish in the same medium.
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Figure 7.4 Cell viability of trophoblast-derived stem-like cells on TiO2 NTs-Au at day 3, 5, 7,
10, 15 and 30 on (A) serum-free and (B) serum media (green: live; red: dead; scale bar: 100
µm).
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Figure 7.5 SEM images of trophoblast-derived stem-like cells on (A) TiO2 NTs-Au NPs, (B)
TiO2 NTs and (C) Petri dish substrate (Cells were grown in serum-free medium).

Research conducted by Schmuki et al. reported that cell adhesion and spreading were
increased for nanotube diameters between 15 and 30 nm, while cell activities were reduced
for diameters larger than 50 nm, and the diameter of nanotube played more dominant role
than surface modification onto the nanotube in affecting cellular function [17]. From our
observation (SEM images), the activity of trophoblast cells did not exhibit obvious decay,
which was different from Schmuki et al. finding [17]. However, it was found that trophoblast
cells grown on three-dimensional TiO2 NTs-Au NPs and TiO2 NTs substrates both possessed
more filaments, compared to cells grown on the flat Petri dish.
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Thus, the SEM results showed that cells grown on nanostructures had more cellular
filaments, suggesting more vigorous interaction with substrates during the growth and
attachment, compared to cells grown on the flat Petri dish, implying that three-dimensional
substrates played an important role in the development of cellular morphology, cytoskeleton
and function under similar conditions. These observations motivated us to seek other biology
method, like qPCR or gene microarray, to examine the ECM-related gene expression that
may help understand the molecular mechanisms of TE cells-TiO2 NTs interaction.
7.6 CONCLUSIONS
In this work we evaluated the behavior of trophoblast cells on nanoscale topographies
of TiO2 NTs. We developed aligned TiO2 NTs layers with ~63 nm diameter and TiO2 NTs
coated with ~140 nm gold nanoparticles on the surface to explore the influence of surface
structures. Cells grown on TiO2 NTs substrates only displayed the Raman peak from TiO2.
To study the biochemical information on three-dimensional substrates, trophoblast cells were
grown on TiO2 NTs-Au substrates because gold nanoparticles can enhance the Raman signal
from cell. It was found that the most significant difference between differentiated and
undifferentiated cells was the Raman peak at 1446 cm-1 (CH2 deformation (proteins &
lipids)), and this Raman peak could be a potential biochemical marker to distinguish
undifferentiated and differentiated trophoblast cells grown on TiO2 NTs-Au NPs substrates
from day 7 to day 15. In addition, cell viability results showed that cells would be alive on
TiO2 NTs-Au NPs substrates up to 30 days, demonstrating the good biocompatibility of
fabricated substrates. SEM images of trophoblast cells grown on three different substrates
(TiO2 NTs-Au NPs, TiO2 NTs and Petri dish substrate) were compared, and it was found that
cells grown on TiO2 NTs-Au and TiO2 NTs substrates both had more cellular filaments and
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more spread on substrates. Integrin may play important roles in the morphological and
functional differences of trophoblast cells grown on three-dimensional nanostructures or twodimensional Petri dishes. The predicted size of an integrin heterodimer is about 10 nm
diameter [18]. It is reported that a 15-20 nm spacing of nanotubes will force integrin
clustering into the closest packing, resulting in integrin activation, and the activation of
integrin-mediated signaling pathways induced by nanotubes could control cell proliferation,
migration, differentiation, and cell survival [6]. In conclusion, this study would benefit to
design and fabricate new biomimetic materials for regenerative medicine and tissue
engineering, providing new understanding of the trophoblast cells-nanotopography
interaction.
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CHAPTER 8
SUMMARY AND FUTURE DIRECTION
8.1 SUMMARY
The focus of this dissertation is on in vitro, non-invasive imaging and detection of
single living mammalian cells interacting with bio-nano-interfaces. We studied the
biophysical and biochemical alterations and cellular responses of mammalian cells (e.g.
human cancer cells and porcine trophoblast-derived stem-like cells) upon external stimuli
(e.g. anticancer drug, diesel exhaust particles, antioxidant, nanoparticles, serum-free media
and nanotubes). This dissertation research of six technical chapters (chapter 2-7) can be
summarized as follows:


Classification of differentiated and undifferentiated trophoblast-derived stem-like
cells grown on Petri dish by biomechanical, biochemical and genetic properties.



Single living cell imaging, biomechanical and biochemical detection and cellular
responses measurement upon different treatments.



Development and synthesis of multifunctional hybrid nanoparticles with the functions
of fluorescence, SERS and photothermal properties for different cancer biomarkers
detection and specifically targeting cancer cells for PTT.



Development and synthesis of three-dimensional TiO2 nanotubes coated with Au to
study the morphological and biochemical alterations of trophoblast-derived stem-like
cells grown on this substrate.
In chapter 2, AFM, RM and qPCR were applied to distinguish between

undifferentiated and differentiated trophoblast-derive stem-like cells grown on Petri dish.

214

Cellular biomechanical, biochemical changes were measured and cellular biophysical and
biochemical properties can be used as differentiation markers to classify cellular
differentiation.
In Chapter 3, the responses of five cancer cells with and without BRMS1 (MDA-MB231, MDA-MB-435, MDA-MB-231/BRMS1, MDA-MB-435/BRMS1 and A549 cells)
treated with anticancer drug (Doxorubicin) were studied by a multimodal approach. It was
found that BRMS1 expression changes cellular biochemical and biomechanical properties.
BRMS1 expression induces a differential biomechanical response when interacting with 4 h
DOX. Cancer cells with or without BRMS1 show similar biochemical changes upon DOX
treatment. ROS, apoptosis expression and cell viability changes of five cells display a similar
pattern from control to 24 h DOX exposure, indicating that BRMS1 has no effect on cellular
chemoresistance.
In chapter 4, diesel exhaust particles (DEP) and an antioxidant resveratrol (RES) were
treated with cells to study the destructive effect from DEP and protective function from RES
by measuring cellular biophysical and biomechanical changes as well as cellular plasma
membrane potential and cell cycles. It was found that RES can alleviate DEP damage on
cellular structure and increase DEP-induced biomechanical changes. In addition, RES could
significantly prevent hyperpolarization of A549 cells, increase DEP-induced ROS generation
and change DEP-induced cell cycle.
In chapter 5, a hybrid nanoparticle with the properties of fluorescence imaging, SERS
detection and PTT was synthesized for single living cell analysis of epidermal growth factor
receptor (EGFR) and specifically killing cancer cells with high EGFR expression.
Fluorescence images demonstrated fluorescence function of NPs with fluorescence at 615 nm
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(5D07F2) on excitation 464 nm. The distribution of EGFR on single living cell was
visualized by SERS mapping. These NPs effectively suppressed A549 cell viability upon 808
nm laser irradiation with good biocompatibility.
In chapter 6, silica coated nanoparticles conjugated with anti-human epidermal
growth factor receptor 2 (HER2) antibody were developed to increase surface area, light-heat
conversion efficiency and biocompatibility, applying for fluorescence imaging, SERS
detection and PTT. SERS mapping demonstrated the distribution of HER2 on single living
cell with HER2 expression. These NPs can kill 435 cells upon 808 nm laser irradiation with
better biocompatibility. These NPs have the potential for cancer diagnostics, treatment and
therapy.
In chapter 7, a three-dimensional TiO2 NTs with or without Au substrate was
synthesized for trophoblast-derived stem-like cell growth. The cell vibiality, morphology and
biochemical changes were analyzed.

8.2 FUTURE DIRECTIONS
8.2.1 AFM/RM system combined with traditional biological methods to characterize
cells
The biophysical and biochemical changes were detected in this dissertation by
AFM/RM system in a non-invasive way, demonstrating the advantage of AFM/RM system
for single living cell biomechanics and biopolymers characterization. AFM/RM system, as a
novel technique, should be complementary with the conventional biological approaches (e. g.
western blot, PCR, flow cytometry) to provide additional cell information for us to analyze.
For example, AFM measures the biophysical properties (topography, Young’s modulus,
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adhesion force) of single living cell. Cellular biomechanics should also be measured in a
large-scale way to make the AFM results more conclusive, although large-scale measurement
of living cells biomechanics is not available currently. Alternatively, cytoskeleton can be
recorded by fluorescence imaging, and cellular biophysical information collected from AFM
and fluorescence imaging can be compared, even cells will be fixed first before fluorescence
imaging. Darling et al. have applied AFM to detect the elastic and viscoelastic properties of
undifferentiated adipose-derived stem cells (ASCs), combining with the detection of lineagespecific metabolite production to purify tissue-specific cells for cell-based regenerative
therapies [1].
RM can record the biochemical information of single living cell without any label by
characteristic Raman peak collection. Traditional methods, like flow cytometry or qPCR
were incorporated to detect the cell responses or genetic changes, trying to find the
connection between cellular biocomponent changes and cellular responses. Turner et al. have
found that undifferentiated human embryonic stem cells possess higher Raman intensities of
nucleic acids than differentiated cells; conversely, differentiated cells have more proteinrelated Raman intensities than undifferentiated cells [2]. These differences were associated
with the cellular biopolymers changes that specifically overlapped with collagen, proline and
hydroxyproline, consistent with Col1a1 gene downregulation in stem cells [3].
In summary, AFM/RM system has the advantage of single living mammalian cell
detection, providing additional information for further characterization of biological systems
compared with traditional biological techniques. Therefore, AFM/RM system combining
conventional biological techniques is still a future research direction.
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8.2.2 Application of hybrid nanoparticles with good biocompatibility
In chapter 5 and chapter 6, our laboratory developed two hybrid nanoparticles
conjugated with two different antibodies (CaMoO4:Eu@Au conjugated with EGFR
antibodies and Silica coated CaMoO4:Eu@GNR conjugated with HER2 antibodies). These
hybrid nanoparticles can be applied to locate the distribution of these receptors at single
living cell level by RM because of the surface plasmon resonance effect from metallic
nanoparticles (GNR).
One future direction in this part is multiplex imaging. By modifying these hybrid
nanoparticles with different antibodies, we can measure the interaction between receptors on
single living cells. For example, one ongoing project in our laboratory is to apply multiplex
SERS detection to track two receptors (GPR120 and CD36) and their interaction because
these two receptors play a critical role in the chemoreception of fatty acids, which is
important to the research area of obesity therapy.
Another future direction is nanoparticle based therapy (e. g. photothermal therapy
(PTT); photodynamic therapy (PDT); drug delivery and controlled release). The hybrid
nanoparticles of chapter 4 and chapter 5 were applied for PTT after confirming the specific
targeting of cancer cells. By external laser irradiation, the temperature of hybrid
nanoparticles rapidly increases, suppressing the viability of cancer cells by hyperthermia.
Similarly, the PDT effect of selectively killing diseased cells comes from the photosensitizer
to produce reactive oxygen species (ROS) by an appropriate light source irradiation.
Application of hybrid nanoparticles in this area can increase PDT efficiency due to the
surface area increase. PTT and PDT can be combined to more effectively kill diseased cells
due to the synergistic effect. Additional, drug molecules can be loaded into a porous
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nanostructure as a carrier for deliver and controlled release. By nanostructure modification,
the drug molecule can be released at target environment (e. g. cancer thrives in an acidic
environment).
These nanostructures must be biocompatible for the human body before the above
applications. So far, we tested the effect of hybrid nanoparticles on cell viability, apoptosis,
cell cycle and ROS level in vitro. To apply these hybrid nanoparticles in vivo, we need to
conduct more experiments (e.g. white blood cell count; distribution and stability of
nanoparticles in body, retention time) in the future.
8.2.3 Fate control of stem-like cell by substrate modification
In chapter 7, three-dimensional TiO2 nanotubes with or without Au substrates were
synthesized for trophoblast-derived stem-like cell growth. One future research in this
direction is to find the potential correlations between structure, function and mechanisms of
cells interacting with nano-interfaces. Previous studies have reported that the size of TiO2
nanotubes can affect the differentiation, proliferation and migration of stem cells [4].
However, few literature reported about the biochemical and genetic changes of stem cells
grown on these nanostructures, and that is the direction we are planning to do in the future.
Another future research on TiO2 nanotubes is to load growth factor or molecules into
the nanotubes to direct the growth of trophoblast-derive stem-like cells growth. It is reported
that TiO2 nanotubes can integrate polymer micelles as drug nanocarriers to load more poorly
water soluble drugs [5], which opens the door for the application of controlling the
development of stem cells by modifying the surface of nanotubes with different molecules.

219

In summary, the future direction is the fate control of trophoblast-derive stem-like
cells by modifying the size of three-dimentional TiO2 nanotubes, coating chemicals or
loading molecules into nanotubes.
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